WO2016050208A1 - Substance d'origine biologique modifiée par un dérivé du polyéthylèneglycol multifonctionnalisé - Google Patents

Substance d'origine biologique modifiée par un dérivé du polyéthylèneglycol multifonctionnalisé Download PDF

Info

Publication number
WO2016050208A1
WO2016050208A1 PCT/CN2015/091176 CN2015091176W WO2016050208A1 WO 2016050208 A1 WO2016050208 A1 WO 2016050208A1 CN 2015091176 W CN2015091176 W CN 2015091176W WO 2016050208 A1 WO2016050208 A1 WO 2016050208A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
acid
polyethylene glycol
independently
atom
Prior art date
Application number
PCT/CN2015/091176
Other languages
English (en)
Chinese (zh)
Inventor
翁文桂
刘超
闫策
周纯
Original Assignee
厦门赛诺邦格生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201410523242.9A external-priority patent/CN104530413B/zh
Priority claimed from CN201510349134.9A external-priority patent/CN104877127B/zh
Application filed by 厦门赛诺邦格生物科技有限公司 filed Critical 厦门赛诺邦格生物科技有限公司
Publication of WO2016050208A1 publication Critical patent/WO2016050208A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/06—Cyclic ethers having no atoms other than carbon and hydrogen outside the ring
    • C08G65/08—Saturated oxiranes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/321—Polymers modified by chemical after-treatment with inorganic compounds
    • C08G65/323—Polymers modified by chemical after-treatment with inorganic compounds containing halogens
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur

Definitions

  • the invention relates to the field of polymer synthesis and biochemical modification, in particular to a bio-related substance modified by a polyfunctional polyethylene glycol derivative.
  • PEGylation is one of the important means of drug modification.
  • functionalized polyethylene glycol can utilize the reactive groups it contains with drug molecules (including protein drugs and small organic drugs), peptides, carbohydrates, lipids, oligonucleotides, affinity Coupling of covalent bonds by bodies, cofactors, liposomes, and biological materials enables the modification of polyethylene glycols for drugs and other biologically relevant substances.
  • the modified drug molecule will possess many of the superior properties of polyethylene glycol (eg, hydrophilicity, flexibility, anticoagulant, etc.).
  • the polyethylene glycol modified drug avoids glomerular filtration and biological reactions such as immune response, which has a longer half-life in the blood than unmodified drugs.
  • Greenwald et al. J. Org. Chem. 1995, 331-336
  • Branched polyethylene glycol with two polyethylene glycol arms represented by this traditional V-shaped structure only a single reactive group can react with drug molecules, and the drug loading is low, and the application range is very limited. .
  • the reactive group is located in the center of the two polyethylene glycol arms, the active group is embedded in the polyethylene glycol chain, resulting in a modification efficiency when the drug molecule is modified.
  • the binding site may be attached to the active site or active site of the drug, or a steric effect is introduced, the drug activity after PEGylation is often caused. Falling or even disappearing.
  • the drug molecule in the case of conventional administration, such as injection, oral administration, etc., in addition to acting on the lesion site, the drug molecule usually accumulates in normal tissues, causing certain or even serious side effects.
  • the PEGylation modification can greatly reduce the side effects, for some drugs, especially anticancer drugs, the biosafety requirements cannot be met by the existing polyethylene glycol modification.
  • An object of the present invention is to provide a bio-related substance modified with a polyfunctionalized H-type polyethylene glycol derivative in order to overcome the deficiencies of the prior art.
  • the present invention discloses a bio-related substance modified with a polyfunctionalized H-type polyethylene glycol derivative.
  • the bio-related substance modified by the polyfunctionalized H-type polyethylene glycol derivative is a stable structure formed by combining a polyfunctionalized H-type polyethylene glycol derivative represented by the general formula (1) with a biologically relevant substance. .
  • the H-type structure consists of a linear PEG spindle and four PEG branching chains, and the total number of oxidized vinyl units of the linear PEG spindle and the four PEG branch chains does not exceed 5000.
  • LPEG is a linear spindle structure
  • LPEG is a monoblock, diblock, triblock or 4 to 150 block segment composed of polyethylene glycol or polyethylene glycol
  • number of oxyethylene units in LPEG The sum is an integer from 2 to 2,000.
  • n 1 , n 2 , n 3 , and n 4 are the polymerization degrees of the four PEG branched chains, respectively, each independently satisfying 2 to 2000, and may be the same or different from each other in the same molecule.
  • the four PEG branched chains corresponding to LPEG and n 1 , n 2 , n 3 , and n 4 are each independently polydisperse or monodisperse.
  • U 1 and U 2 are each a trivalent branched group linking LPEG and two PEG branching chains;
  • the structure of U 1 is The structure of U 2 is U 01 and U 02 are each independently a trivalent group.
  • L 1 , L 2 , L 3 , and L 4 are respectively a linking group of a polyethylene glycol unit in which the number of oxyethylene units is n 1 , n 2 , n 3 , and n 4 , and L 5 and L 6 are connected linear spindles.
  • the linking group of the polyethylene glycol unit, L 1 , L 2 , L 3 , L 4 , L 5 , L 6 are each independently present or absent, and may be the same or different from each other in the same molecule.
  • F 1 and F 2 contain a functional group or a protected form thereof, and in the same molecule, F 1 and F 2 may be the same or different from each other.
  • F 1 and F 2 are each independently expressed as
  • LPEG In the same molecule, LPEG, U 1 , U 2 , U 01 , U 02 , L 1 , L 2 , L 3 , L 4 , L 5 , L 6 , L 0 (F 1 ), G(F 1 ), Z Any one or any of 1 (F 1 ), Z 2 (F 1 ), L 0 (F 2 ), G(F 2 ), Z 1 (F 2 ), Z 2 (F 2 ) and adjacent heteroatoms
  • the linker formed by the group can be stably present or degradable.
  • the bio-related substance modified by the polyfunctionalized H-type polyethylene glycol derivative contains at least one bio-related substance molecule.
  • the type of the bio-related substance to be combined is one or two.
  • the manner in which the polyfunctionalized H-type polyethylene glycol derivative is combined with a biologically relevant substance is a covalently linked or non-covalently linked means.
  • the manner in which any of the functional groups or protected functional groups of the polyfunctionalized H-type polyethylene glycol derivative and the biologically relevant substance are independently stabilized or degradable. Wherein the functional group modified by the polyfunctionalized H-type polyethylene glycol derivative or the protected form thereof may participate in the modification of the biologically relevant substance in whole or in part.
  • a functional group or a protected functional group that is not bound to a biologically relevant substance may retain a structural form before the reaction, may also form a deprotected functional group, or may be blocked by a non-biologically related substance.
  • the F 1 modified bio-related substance may be the same as or different from the F 2 modified bio-related substance.
  • F 1 or F 2 When F 1 or F 2 is combined with a biologically relevant substance, they are each independently expressed as In the same molecule, they may be the same or different from each other; wherein D is a residue formed by reacting a modified bio-related substance with a polyfunctionalized H-type polyethylene glycol; and L is a polyfunctionalized H-type polyethylene glycol derivative a linking group formed by reacting a functional group or a protected form thereof with a biologically relevant substance; any one of L may be stably present or degradable independently, and a linking group of L and an adjacent hetero atom group may be stably present Or degradable; wherein E 01 is R 01 , protected R 01 , deprotected R 01 or blocked R 01 ; wherein k 0 is a site in F 1 or F 2 that reacts with a biologically relevant substance The number of k 0 is an integer from 1 to k.
  • the present invention has the following beneficial effects:
  • H-type structure design by adjusting the length of the linear spindle, the distance between the branches on both sides can be adjusted. In the case of a certain overall molecular weight, the length of the main axis and each branch can be separately adjusted, so that the polyethylene glycol modified product It has adjustable, easy-to-control, optimizable pharmacokinetics and tissue distribution properties to improve drug efficacy and reduce side effects.
  • One or more drug molecules can be linked at the end of the polyethylene glycol branching chain, and have a high drug loading amount.
  • the structure may contain a degradable group, which allows the steric effect to be weakened by the modification of the product to a low molecular weight product under the stimulation of enzyme, light, temperature, acidity, alkalinity, redox, etc., or by the modified organism.
  • the detachment of the substance from the polyethylene glycol results in a highly active drug molecule; it also improves the pharmacokinetics or tissue distribution.
  • the end of the polyethylene glycol chain of the unmodified bio-related substance can be replaced with a hydroxy end group instead of the conventional methoxy group, thereby reducing the immunogenicity of the modified drug.
  • hydrocarbon means a hydrocarbon composed of a carbon atom and a hydrogen atom.
  • the hydrocarbons in the present invention are classified into aliphatic hydrocarbons and aromatic hydrocarbons.
  • a hydrocarbon having no structure of any one of a benzene ring and a hydrocarbyl-substituted benzene ring is defined as an aliphatic hydrocarbon.
  • a hydrocarbon containing at least one benzene ring or a hydrocarbyl-substituted benzene ring is defined as an aromatic hydrocarbon.
  • the aromatic hydrocarbon may have an aliphatic hydrocarbon group structure such as toluene, diphenylmethane, 2,3-dihydroanthracene or the like.
  • Hydrocarbons are classified into two types: saturated hydrocarbons and unsaturated hydrocarbons. All aromatic hydrocarbons are unsaturated hydrocarbons. Saturated aliphatic hydrocarbons are also known as alkanes. The degree of unsaturation of the unsaturated aliphatic hydrocarbon is not particularly limited. By way of example, and not limited to, olefins (including double bonds), alkynes (including triple bonds), diolefins (containing two conjugated double bonds), and the like. When the aliphatic hydrocarbon moiety in the aromatic hydrocarbon is a saturated structure, it is also called an aralkyl hydrocarbon such as toluene.
  • the structure of the hydrocarbon is not particularly limited and may be a linear structure having no pendant group, a branched structure containing a side group, a ring-containing structure, a dendritic structure, a comb structure, a hyperbranched structure or the like.
  • a linear structure having no pendant group, a branched structure containing a pendant group, and a cyclic containing structure are preferable, and each corresponds to a linear hydrocarbon, a branched hydrocarbon, or a cyclic hydrocarbon.
  • the hydrocarbons having no cyclic structure are collectively referred to as open-chain hydrocarbons, including but not limited to linear structures having no pendant groups and branched structures having pendant groups.
  • Open chain hydrocarbons are aliphatic hydrocarbons. Therefore, linear hydrocarbons can also be linear aliphatic hydrocarbons. Branched hydrocarbons can also be branched aliphatic hydrocarbons.
  • the ring structure in the present invention is not particularly limited as long as there is at least one closed loop that is connected end to end.
  • the ring-forming atoms together form a ring skeleton.
  • Hydrocarbons containing a cyclic structure are referred to as cyclic hydrocarbons, and corresponding cyclic structures are carbocyclic rings, all composed of carbon atoms. Cyclic hydrocarbons are classified into alicyclic hydrocarbons and aromatic hydrocarbons.
  • cyclic hydrocarbons are classified into alicyclic hydrocarbons and aromatic hydrocarbons.
  • an aliphatic hydrocarbon having a closed carbocyclic ring is called an alicyclic hydrocarbon, and a corresponding cyclic structure is called an alicyclic ring.
  • Alicyclic hydrocarbons are classified into saturated alicyclic hydrocarbons and unsaturated alicyclic hydrocarbons. Saturated alicyclic hydrocarbons are referred to as cycloalkanes. Unsaturated alicyclic hydrocarbons can also be classified into cyclic olefins, cycloalkynes, cyclic diolefins, and the like, depending on the degree of unsaturation.
  • All aromatic hydrocarbons are cyclic hydrocarbons, contain at least one benzene ring or substituted benzene ring, and may contain no alicyclic ring or alicyclic ring.
  • the aromatic ring in the present invention specifically means a benzene ring or a fused ring formed of two or more benzene rings.
  • the structural unit constituting the ring skeleton is not particularly limited and may or may not contain a nested cyclic structure.
  • a ring skeleton of cyclopentane, cyclohexane, cycloheptane, benzene, furan, pyridine, benzotriazole, anthracene, etc. does not contain a nested cyclic structure, and a cyclodextrin is composed of a plurality of D- The glucopyranose monocyclic rings are connected end to end to form a nested cyclic structure.
  • Non-carbon atoms are defined as heteroatoms.
  • the hetero atom in the present invention is not particularly limited and includes, but not limited to, O, S, N, P, Si, F, Cl, Br, I, B and the like.
  • the cyclic structure containing a hetero atom in a ring-forming atom is referred to as a heterocyclic ring with respect to a carbocyclic ring.
  • the ring-forming atom of the alicyclic ring is replaced by a hetero atom to form a heteroalicyclic ring, and the ring-forming atom of the aromatic ring is replaced by a hetero atom to form a heteroaromatic ring.
  • the heterocycles can be of different types including, but not limited to, oxa, aza, thia, phosphine, and the like.
  • nitrogens such as pyridine, pyran, pyrrole, oxazole, indole, isoindole, pyrimidine, imidazole, indole, pyrazole, pyrazine, pyridazine, oxazole, quinazoline, triazole, tetra Azaindole and the like.
  • oxa group examples include, for example, ethylene oxide, furan, tetrahydrofuran, pyran, tetrahydropyran, dioxane, ethylene oxide and the like.
  • thia such as thiophene and the like.
  • the number of hetero atoms is not particularly limited and may be one or more, such as furan, tetrahydrofuran, pyridine, pyran, pyrrole, tetrahydropyran, carbazole, anthracene, isoindole, etc. containing one hetero atom, including two a hetero atom of pyrimidine, isoxazole, imidazole, pyrazole, pyrazine, pyridazine, thiazole, isothiazole, oxazole, quinazoline, etc., triazole containing three heteroatoms, s-triazine, including four A heteroatom of tetraazaindene, anthracene, etc.
  • the types of the hetero atoms may be the same or different.
  • Examples of the same hetero atom include, but are not limited to, the above-described aza, oxa, thia, and the like.
  • hetero atoms examples include nitroxides such as oxazole, isoxazole, oxirane, etc., nitrogen thia compounds such as thiazole, isothiazole and the like.
  • the position of the hetero atom is not particularly limited and may be located on the same ring, such as benzotriazole, or may be located on a different ring, such as ruthenium. Can be located on the side of the shared ring, such as
  • cyclic structures in one molecule there is no particular limitation on the number of cyclic structures in one molecule. When there is only one closed cyclic structure, it is defined as a monocyclic compound. When having at least two cyclic structures, if any ring shares at least one atom with the ring, it is called a polycyclic compound.
  • the number of rings by way of example, it can be divided into, for example, bicyclo (norbornene, naphthalene, anthracene, isoindole, carbazole, benzotriazole, benzopyran, benzothiophene, quinolinazole), three Rings (such as adamantane, anthracene, phenanthrene, anthracene), four rings (such as ruthenium) and so on.
  • bicyclo norbornene, naphthalene, anthracene, isoindole, carbazole, benzotriazole, benzopyran, benzothiophene, quinolinazole
  • three Rings such as adamantane, anthracene, phenanthrene, anthracene
  • four rings such as ruthenium
  • the manner of connection between two or more annular structures in the plurality of rings is not particularly limited.
  • a spiro ring is formed; when the two rings pass through a common ring edge (ie, sharing two adjacent skeleton atoms), a fused ring such as a hydrazine or a benzoheterocyclic ring is formed;
  • a bridged ring such as norbornene or adamantane is formed.
  • biphenyl has two benzene rings, but does not belong to a polycyclic structure because it does not share any atoms.
  • Atoms that are shared can be shared by two or more rings at the same time, such as ⁇ .
  • Any two linked rings in the polycyclic ring may each independently be an alicyclic or heteroalicyclic ring, or may each independently be an aromatic ring or a heteroaromatic ring, or may be independently an alicyclic ring, an aromatic ring or a heteroalicyclic ring. Or a heterocyclic ring.
  • the hybridized monocyclic ring is referred to as a heteromonocyclic ring or a monoheterocyclic ring such as furan, tetrahydrofuran, pyridine, pyran, dioxane, cyclic glucose isomers and the like.
  • the hybridized polycyclic ring is called a heteropolycyclic ring, and according to the difference of the polycyclic structure, including a heterospiro ring, a heterobridge ring, and a heterocyclic ring, respectively, a spiro ring, a bridge ring, and a fused ring in which a ring atom is replaced by a hetero atom. .
  • fused rings it is divided into a fused aromatic ring and a fused heterocyclic ring.
  • the fused aromatic ring is composed of two or more benzene rings.
  • a heterocyclic ring that is, a fused ring containing a hetero ring, which is also called a fused heterocyclic ring, is classified into an aromatic fused heterocyclic ring and a hetero fused heterocyclic ring.
  • the aromatic fused heterocyclic ring is also called an arylheterocyclic ring, and is fused by an aromatic ring and a heterocyclic ring, and is typically represented by a benzoheterocyclic ring such as benzotriazole.
  • the heterocyclic heterocyclic ring is formed by condensing a heterocyclic ring and a heterocyclic ring.
  • the hybrid fused aromatic ring corresponds to a hetero-fused aromatic ring.
  • the hydrocarbon-derived ring includes, but is not limited to, an alicyclic ring, an aromatic ring, a monocyclic ring, a polycyclic ring, a spiro ring, a bridged ring, a fused ring, a fused aromatic ring, a fused heterocyclic ring, an aromatic fused heterocyclic ring, and an aromatic heterocyclic ring.
  • cyclic hydrocarbons For cyclic hydrocarbons, it is divided into monocyclic hydrocarbons and polycyclic hydrocarbons. Among them, monocyclic hydrocarbons such as cyclobutane, cyclopentane, cyclohexane, benzene, etc., polycyclic hydrocarbons such as hydrazine, hydrazine, and the like. Polycyclic hydrocarbons are classified into spirocyclic hydrocarbons, bridged cyclic hydrocarbons, and fused cyclic hydrocarbons.
  • any two of the linked rings may be alicyclic, such as norbornene, or both benzene rings, such as naphthalene, anthracene, anthracene, phenanthrene, or any of an alicyclic ring and a benzene ring.
  • Combination such as 2,3-dihydroanthracene.
  • a fused ring hydrocarbon composed of two or more benzene rings is called a condensed aromatic hydrocarbon.
  • cyclic hydrocarbons can also be classified into saturated cyclic hydrocarbons and unsaturated cyclic hydrocarbons.
  • saturated cyclic hydrocarbons are cycloalkanes.
  • Unsaturated cyclic hydrocarbons are classified into unsaturated alicyclic hydrocarbons and aromatic hydrocarbons.
  • a compound in which a carbon atom at any position in a hydrocarbon is substituted with a hetero atom is collectively referred to as a hetero hydrocarbon.
  • Heterocarbons are classified into aliphatic hydrocarbons and aromatic hydrocarbons depending on the source of the hydrocarbon.
  • the aliphatic hydrocarbon refers to a hetero hydrocarbon derived from an aliphatic hydrocarbon, including an aliphatic heterocyclic hydrocarbon and an aliphatic open chain hydrocarbon.
  • the saturated aliphatic hydrocarbon is a heteroalkane.
  • Aromatic hydrocarbon refers to a hydrocarbon derived from an aromatic hydrocarbon, including but not limited to a heteroaromatic hydrocarbon, a viscous hydrocarbon.
  • the fused heterocyclic hydrocarbon refers to a fused ring hydrocarbon in which a ring atom is replaced by a hetero atom, and is classified into an aromatic fused heterocyclic hydrocarbon, a hetero fused heterocyclic hydrocarbon or the like.
  • the hybrid aralkyl hydrocarbon is a heteroaromatic hydrocarbon.
  • heterocyclic hydrocarbon When a heterocyclic hydrocarbon does not contain a cyclic structure, it is collectively referred to as an open chain hetero hydrocarbon. All open chain heterones are aliphatic hydrocarbons.
  • heterocyclic hydrocarbons When a ring-forming carbon atom in a cyclic hydrocarbon is replaced by a hetero atom, the heterocyclic ring formed is referred to as a heterocyclic hydrocarbon. Heterocyclic hydrocarbons are further classified into aliphatic heteroatoms and aromatic hydrocarbons depending on the source of the cyclic hydrocarbon.
  • the heteroheterocyclic hydrocarbon refers to a heterocyclic hydrocarbon derived from an alicyclic hydrocarbon such as 1,4-oxetane or 1,4-dioxane.
  • the heteroatom of the aromatic hydrocarbon may be located on an aromatic ring in the aromatic hydrocarbon, also known as a heteroaromatic hydrocarbon such as pyridine, pyrimidine.
  • the fused heterocycles are all heterocyclic hydrocarbons including, but not limited to, aromatic fused heterocyclic hydrocarbons (such as benzotriazole, etc.), hetero-fused heterocyclic hydrocarbons, and the like.
  • a "group” in the present invention contains at least two atoms, meaning that the compound loses free radicals formed by one or more atoms.
  • the group formed after the partial group is lost relative to the compound is also referred to as a residue.
  • the valence state of the group is not particularly limited, and may be, for example, a monovalent group, a divalent group, a trivalent group, a tetravalent group, ..., a one hundred valent group or the like.
  • groups having a valence of 2 or more are collectively referred to as a linking group.
  • the linker may also contain only one atom, such as an oxy group or a thio group.
  • Hydrocarbon refers to a residue formed after a hydrocarbon loses at least one hydrogen atom. According to the amount of hydrogen lost, it can be divided into a monovalent hydrocarbon group (loss of one hydrogen atom), a divalent hydrocarbon group (loss of two hydrogen atoms, also called an alkylene group), a trivalent hydrocarbon group (loss of three hydrogen atoms), etc.
  • n hydrogen atoms when n hydrogen atoms are lost, the valence state of the hydrocarbon group formed is n.
  • the hydrocarbon group in the present invention is specifically a monovalent hydrocarbon group unless otherwise specified.
  • hydrocarbons aliphatic hydrocarbons, aromatic hydrocarbons, aromatic hydrocarbons, saturated hydrocarbons, alkanes, unsaturated hydrocarbons, olefins, alkynes, diolefins, open chain hydrocarbons, linear hydrocarbons (linear aliphatic hydrocarbons), branched hydrocarbons (branched aliphatic hydrocarbons) ), cyclic hydrocarbons, alicyclic hydrocarbons, cycloalkanes, unsaturated alicyclic hydrocarbons, cyclic olefins, cycloalkynes, cyclic diolefins, monocyclic hydrocarbons, polycyclic hydrocarbons, spirocyclic hydrocarbons, bridged cyclic hydrocarbons, fused cyclic hydrocarbons, thick One of an aromatic hydrocarbon, a hetero hydrocarbon, a fatty hydrocarbon, an open chain hetero hydrocarbon, a heterocyclic hydrocarbon, an aliphatic heterocyclic hydrocarbon, an aromatic hydrocarbon,
  • a hydrocarbon a substituted olefin, a substituted alkyne, a substituted diolefin, a substituted open chain hydrocarbon, a substituted linear hydrocarbon (substituted linear aliphatic hydrocarbon), a substituted branched hydrocarbon (substituted branched aliphatic hydrocarbon), Substituted cyclic hydrocarbons, substituted alicyclic hydrocarbons, substituted cycloalkanes, substituted unsaturated alicyclic hydrocarbons, substituted cyclic olefins, substitutions a cycloalkyne, a substituted cyclodiene, a substituted monocyclic hydrocarbon, a substituted polycyclic hydrocarbon, a substituted spirocyclic hydrocarbon, a substituted bridged cyclic hydrocarbon, a substituted fused cyclic hydrocarbon, a substituted fused aromatic hydrocarbon, a substituted heterohydrocarbon, Substituted aliphatic hydrocarbon
  • the hetero atom is not particularly limited, and a halogen atom is preferred.
  • the substituent is not particularly limited and may be selected from a hydrocarbon group substituent or a hetero atom-containing group.
  • the substituent in the present invention may contain a hetero atom or may not contain a hetero atom, unless otherwise specified.
  • two hydrogen atoms in the secondary carbon may be independently substituted by two identical or different heteroatoms or monovalent hydrocarbon groups, such as -C(CH 3 ) 2 -, -CH(OCH 3 ) 2 -, - CF(OCH 3 ) 2 -; can also be substituted by a cyclic structure at the same time, such as It may also be substituted by only the same hetero atom to form a group including, but not limited to, a carbonyl group, a thiocarbonyl group, an imino group, etc., such as adenine, guanine, cytosine, uracil, thymine, N, N-di Methyl guanine, 1-methylguanine, hypoxanthine, 1-methyl hypoxanthine, and the like.
  • two identical or different heteroatoms or monovalent hydrocarbon groups such as -C(CH 3 ) 2 -, -CH(OCH 3 ) 2 -, - CF(OC
  • the hydrocarbon formed is also a branched hydrocarbon, and the monovalent hydrocarbon group exists as a pendant group.
  • hydrocarbons aliphatic hydrocarbons, aromatic hydrocarbons, aromatic hydrocarbons, saturated hydrocarbons, alkanes, unsaturated hydrocarbons, olefins, alkynes, diolefins, open chain hydrocarbons, linear hydrocarbons, branched hydrocarbons, cyclic hydrocarbons, alicyclic hydrocarbons, rings Alkanes, unsaturated alicyclic hydrocarbons, monocyclic hydrocarbons, polycyclic hydrocarbons, hetero hydrocarbons, aliphatic hydrocarbons, heteroalkanes, open chain hetero hydrocarbons, heterocyclic hydrocarbons, aliphatic heterocyclocarbons, aromatic hydrocarbons, heteroaromatic hydrocarbons, heteroaromatic hydrocarbons Any one of a condensed hydrocarbon, a condensed aromatic hydrocarbon, a fused heterocyclic hydrocarbon, an aromatic fused heterocyclic hydrocarbon, a hetero fused heterocyclic hydrocarbon, or the like, which may be obtained, but not limited to, a hydrocarbons,
  • Base saturated hydrocarbon group, alkyl group, unsaturated hydrocarbon group, alkenyl group, alkynyl group, dienyl group, alkene group, alkyne group, diolefin group, open chain hydrocarbon group, linear hydrocarbon group, branched hydrocarbon group, cyclic hydrocarbon group, alicyclic hydrocarbon group , cycloalkane group, unsaturated alicyclic hydrocarbon group, monocyclic hydrocarbon group, polycyclic hydrocarbon group, fused ring hydrocarbon group, fused aryl group, hetero hydrocarbon group, heterocyclic hydrocarbon group, aliphatic hydrocarbon group, heteroalkyl group, open chain hetero hydrocarbon group, heteroalicyclic group Hydrocarbyl, arylheteroalkyl, heteroarylalkyl, heteroaryl, heteroaryl, fused cycloalkyl, fused aryl, fused heterocycloalkyl, aromatic Any of a hydrocarbon heterocycloalkyl, heterocycloalkyl fused heteroaryl
  • the substituent containing no hetero atom is a hydrocarbon group.
  • a hydrocarbon group Including but not limited to aliphatic hydrocarbon groups, aryl groups, aromatic hydrocarbon groups, aralkyl groups, saturated hydrocarbon groups, alkyl groups, unsaturated hydrocarbon groups, alkenyl groups, alkynyl groups, dienyl groups, alkene groups, alkyne groups, diolefin groups, open chain hydrocarbon groups , a straight-chain hydrocarbon (linear aliphatic hydrocarbon group), a branched hydrocarbon (branched aliphatic hydrocarbon group), a cyclic hydrocarbon group, an alicyclic hydrocarbon group, a cycloalkane group, an unsaturated alicyclic hydrocarbon group, a monocyclic hydrocarbon group, a polycyclic hydrocarbon group, a condensed hydrocarbon group, Any of the thick aryl groups.
  • hydrocarbyl groups include, but are not limited to, methyl, ethyl, vinyl, propyl, allyl, propenyl, propargyl, propynyl, isopropyl, butyl, t-butyl, pentyl, g.
  • a hydrocarbyloxy group, a hydrocarbylthio group, an acyl group, an acyloxy group, a hydrocarbyloxyacyl group, an aminoacyl group, an acylamino group or the like is sequentially formed.
  • the acyl group in the present invention includes a carbonyl group and a non-carbonyl group, and includes, by way of example only, but not limited to, a carbonyl group, a sulfonyl group, a sulfinyl group, a phosphoryl group, a phosphorous group, a hypophosphoryl group, a nitroxyl group, a nitrosyl group, and a thio group.
  • the acyl group refers specifically to a carbonyl group unless otherwise specified.
  • a hydrocarbyloxy group for example, an alkoxy group formed by an alkyl group and an oxy group (e.g., a methoxy group, an ethoxy group, a t-butoxy group, etc.), an aryloxy group formed by an aromatic ring and an oxy group (e.g., a phenoxy group, etc.)
  • An aryl-substituted aromatic hydrocarbon group (such as a benzyloxy group) formed by linking an aromatic hydrocarbon group and an oxy group, an alkenyl group formed by an alkenyl group and an oxy group, an alkynyl group formed by an alkynyl group and an oxy group, and the like .
  • a hydrocarbylthio group for example, an alkylthio group, an arylthio group, an aromatic alkylthio group, an alkenethio group, an alkynethio group or the like.
  • the acyloxy group also referred to as an acyloxy group, corresponds to the above acyl group, and includes a sulfonyloxy group, a sulfinyloxy group and the like in addition to the carbonyloxy group, and the description thereof will not be repeated.
  • the oxyacyl group corresponds to the above acyl group, and includes an oxysulfonyl group in addition to the oxycarboyl group, and corresponds to the type of the acyl group, and the description thereof will not be repeated.
  • the aminoacyl group and the acylamino group include, in addition to the aminocarbonyl group and the carbonylamino group, a sulfamoyl group or a sulfonylamino group, respectively, and correspond to the type of the acyl group, and the description thereof will not be repeated.
  • the above substituted hydrocarbyl group includes both a hydrocarbyl-substituted hydrocarbyl group (still belonging to a hydrocarbyl group) and a heterohydrocarbyl-substituted hydrocarbyl group (which belongs to a heterohydrocarbyl group).
  • the heterohydrocarbyl group is classified into a fatty hydrocarbon group and an aromatic hydrocarbon group depending on the source.
  • the heterohydrocarbyl group includes, but is not limited to, an open-chain heterohydrocarbyl group, a heterocycloalkyl group, a heterocyclic-substituted hydrocarbyl group.
  • the aliphatic hydrocarbon group includes an open-chain heteroalkyl group and an aliphatic heterocyclic hydrocarbon group.
  • the aromatic hydrocarbon group includes, but is not limited to, a heteroaryl group, a heteroaryl hydrocarbon group, an aromatic fused heterocyclic hydrocarbon group, and the like.
  • Heterocycloalkyl groups include, but are not limited to, an aliphatic heterocycloalkyl group and an aromatic heterohydrocarbyl group.
  • a compound for a compound, a group or an atom, it may be substituted and hybridized at the same time, for example, a nitrophenyl group is substituted for a hydrogen atom, and a -CH 2 -CH 2 -CH 2 - is replaced by -CH 2 -S- CH(CH 3 )-.
  • the hydrocarbon group formed by the aliphatic hydrocarbon is an aliphatic hydrocarbon group.
  • the hydrocarbon group formed by an alkane is referred to as an alkyl group.
  • the hydrocarbon group formed by the loss of a hydrogen atom by an unsaturated hydrocarbon is an unsaturated hydrocarbon group.
  • the unsaturated hydrocarbon loses a hydrocarbon group formed by a hydrogen atom on the unsaturated carbon, and may be classified into an alkenyl group, an alkynyl group, a dienyl group or the like, and examples thereof include a propenyl group and a propynyl group.
  • the hydrocarbon group formed by the unsaturated hydrocarbon losing the hydrogen atom on the saturated carbon may be, for example, an olefin group, an alkyne group, a diolefin group or the like depending on the unsaturated bond, specifically, an allyl group, a propargyl group.
  • the open chain hydrocarbon group is an alkyl group in which an open chain hydrocarbon loses a hydrogen atom.
  • the linear hydrocarbon loses one hydrogen atom on the primary carbon to form a linear hydrocarbon group
  • the linear hydrocarbon loses the hydrogen atom on the secondary or tertiary carbon to form a branched hydrocarbon group
  • the branched hydrocarbon loses one hydrogen atom at any position to form a branched hydrocarbon group.
  • a hydrocarbon group formed by a cyclic hydrocarbon losing one hydrogen atom on the ring is referred to as a cyclic hydrocarbon group.
  • the alicyclic hydrocarbon loses one hydrogen atom on the ring to form an alicyclic hydrocarbon group.
  • the hydrocarbon group formed by the aromatic hydrocarbon is classified into an aryl group and an aromatic hydrocarbon group.
  • the aromatic hydrocarbon loses one hydrogen atom on the aromatic ring to form an aryl group.
  • the aromatic hydrocarbon loses a hydrogen atom on the non-aromatic ring to form an aromatic hydrocarbon group.
  • the aralkyl hydrocarbon loses a hydrogen atom on the non-aromatic ring to form an aralkyl group.
  • the aralkyl group belongs to the category of an aromatic hydrocarbon group.
  • the most typical aryl groups are phenyl, phenylene, most typically aromatic hydrocarbon groups such as benzyl.
  • Hydrocarbons lose hydrogen atoms to form heterohydrocarbyl groups.
  • the heteroalkane forms a heteroalkyl group.
  • the aliphatic hydrocarbon loses a hydrogen atom to form a fatty hydrocarbon group.
  • the aromatic hydrocarbon loses a hydrogen atom to form an aromatic hydrocarbon group.
  • the open chain hetero hydrocarbon loses a hydrogen atom to form an open chain heteroalkyl group.
  • the heterocyclic hydrocarbon loses the heterocyclic hydrocarbon group formed by the hydrogen atom on the ring.
  • the alicyclic hydrocarbon loses the hydrogen atom on the alicyclic ring to form an aliphatic heterocycloalkyl group.
  • the aromatic hydrocarbon loses a hydrogen atom on the aromatic ring to form a heteroaryl group, and the aromatic hydrocarbon loses a hydrogen atom on the non-aromatic ring to form a heteroaromatic hydrocarbon group.
  • the heteroaromatic hydrocarbon loses a hydrogen atom on the non-aromatic ring to form a heteroaralkyl group.
  • the fused ring hydrocarbon loses the hydrogen atom on the ring to form a fused ring hydrocarbon group.
  • the fused aromatic hydrocarbon loses the hydrogen atom on the benzene ring to form a fused aryl group.
  • the aromatic fused heterocyclic hydrocarbon loses a hydrogen atom to form an aromatic fused heterocycloalkyl group
  • the hetero fused heterocyclic hydrocarbon loses a hydrogen atom to form a heterocyclic heterocyclic hydrocarbon group.
  • heterohydrocarbyl group in the present invention is not particularly limited.
  • heteroatom-containing aliphatic hydrocarbon groups open chain heterohydrocarbyl groups, aliphatic heterocycloalkyl groups, aromatic heteroalkyl groups, heteroaryl groups, aromatic heteroalkyl groups, aromatic fused heterocycloalkyl groups, hetero fused heterocyclic hydrocarbon groups, oxygen Heterohydrocarbyl, azahydrocarbyl, thiahydrocarbyl, phosphahydrocarbyl, monoheterohydrocarbyl, diheterohydrocarbyl, polyheterohydrocarbyl, and the like.
  • the source of the alkylene group in the present invention is not particularly limited, and may be, for example, derived from an aliphatic hydrocarbon or an aromatic hydrocarbon, or may be derived from a saturated hydrocarbon or an unsaturated hydrocarbon, or may be derived from a linear hydrocarbon, a branched hydrocarbon or a cyclic hydrocarbon, or a source thereof. From hydrocarbons or hydrocarbons and so on.
  • a cyclic hydrocarbon for example, it may be derived from an alicyclic hydrocarbon or an aromatic hydrocarbon, a monocyclic hydrocarbon or a polycyclic hydrocarbon; for a heterocyclic hydrocarbon, for example, From an aliphatic heterocyclic hydrocarbon or an aromatic heterocyclic hydrocarbon.
  • alkylene group formed by an alkane is also called an alkylene group
  • common alkylene groups include, but are not limited to, methylene, 1,2-ethylene, 1,3-propylene, 1,2-propylene, and Propylene, butylene, pentylene, hexylene, heptylene, octylene, fluorene, aa Base and so on.
  • the position of the two hydrogen atoms which are lost is not particularly limited as long as it is not bonded to one carbon atom at the same time.
  • the cyclic structure exists as a substituent of the carbon atom.
  • An alicyclic hydrocarbon loses two hydrogen atoms on the same ring to form an alicyclic hydrocarbon group, such as Wait.
  • An aromatic hydrocarbon loses two hydrogen atoms on the same aromatic ring to form an arylene group, such as p-phenylene in phenylene Benzene O-phenylene
  • an aromatic hydrocarbon group such as Wait.
  • An example of a cyclic structure as a substituent is as Wait.
  • the alkylene group may or may not contain a substituent or a pendant group, including but not limited to a linear chain.
  • Branch chain eg
  • a ring structure such as ).
  • the two positions of the alkylene group to which other groups are bonded are not particularly limited, and for example, the phenylene group may include p-phenylene, o-phenylene, and m-phenylene, and for example, the propylene group may include 1,3-arylene. Propyl, 1,3-propylene, 1,2-propylene, isopropylidene, and the like.
  • fused ring structure in addition to the cyclic structure exemplified above, it may also be, for example, phthalimide, phthaloyl hydrazide, phthalic anhydride,
  • the protecting group (for example, a mercapto protecting group, an alkynyl protecting group, a hydroxy protecting group, an amino protecting group, and the like) in the present invention is not particularly limited.
  • the above-mentioned protecting groups in the published patents and documents can be incorporated into the present invention by reference.
  • the hydroxyl group protected by the hydroxy protecting group is not particularly limited, and may be, for example, a hydroxyl group such as an alcoholic hydroxyl group or a phenolic hydroxyl group.
  • the amino group protecting the amino group is not particularly limited, and may be, for example, a primary amine, a secondary amine, a hydrazine, an amide or the like.
  • the amino group in the present invention is not particularly limited and includes, but not limited to, a primary amino group, a secondary amino group, and a tertiary amino group.
  • the range of the number of carbon atoms in the group is also indicated in the subscript position of C, indicating the number of carbon atoms of the group, for example, C 1-10 means “having 1 to 10 The carbon atom", C 3-20 means “having 3 to 20 carbon atoms”.
  • the "substituted C 3-20 hydrocarbon group” means a compound obtained by substituting a hydrogen atom of a C 3-20 hydrocarbon group.
  • the "C 3-20 substituted hydrocarbon group” means a compound having a hydrogen atom of a hydrocarbon group substituted with 3 to 20 carbon atoms.
  • the divalent linking group in the present invention for example, an alkylene group, an alkylene group, an arylene group, an amide bond or the like, is not particularly limited, and any one of the two linking ends may be selected when it is bonded to another group, for example.
  • the structure involved has an isomer, it may be any one of them unless otherwise specified.
  • the structure in which a cis-trans isomer exists it may be either a cis structure or a trans structure.
  • the alkyl group is not particularly specified, it means a hydrocarbon group formed by losing a hydrogen atom at any position.
  • propyl refers to any of n-propyl and isopropyl
  • propylene refers to any of 1,3-propylene, 1,2-propylene, and isopropylidene.
  • a dotted line is used for the structural formula of some skeleton groups to indicate that the skeleton is specified.
  • the groups shown in the structural formula are directly linked.
  • the ring structure is represented by a circle, and is marked differently depending on the ring structure.
  • An aromatic ring structure having at least one aromatic ring or heteroaryl ring also called an aromatic ring;
  • a skeleton representing a sugar or a saccharide derivative having a cyclic monosaccharide skeleton also referred to as a sugar ring;
  • a ring representing a chemical bond such as an amide bond, an ester bond, an imide or an acid anhydride in the ring also called a condensed ring;
  • the cyclic skeleton of the water-soluble polymer is also referred to as a polymer ring; the molecular weight of the water-soluble polymer is not particularly limited.
  • Each represents a cyclic structure containing a nitrogen atom, a double bond, an azo group, a triple bond, a disulfide bond, a conjugated diene bond, an acid anhydride, an imide bond, and a triazole.
  • the cyclic structure of the present invention includes, but is not limited to, an aliphatic ring, unless otherwise specified.
  • Aliphatic rings include alicyclic and heterocyclic rings including, but not limited to, monocyclic, polycyclic, spiro, bridged, fused, carbocyclic, heterocyclic, heterocyclic, heteromonocyclic, heteropolycyclic, heterohydra Any one of a ring structure, a heterocyclic ring, a heteroalicyclic ring, or a combination of two or more ring types.
  • a ring structure such as triazole may be a ring formed by a chemical reaction. It should be noted that although Rings belonging to the nature of the aliphatic heterocycle are sometimes listed as a single class in view of their particularity.
  • the aliphatic ring is exemplified as follows:
  • the aromatic ring is composed of an aromatic ring and an aromatic heterocyclic ring, including but not limited to a monocyclic ring, a polycyclic ring, a fused ring, a fused aromatic ring, a fused heterocyclic ring, an aromatic fused heterocyclic ring, an aromatic heterocyclic ring, a benzoheterocyclic ring, and a heterocyclic ring.
  • a heterocyclic ring a carbocyclic ring, a heterocyclic ring, an aromatic heterocyclic ring, a heteromonocyclic ring, a heteropolycyclic ring, a heterocyclic ring, and a heteroaryl ring, or a combination of two or more ring types.
  • substituted by “substituted” “hydrocarbyl”, exemplifies that any one or more hydrogen atoms at any position in the substituted "hydrocarbyl group” may be substituted by any one or any substituent.
  • the substituent atom is not particularly limited, and is preferably a halogen atom.
  • the substituents therein are not particularly limited, and include, but are not limited to, all of the substituents recited in the above terms, and are selected from any one of the hydrocarbyl substituent or the hetero atom-containing substituent.
  • the substituted atom or substituent is selected from a halogen atom, a hydrocarbyl substituent, or a hetero atom-containing substituent.
  • “Degradable” refers to the occurrence of a break in a chemical bond and the breaks are at least two residues independent of each other. If after chemical changes The structure is changed, but the entire linker is still only a complete linker, and the linker still falls into the category of "stability stable".
  • the conditions for the degradation are not particularly limited, and include, but are not limited to, degradation under conditions of light, heat, enzyme, redox, acid, alkaline, physiological conditions, in vitro simulated environment, etc., preferably in light, heat, enzyme, oxidation. It can be degraded under conditions of reduction, acidity and alkalinity.
  • the light conditions include, but are not limited to, illumination conditions such as visible light, ultraviolet light, infrared light, near-infrared light, and mid-infrared light.
  • the thermal conditions are above normal physiological temperatures, generally referred to as temperature conditions above 37 °C, and typically below 45 °C, preferably below 42 °C.
  • the enzyme conditions are not particularly limited, and enzymes which can be produced under physiological conditions are included, and examples thereof include peptidases, proteases, lyases and the like.
  • the redox condition is not particularly limited, such as a redox transition between a thiol group and a disulfide bond.
  • the physiological condition is not particularly limited, and includes, but not limited to, serum, heart, liver, spleen, lung, kidney, bone, muscle, fat, brain, lymph node, small intestine, gonad, etc., and may be referred to as intracellular or extracellular.
  • the matrix it can refer to normal physiological tissues, and can also refer to diseased physiological tissues (such as tumors, inflammation, etc.).
  • the in vitro simulated environment is not particularly limited and includes, but is not limited to, physiological saline, a buffer, a culture medium, and the like.
  • the rate of the degradable is not particularly limited, and may be, for example, rapid degradation under the action of an enzyme, or slow hydrolysis under physiological conditions.
  • the linker remains as a complete linker, it is defined as "stably stable” in which chemical changes that maintain the integrity of the link are allowed to occur.
  • the chemical change is not particularly limited and includes, but not limited to, isomerization conversion, protonation, substitution reaction, and the like.
  • the conditions which can be stably present are not particularly limited, and include, but are not limited to, light, heat, enzyme, redox, neutral, acidic, basic, physiological conditions, in vitro simulated environment, and the like.
  • “stable presence” is not an absolute concept for the same linker, for example, the amide bond is more stable than the ester bond under acidic or basic conditions, and the “stable presence” in the present invention
  • the linker contains an amide bond.
  • a urethane group, a thiourethane group, etc. may be a linker which can be stably existed, or a degradable linker.
  • the type of the amino acid structure in the present invention is not particularly limited unless otherwise specified, and may be either L -form or D -form.
  • the amino acid skeleton in the present invention refers to a residue having the essential characteristics of an amino acid, specifically, a carboxyhydroxy group (including all C-terminal carboxyhydroxy groups, and also includes a carboxyhydroxy group such as aspartic acid or a side group in glutamic acid), and a hydroxyl group.
  • a hydrogen atom a hydrogen atom on a phenolic hydroxyl group (stirine), a hydrogen atom on a sulfhydryl group (such as cysteine), and a hydrogen atom on a nitrogen atom (including all N-terminal hydrogen atoms, including side groups) a hydrogen atom in the amino group such as a hydrogen atom on the ⁇ -amino group on lysine, a hydrogen atom in the amino group on the pendant ring of histidine and tryptophan, etc., and an amino group on the amide (such as aspartame)
  • a residue formed by an amino group in a pendant thiol group or a hydrogen atom in an amino group such as an acid or glutamic acid.
  • the glycine skeleton structure is Another example is the lysine skeleton. The structural formulas are no longer given here one by one.
  • amino acid derivative skeleton in the present invention refers to an atom or a group portion having an essential feature in addition to an amino acid skeleton, such as a hydroxyproline skeleton.
  • amino acid skeleton such as a hydroxyproline skeleton.
  • sarcosine also known as N-methylglycine
  • the cyclic monosaccharide skeleton in the present invention means a residue formed by losing a monovalent sugar of a monosaccharide having a cyclic structure.
  • the description of the degree of polymerization of the PEG chain or the PEG block in the patent of the present invention may take the form of "satisfying 2 to 2000" or "integer of 2 to 2000", see n 1 , n 2 , n 3 , n 4 . , m 1 , m 2 , m 3 .
  • the compound prepared by the method described in the invention is an aggregate composed of a large number of molecules. For any one of the molecules, n 1 is taken as an example, and only an integer can be taken, corresponding to the number of EO units, and for the aggregate, n 1 behaves. A number average of a series of integers, allowed as a non-integer within the range.
  • the present invention discloses a bio-related substance modified with a polyfunctionalized H-type polyethylene glycol derivative.
  • the bio-related substance modified by the polyfunctionalized H-type polyethylene glycol derivative is a stable structure formed by combining a polyfunctionalized H-type polyethylene glycol derivative represented by the general formula (1) with a biologically relevant substance. .
  • the H-type structure is composed of a linear PEG main axis and four PEG branching chains, and the total number of oxidized vinyl units of the linear PEG main axis and the four PEG branching chains is not more than 5,000, preferably not more than 4,000, more preferably not more than 3,000. More preferably, it does not exceed 2,500, more preferably does not exceed 2,000, and more preferably does not exceed 1,500.
  • LPEG is a linear spindle structure; and LPEG is a monoblock, diblock, triblock or a fragment of 4 to 150 blocks composed of polyethylene glycol or polyethylene glycol.
  • the total number of oxyethylene units in the LPEG is an integer of from 2 to 2,000; preferably an integer of from 5 to 2,000; more preferably an integer of from 5 to 1,000; more preferably an integer of from 10 to 1,000; more preferably an integer of from 10 to 500; more preferably 20 An integer of ⁇ 500; more preferably an integer of 20 to 250; more preferably an integer of 50 to 250.
  • n 1 , n 2 , n 3 , and n 4 are the polymerization degrees of the four PEG branching chains, respectively, each independently satisfying 2 to 2000, and may be the same or different from each other in the same molecule; preferably satisfying 5 to 2000; more preferably satisfying 5 More preferably, it is 10 to 1000; more preferably 20 to 1000; more preferably 20 to 500; more preferably 50 to 500.
  • any one of the PEG blocks in the molecule is independently polydisperse or monodisperse.
  • LPEG is polydisperse as long as at least one polydisperse PEG block is present in the constituent LPEG.
  • LPEG is monodisperse only if all of the PEG blocks that make up the LPEG are monodisperse.
  • the LPEG and the four PEG branched chains corresponding to n 1 , n 2 , n 3 , and n 4 are each independently polydisperse or monodisperse.
  • U 1 and U 2 are trivalent branching groups linking LPEG and two PEG branching chains; the structure of U 1 is The structure of U 2 is U 01 and U 02 are each independently a trivalent group.
  • L 1 , L 2 , L 3 , and L 4 are respectively a linking group of a polyethylene glycol unit in which the number of oxyethylene units is n 1 , n 2 , n 3 , and n 4 , and L 5 and L 6 are connected linear spindles.
  • the linking group of the polyethylene glycol unit, L 1 , L 2 , L 3 , L 4 , L 5 , L 6 are each independently present or absent, and may be the same or different from each other in the same molecule.
  • F 1 and F 2 contain a functional group or a protected form thereof, and in the same molecule, F 1 and F 2 may be the same or different from each other.
  • F 1 and F 2 are each independently expressed as
  • LPEG In the same molecule, LPEG, U 1 , U 2 , U 01 , U 02 , L 1 , L 2 , L 3 , L 4 , L 5 , L 6 , L 0 (F 1 ), G(F 1 ), Z Any one or any of 1 (F 1 ), Z 2 (F 1 ), L 0 (F 2 ), G(F 2 ), Z 1 (F 2 ), Z 2 (F 2 ) and adjacent heteroatoms
  • the linker formed by the group can be stably present or degradable.
  • LPEG In the same molecule, LPEG, U 1 , U 2 , U 01 , U 02 , L 1 , L 2 , L 3 , L 4 , L 5 , L 6 , L 0 (F 1 ), G(F 1 ), Z Any one or any of 1 (F 1 ), Z 2 (F 1 ), L 0 (F 2 ), G(F 2 ), Z 1 (F 2 ), Z 2 (F 2 ) and adjacent heteroatoms
  • the conditions in which the group is formed to be stably present or degradable are not particularly limited, and include, but are not limited to, stable in light, heat, enzyme, redox, acid, alkaline, physiological conditions, in vitro simulated environment, or the like. Degradable, preferably stable or degradable under conditions of light, heat, enzyme, redox, acid, alkaline, and the like.
  • the position of a certain linker may be stably present or may be degraded, and includes a group consisting of the linker and the linker and the adjacent hetero atom group.
  • the stability of the polymer and the releasability of the modified drug are important.
  • (1) When degradation occurs between a functional group at the end of four polyethylene glycol chains and a polyethylene glycol chain, including L 0 (F 1 ), L 0 (F 2 ), Z 1 (F 1 ), Z 1 (F 2 ), Z 2 (F 1 ), Z 2 (F 2 ), G(F 1 ), G(F 2 ), the drug molecule and the polyethylene glycol structure are separated, Maximizing the active site of the drug molecule; in particular, any of Z 1 (F 1 ), Z 1 (F 2 ), Z 2 (F 1 ), Z 2 (F 2 ), more particularly Z When any of 1 (F 1 ) and Z 1 (F 2 ) is degraded, the drug molecule can be as close as possible to the state before unmodification.
  • the polyfunctionalized H-type polyethylene glycol derivative-modified bio-related substance contains at least one molecule of a biologically relevant substance.
  • the manner of binding the polyfunctionalized H-type polyethylene glycol derivative to the bio-related substance is not particularly limited, and may be a covalently linked method or a non-covalently linked method. Preference is given to covalent attachment or hydrogen bonding. More preferably, the covalent attachment means.
  • the type of the bio-related substance to be combined is one or two.
  • the F 1 modified bio-related substance may be the same as or different from the F2 modified bio-related substance.
  • F 1 and F 2 have the same R 01 (allowing F 1 ⁇ F 2 due to the difference in the number of R 01 )
  • F 1 and F 2 preferably modify the same biologically relevant substance; when F 1 ⁇ F 2 and have different At R 01 , F 1 and F 2 preferably modify different biologically relevant substances.
  • the functional group modified by the polyfunctionalized H-type polyethylene glycol derivative or a protected form thereof may participate in all or part of the modification of a biologically relevant substance.
  • a functional group or a protected functional group that is not bound to a biologically relevant substance may retain a structural form before the reaction, or may form Deprotected functional groups can also be blocked by non-biologically related substances.
  • the position of the bio-related substance is not particularly limited, and may be located in the same or different polyethylene glycol branched chain, or may be located on the same side or on different sides of the polyethylene glycol. Branch chain.
  • F 1 or F 2 When F 1 or F 2 is combined with a biologically relevant substance, they are each independently expressed as They may be the same or different from each other in the same molecule;
  • D is a residue formed by reacting a modified bio-related substance with a polyfunctionalized H-type polyethylene glycol.
  • the same bio-related substance reacts with the same R 01 to obtain the residue formed by the same or different reaction sites participating in the reaction.
  • the D content (the number of D with respect to the theoretical reaction site) is not particularly limited and may be more than about 75% or less than about 75%.
  • the D content of the two different biologically relevant substances are calculated independently.
  • the D content of each molecule constituting the macroscopic substance of the polyethylene glycol derivative may be the same or different, and is exemplified by, for example, 100%, or as 65 to 90%, or as 75 to 94%. The higher the D content, that is, the higher the drug loading, the more easily the effect of the bio-related substance is, and the higher the homogeneity of the product structure, the better the performance.
  • the same biologically relevant substance can be reacted with the same R 01 to obtain the same or different residue D, preferably the same residue D is obtained, and the performance of the product is higher. Uniform and stable.
  • the D content is greater than about 75%, more preferably greater than about 80%, more preferably greater than about 85%, more preferably greater than about 90%, more preferably greater than about 94%, and most preferably equal to 100%.
  • the average level of D can be greater than about 75% or less than about 75%, preferably greater than about 75%, more preferably greater than about 80%, more preferably greater than about 85%, more preferably greater than about 90%, and even more preferably greater than About 94%, most preferably equal to 100%.
  • L is a functional group in the polyfunctionalized H-type polyethylene glycol derivative or a linker formed by reacting the protected form with a biologically relevant substance.
  • L can be a covalent connection or a non-covalent connection. Preference is given to covalent linking groups; it may also be a dihydrogen bond or a multiple hydrogen bond. Any one of L may be independently present or degradable independently, and a linking group of L and an adjacent hetero atom group may be stably present or degradable. Since it is allowed to react with different sites from the same bio-related substance, several PEG chain ends of the same molecule are allowed to correspond to different L, preferably L of the ipsilateral PEG chain end is the same.
  • any one of L may be independently present or degradable independently, and a linking group of L and an adjacent hetero atom group may be stably present or degradable.
  • any one of (Z 2 ) q -L may be independently present or degradable independently, and a linking group of (Z 2 ) q -L and an adjacent hetero atom group may be stably present or degradable.
  • the L of the ipsilateral PEG chain end has the same stability, that is, both can be stably present or both can be degraded.
  • (Z 2 ) q -L at the end of the ipsilateral PEG chain also has the same stability.
  • E 01 is R 01 , protected R 01 , deprotected R 01 or terminated R 01 .
  • E 01 is preferably R 01 .
  • the group for blocking R 01 is not particularly limited, and is preferably blocked with a C 1-6 alkyl group or an amino acid, more preferably with a methyl group, an ethyl group or a glycine group.
  • the definition of R 01 is consistent with the above.
  • Succinimide active ester Glycine terminated As another example, the hydroxyl group can be blocked with methyl groups by methanol.
  • the bio-related substance modified by the polyfunctionalized H-type polyethylene glycol derivative preferably has the formula represented by formula (2), formula (3), formula (4), formula (5) or formula (6)
  • the structure is more preferably a general structure represented by formula (3) or formula (6), and most preferably has a general structure represented by formula (6).
  • LPEG polyfunctionalized H-type polyethylene glycol derivative
  • D 1 , D 2 , D 3 , and D 4 are each independently represented as And they may be the same or different from each other in the same molecule.
  • EF 1 and EF 2 are each independently expressed as And they may be the same or different from each other in the same molecule. That is, EF 1 is F 1 , protected F 1 , deprotected F 1 or blocked F 1 , EF 2 is F 2 , protected F 2 , deprotected F 2 or blocked F 2 . EF 1 and EF 2 are preferably F 1 and F 2 , respectively.
  • the capped F 1 , capped F 2 are each independently preferably capped with a C 1-6 alkyl or amino acid, more preferably terminated with a methyl, ethyl or glycine.
  • D 1 , D 2 , and EF 1 are on the right side, and D 3 , D 4 , and EF 2 are on the left side; wherein, i, g, L 0 , g 0 , Z 2 , q, Z 1 on the same side , q 1 , E 01 are the same, and D is from the same biologically relevant substance, k, k 0 , G, L in the same side may be the same or different; wherein, the opposite side k, G, g, L 0 , g 0 Z 2 , q, Z 1 , q 1 , E 01 may each independently be the same or different, and the D sides may be derived from the same or different biologically relevant substances.
  • residues generated after reaction with R 01 are allowed for different reaction sites. Especially when there are multiple identical reactive groups in a biologically relevant substance.
  • the structural form of LPEG includes but is not limited to
  • W 0 , W 01 , and W 02 are each independently a linking group having 1 to 100 atoms; and W 0 , W 01 , and W 02 are each independently stable or degradable;
  • m 1 , m 2 , and m 3 are the degrees of polymerization of the respective PEG blocks, each independently satisfying 0 to 2000, and may be the same or different from each other in the same molecule; preferably, m 1 , m 2 , and m 3 are each independently satisfied. 0 to 1000; and the PEG blocks corresponding to m 1 , m 2 , and m 3 are each independently polydisperse or monodisperse;
  • j is an integer of 1 or 2 to 100.
  • LPEG is preferably
  • m 2 is selected from 2 to 2000 (m 2 is 0 to 2000, LPEG is 2 to 2000, and the intersection is obtained). m 2 more preferably satisfies 5 to 2000; more preferably satisfies 5 to 1000; m 2 more preferably satisfies 10 to 1000; more preferably satisfies 10 to 500; more preferably 20 to 500; more preferably 20 to 250; more preferably 50 ⁇ 250.
  • m 1 is selected from 2 to 2000 (m 1 is 0 to 2000, LPEG is 2 to 2000, and the intersection is obtained).
  • m 1 preferably satisfies 5 to 2000; more preferably satisfies 5 to 1000; m 1 more preferably satisfies 10 to 1000; more preferably 10 to 500; more preferably 20 to 500; more preferably 20 to 250; more preferably 50 to 50 250.
  • LPEG is most preferably
  • the bio-related substance modified by the polyfunctionalized H-type polyethylene glycol derivative can also be represented by the formula (6-2) or the formula (6-3).
  • the formula (6-2) is preferably represented by the formula (6-4), the formula (6-4b), the formula (6-5), the formula (6-5b) or the formula (6-6). Structure.
  • n 1 , n 2 , n 3 , n 4 U 1 , U 2 , D 1 , D 2 , D 3 , D 4 , W 0 , W 01 , W 02 , m 1 , m 2 , m 3 ,
  • the definition of j is consistent with the above, and will not be described here.
  • the general formulae (1) to (6) also include the general formula (6-2), the general formula (6-3), the general formula (6-4), the general formula (6-4b), and the general formula ( 6-5), general formula (6-5b) or general formula (6-6).
  • the "molecular weight” referred to in this invention is "number average molecular weight", and M n can be the molecular weight of a polydisperse block or substance, and can also be monodisperse embedded.
  • the number average molecular weight is preferably from 2 to about 1000; more preferably from 2 to about 500; more preferably from 5 to About 500; more preferably from about 11 to about 500; more preferably from about 22 to about 500; more preferably from about 30 to about 250; more preferably from about 34 to about 150.
  • the more conventional the molecular weight of the corresponding PEG segment the simpler and easier to prepare, the narrower the PDI (polydispersity coefficient) of the molecular weight, and the more uniform the performance.
  • the linear PEG obtained by the usual polymerization method has a number average molecular weight of about 2 kDa to 40 kDa.
  • the molecular weight is defined by the number of oxyethylene units (hereinafter referred to as EO units).
  • the monodisperse polyethylene glycol prepared according to the prior art has an EO unit number of between about 1 and 70, including but not limited to the reference "Expert Rev. Mol. Diagn. 2013, 13(4), 315-319. , J. Org. Chem. 2006, 71, 9884-9886, Angew. Chem. 2009, 121, 1274-1278, Bioorganic & Medicinal Chemistry Letters, 2015, 25: 38-42, Angew. .Int. Ed., 2015, 54: 3763-3767 and the number of EO units listed in the documents cited in the above documents.
  • the number of EO units of a typical monodisperse PEG includes, but is not limited to, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 13, 16, 20, 22, 24, 27, 29, 36 44, 48, 56, 62, 64, 67, etc.
  • the monodispersity referred to in the present invention may be a monodisperse mixture in addition to a single component having only one EO unit number, but it is required that the relative content percentage of the different components is determined. That is, the PDI of the mixture is 1, and the corresponding number average degree of polymerization may be an integer or a non-integer.
  • the PDI is greater than 1, still forming a polydisperse block or substance.
  • the monodisperse PEG block preferably has 2 to 70 EO units; more preferably 3 to 70; more preferably 3 to 70; more preferably 3 to 50; more preferably 3 to 25. The more preferred the case, the more diverse the preparation process.
  • the polyfunctionalized H-type polyethylene glycols of the formulas (1) to (6) include, but are not limited to, the following depending on the difference in the dispersibility of the PEG segments in the molecule:
  • the LPEG is polydisperse.
  • the number average molecular weight of the LPEG may preferably be about 500, 600, 700, 800, 900, 1000, 1500, 2000, 2500, 3000, 3350, 3500, 4000, 5000, 5500, 6000. ,6500,7000,7500,8000,8500,9000,9500,10000,11000,12000,13000,14000,15000,16000,17000,18000,19000,20000,25000, 30000, 35000, 40000, 50000 or 60000 in Da.
  • the LPEG is monodisperse.
  • linear polyethylene glycol spindle LPEG of the present invention allows for 1, 2, 3 or more PEG blocks, and when LPEG is monodisperse, all of the PEG blocks are required to be monodisperse.
  • the number of EO units of LPEG may preferably be an integer of from 2 to 70; more preferably an integer of from 3 to 70; more preferably an integer of from 5 to 70; more preferably an integer of from 5 to 50.
  • the total number of EO units of LPEG may preferably be an integer of from 2 to 140; more preferably an integer of from 3 to 140; more preferably an integer of from 5 to 140; more preferably an integer of from 5 to 70; more preferably An integer from 5 to 50.
  • the total number of EO units of LPEG may preferably be an integer of from 3 to 210; more preferably an integer of from 5 to 210; more preferably an integer of from 5 to 150; more preferably an integer of from 5 to 100; more preferably An integer of 5 to 70; more preferably an integer of 5 to 50.
  • the total number of EO units of LPEG may preferably be an integer of 4 to 500; more preferably an integer of 5 to 500; more preferably an integer of 5 to 250; more preferably 5 to 200 An integer; more preferably an integer of 5 to 100; more preferably an integer of 5 to 50.
  • the PEG branching chain corresponding to the n 1 , n 2 , n 3 or n 4 is polydisperse.
  • the number average molecular weight of the corresponding PEG branching chain is preferably about 500, 600, 700, 800, 900, 1000, 1500, 2000. , 2500, 3000, 3350, 3500, 4000, 5000, 5500, 6000, 6500, 7000, 7500, 8000, 8500, 9000, 9500, 10000, 11000, 12000, 13000, 14000, 15000, 16000, 17000, 18000, 19000 , 20000, 25000, 30000, 35000, 40000, 50000 or 60000, in Da.
  • the PEG branching chain corresponding to the n 1 , n 2 , n 3 or n 4 is monodisperse.
  • the PEG branched chain corresponding to n 1 , n 2 , n 3 or n 4 is monodisperse, it is preferably an integer of 2 to 70; more preferably an integer of 3 to 70; more preferably an integer of 5 to 70; more preferably 5 An integer of ⁇ 50.
  • the PEG branching chain corresponding to the n 1 , n 2 , n 3 , and n 4 is polydisperse, and the LPEG is monodisperse.
  • the number of blocks of LPEG is not particularly limited.
  • the LPEG is a monodisperse monoblock, diblock or triblock.
  • LPEG is polydisperse or monodisperse.
  • the PEG branching chain corresponding to the n 1 , n 2 , n 3 , and n 4 is monodisperse, and the LPEG is polydisperse.
  • the number of blocks of LPEG is not particularly limited.
  • the LPEG is a monoblock, a diblock or a triblock and contains at least one polydisperse block.
  • the PEG branching chain and the LPEG corresponding to the n 1 , n 2 , n 3 , and n 4 are all polydisperse.
  • U 1 and U 2 are each independently equal to U 01 , U 02 or each independently contain U 01 , U 02 .
  • U 1 and U 2 are each independently a symmetric type or an asymmetric type.
  • either of the connecting ends may be directed to the spindle polyethylene glycol unit.
  • the end marked by the asterisk * points to the spindle PEG unit.
  • Trivalent group As an example, there are two different types of connectors, e1 and e2.
  • U 01 or U 02 When it is used as the trivalent group U 01 or U 02 , it can be pointed from the e1 end to the main axis polyethylene glycol unit. In this case, it corresponds to the symmetric U 01 or U 02 , and can also be directed to the main axis by any e2 end.
  • the diol unit which corresponds to the asymmetric U 01 or U 02 at this time.
  • U 01 and U 02 are each independently selected from any of the trivalent groups in the set G 3 of the trivalent group.
  • U 01 and U 02 are each independently a symmetric type or an asymmetric type.
  • U 1 and U 2 are each independently a symmetric type or an asymmetric type in the same molecule.
  • L 1 ⁇ L 2 or L 3 ⁇ L 4 U 1 and U 2 are of an asymmetric type.
  • U 01 and U 02 are of an asymmetric type
  • U 1 and U 2 are asymmetric types.
  • the stability of U 1 and U 2 is not particularly limited, and each is independently a group which is stably present or degradable.
  • the structure of U 1 and U 2 is not particularly limited.
  • the structures of U 01 and U 02 each independently include, but are not limited to, a branched structure or a ring-containing structure.
  • the stability of U 01 and U 02 is not particularly limited, and each is independently a group which can be stably present or degradable.
  • the structure of U 01 and U 02 is not particularly limited.
  • the structures of U 01 and U 02 each independently include, but are not limited to, a branched structure or a ring-containing structure.
  • a polyethylene glycol unit may be directed to the branched chain by any of the linking ends.
  • the junction marked by an asterisk * points to the branched-chain PEG unit.
  • the structure of G is not particularly limited, and includes, but not limited to, a branch, a ring-containing structure, a comb, a tree, a hyperbranched, and the like.
  • k is the number of functional groups in a PEG branching chain or a protected form thereof, and is also the number of bio-related material molecules that can be modified by a PEG branching chain.
  • G is a linker having a valence of k+1.
  • k may be 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, An integer of 24, 25, 26, 27, 28, 29, 30, 31, 32 or 33-251.
  • the valence of G is 3 to 251, that is, G is trivalent, tetravalent, pentavalent, hexavalent, seven-valent, eight-valent, nine-valent, ten-price, eleven-valent, twelve-valent, and thirteen-valent.
  • k is preferably 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 or 9 to 100; more preferably 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 or 33-64; more preferably 1, 2, 3, 4 , 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20. .
  • G is selected from any one of the k+1-valent groups of the set G k+1 of the k+1-valent group.
  • the stability of any one of the k+1-valent groups of the group G k+1 is not particularly limited, and may be a group which is stable or a group which is degradable.
  • the steadily present condition is not particularly limited, and is preferably stable under conditions including, but not limited to, light, heat, enzyme, redox, acid, basic, physiological conditions, in vitro simulated environment, and more preferably, in light and heat. It can be stably present under the conditions of enzyme, redox, acidity and alkalinity.
  • the degradable conditions are also not particularly limited, and are preferably degradable under conditions including, but not limited to, light, heat, enzymes, redox, acid, basic, physiological conditions, in vitro simulated environment, and more preferably, in light, heat, It can be degraded under the conditions of enzyme, redox, acidity and alkali.
  • U 01 , U 02 , and trivalent G are each independently selected from any one of the trivalent groups of the group G 3 of the trivalent group, and may be the same or different from each other in the same molecule.
  • the trivalent group in the set G 3 contains a trivalent core structure.
  • the trivalent core structure may be one atom CM 3 , one unsaturated bond CB 3 or one cyclic structure CC 3 .
  • the trivalent nuclear atom CM 3 is not particularly limited as long as three covalent single bonds are allowed to be simultaneously formed.
  • a trivalent nitrogen atom nucleus, a trivalent carbon nucleus, a trivalent silicon nucleus, a trivalent phosphorus nucleus, or the like can be mentioned.
  • a trivalent nuclear atom may not be attached to any atom or group, such as a trivalent nitrogen nucleus. It is also possible to connect other atoms or groups, such as trivalent carbon nuclei.
  • Trivalent silicon nucleus Trivalent phosphorus nucleus Wait.
  • R 1 is a hydrogen atom or a substituent on a carbon atom or a silicon atom.
  • R 1 are not particularly limited. Substituents which are stable in anionic polymerization conditions are preferred.
  • the number of carbon atoms of R 1 is not particularly limited, but the number of carbon atoms is preferably from 1 to 20, and more preferably from 1 to 10.
  • R 1 may contain a hetero atom, may contain hetero atoms.
  • the structure of R 1 is not particularly limited and includes, but not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • R 1 is a hydrogen atom or a group selected from any one of a C 1-20 hydrocarbon group, a substituted C 1-20 hydrocarbon group and the like.
  • the substituted atom or substituent in R 1 is not particularly limited, and includes, but is not limited to, any one of the substituted atoms or any of the substituents listed in the term, and is selected from a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent.
  • R 1 is preferably a hydrogen atom or a C 1-20 alkyl group, an aralkyl group, a C 1-20 open-chain heteroalkyl group, a heteroaryl hydrocarbon group, a substituted C 1-20 alkyl group, a substituted aromatic hydrocarbon group, a substituted C 1 - Any one of 20 open-chain heteroalkyl groups, substituted heteroaryl hydrocarbon groups, and the like.
  • R 1 is selected from a hydrogen atom or includes, but is not limited to, methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, Undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, Any one of a benzyl group, a substituted C 1-20 alkyl group, a substituted aromatic hydrocarbon group, a substituted C 1-20 open chain heterohydrocarbyl group, a substituted heteroaryl hydrocarbon group, and the like.
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the substituted atom and the substituent are selected from a halogen atom, a hydrocarbyl substituent, and a hetero atom-containing substituent, preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a C 1-6 alkyl group, an alkoxy group. Or nitro.
  • R 1 is preferably a hydrogen atom, methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, C 1-10 halogenated hydrocarbon, halogen An acetyl or alkoxy-substituted C 1-10 aliphatic hydrocarbon group.
  • the halogen atom is F, Cl, Br or I.
  • R 1 is most preferably a hydrogen atom, a methyl group or an ethyl group.
  • R 37 is a substituent of a trivalent silicon branching center selected from a hydrocarbon group, preferably a C 1-20 hydrocarbon group, more preferably a C 1-20 alkyl group, most preferably a methyl group.
  • the trivalent unsaturated bond core structure CB 3 is not particularly limited as long as three covalent single bonds can be simultaneously formed.
  • the unsaturated bond may have two or more bonding atoms. Preferably 2 or 3 are used. More preferably, two. As an example, such as Wait.
  • the trivalent cyclic core structure CC 3 is not particularly limited as long as three covalent single bonds can be simultaneously taken out.
  • the ring-forming atoms which lead to the covalent single bond are not particularly limited, and include, but are not limited to, N, C, Si, P, and the like.
  • the cyclic structure is selected from the group consisting of, but not limited to, an aliphatic ring, an aromatic ring, a sugar ring, and a condensed ring.
  • the annular structure may be a single ring, for example Can also be multi-ring, for example It may be a naturally occurring cyclic structure, such as any trivalent monocyclic ring from any cyclic monosaccharide, for example Etc.; may also be a ring formed by a chemical reaction, such as a cyclic peptide, a lactone, a lactam, a lactide, etc., for example
  • the extracted covalent single bond can be directly extracted from the ring-forming atom and can be taken out through the unsaturated bond.
  • the three covalent single bonds that are extracted can simultaneously elicit three covalent single bonds from three ring-forming atoms.
  • M 5 , M 6 , M 7 and M 23 are ring-forming atoms, that is, atoms located on the ring.
  • M 5 , M 6 , M 7 and M 23 are each independently a carbon atom or a hetero atom, and may be the same or different from each other in the same molecule.
  • M 5 , M 6 , M 7 and M 23 are each independently preferably a carbon atom, a nitrogen atom, a phosphorus atom or a silicon atom.
  • the number of ring-forming atoms of the ring in which M 5 , M 6 , M 7 and M 23 are present is not particularly limited, but is preferably a 3- to 50-membered ring, more preferably 3 to 32, and still more preferably 3 to 18.
  • M 23 is a carbon atom, a nitrogen atom, a phosphorus atom or a silicon atom which leads to two single bonds on the ring. When it is a nitrogen atom, it exists as a quaternary ammonium cation.
  • M 5 , M 6 , M 7 and M 23 may each independently be a carbon atom or a hetero atom of a ring of 3 to 50 members, preferably a carbon atom or a hetero atom of a ring of 3 to 32 members, more preferably a ring of 3 to 32 members.
  • the carbon atom, the nitrogen atom, the phosphorus atom or the silicon atom is more preferably a carbon atom, a nitrogen atom, a phosphorus atom or a silicon atom on the ring of 3 to 18 members.
  • a ring in which any one of M 5 , M 6 or M 7 is located, a ring in which M 5 , M 6 , and M 7 are located, and a ring in which M 23 and M 6 are located are not particularly limited, including but not limited to Wait.
  • any alicyclic or aliphatic heterocyclic ring and the ring-forming atoms are each independently a carbon atom or a hetero atom; the hetero atom is not particularly limited and includes, but not limited to, a nitrogen atom, an oxygen atom, a sulfur atom, a phosphorus atom, and silicon. Atom, boron atom, etc.
  • the hydrogen atom on the ring-forming atom of the alicyclic ring may or may not be substituted by any substituted atom or substituent.
  • the substituted hetero atom or the substituent is not particularly limited and includes, but is not limited to, any one of the substituted hetero atoms or any of the substituents listed in the term, and any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent. .
  • the definition of the alicyclic or heteroalicyclic ring is defined in detail in the terminology and will not be repeated here.
  • the alicyclic and aliphatic heterocycles include, but are not limited to, monocyclic, polycyclic, spiro, bridged, fused, carbocyclic, heterocyclic, heteroalicyclic, heteromonocyclic, heteropolycyclic, hetero Any one of a spiral structure, a heterocyclic ring, and a heteroalicyclic ring, or a combination of two or more ring types.
  • any one of an aromatic ring or an aromatic heterocyclic ring, and the ring-forming atoms are each independently a carbon atom or a hetero atom; the hetero atom is not particularly limited and includes, but not limited to, a nitrogen atom, a phosphorus atom, a silicon atom, a boron atom and the like.
  • the hydrogen atom on the ring-forming atom of the aromatic ring may or may not be substituted by any of the substituted atoms or any of the substituents.
  • the substituted hetero atom or the substituent is not particularly limited and includes, but is not limited to, any one of the substituted hetero atoms or any of the substituents listed in the term, and any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent. .
  • the substituted atom is preferably a halogen atom.
  • the substituent is preferably a group which contributes to the induction and conjugation effect of an unsaturated bond electron.
  • the definitions of the aromatic ring and the aromatic heterocyclic ring are defined in detail in the terminology, and are not described herein again.
  • the aromatic ring and the aromatic heterocyclic ring include, but are not limited to, a monocyclic ring, a polycyclic ring, a fused ring, a fused aromatic ring, a fused heterocyclic ring, an aromatic fused heterocyclic ring, an aromatic heterocyclic ring, a benzoheterocyclic ring, and a heterocyclic ring.
  • the aromatic ring is preferably the above-mentioned benzene, pyridine, pyridazine, pyrimidine, pyrazine, 1,3,5-triazine, tetrazine (1,2,3,4-, 1,2,4,5- and 1, 2,3,5-three isomers), anthracene, anthracene, anthracene, anthracene, anthracene, naphthalene, dihydroanthracene, xanthene (xanthene), thioxanthene, dihydrophenanthrene , 10,11-dihydro-5H-dibenzo[a,d]cycloheptane, dibenzocycloheptene, 5-dibenzocycloheptenone, quinoline, isoquinoline, indole, carbazole , iminodibenzyl, naphthylethylcyclo, dibenzocyclooctyne, aza
  • the source of the saccharide or saccharide derivative is a natural monosaccharide or a non-natural monosaccharide.
  • the cyclic monosaccharide has the structure of any one of its isomers, chiral isomers, optical isomers, conformational isomers, and rotamers, or any two or more thereof. Combination.
  • the skeleton of the cyclic monosaccharide or cyclic monosaccharide derivative is represented as The carbon atom number is 3, 4, 5, 6 or 7, and its structure is any one of an isomer, a chiral isomer, an optical isomer, a conformational isomer, a rotamer or Any combination of two or more forms.
  • Preferred are monosaccharide or monosaccharide derivatives of a cyclic monosaccharide backbone having 6 carbon atoms, including, but not limited to, glucose, allose, altrose, mannose, gulose, idose, and half. Any of monosaccharides such as lactose, talose, psicose, fructose, sorbose, tarulose, and inositol.
  • the skeleton of the oligosaccharide or oligosaccharide derivative is represented as
  • the combination between the cyclic monosaccharide skeletons includes, but is not limited to, linear, branched, hyperbranched, dendritic, comb, and cyclic.
  • the number of monosaccharide units is 2 to 10.
  • any of cyclodextrin or a derivative thereof may be formed in combination with ⁇ -cyclodextrin, ⁇ -cyclodextrin, and ⁇ -cyclodextrin.
  • the polysaccharide or polysaccharide derivative skeleton is expressed as
  • the combination between the cyclic monosaccharide skeletons includes, but is not limited to, linear, branched, hyperbranched, dendritic, comb, and cyclic.
  • the number of monosaccharide units is greater than 10.
  • D-glucopyranose units are sequentially joined by ⁇ -1,4 glycosidic bonds to form a linear combination; the above linear structures are connected end to end to form a cyclic combination.
  • the polysaccharide or the polysaccharide derivative may be any of starch, chitin, cellulose, and dextran.
  • a lactone, a lactam, a cyclic imide, a cyclic acid anhydride, a cyclic peptide, etc. are mentioned.
  • CC 3 is selected from, but not limited to, Any of the trivalent cyclic core structures.
  • X 1 and X 4 are each independently a hydrogen atom to which an oxy group is bonded, a hydroxy protecting group or a group LG 4 .
  • X 1 and X 4 are selected from the hydroxy protecting group in the combination exemplified by PG 4 .
  • the protected hydroxy group is referred to as OPG 4 .
  • the hydroxy protecting group is not particularly limited.
  • the number of carbon atoms of LG 4 is not particularly limited.
  • the number of carbon atoms of LG 4 is preferably from 1 to 20, and more preferably from 1 to 10.
  • the structure of LG 4 is not particularly limited and includes, but is not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • LG 4 may or may not contain heteroatoms.
  • LG 4 is selected from any one of a C 1-20 hydrocarbyl group, a C 1-20 heterohydrocarbyl group, a substituted C 1-20 hydrocarbyl group, and a substituted heterohydrocarbyl group.
  • the substituted hetero atom or substituent in LG 4 is not particularly limited, and includes, but is not limited to, any of the substituted hetero atoms or any substituents recited in the terminology, selected from a halogen atom, a hydrocarbyl substituent, a hetero atom-containing substituent. Any of them.
  • LG 4 is a C 1-20 alkyl group, a C 1-20 unsaturated aliphatic hydrocarbon group, an aryl group, an aromatic hydrocarbon group, a C 1-20 heteroalkyl group, a C 1-20 aliphatic arene group, a C 1-20 aliphatic hydrocarbon group.
  • Acyl, aryl acyl, heteroaryl acyl, C 1-20 hydrocarbyloxyacyl, C 1-20 hydrocarbylthioacyl, C 1-20 hydrocarbylaminoacyl, C 1-20 heteroalkyloxyacyl, C 1- 20 heterohydrocarbyl thio group, C 1-20 aminoacyl heterohydrocarbyl any one group or any one group are substituted form.
  • the acyl group in LG 4 is not particularly limited and includes, but is not limited to, any of the acyl groups listed in the terminology.
  • the acyl group in LG 4 may be selected from the group consisting of a carbonyl group, a sulfonyl group, a sulfinyl group, a phosphoryl group, a phosphorous acid group, a phosphoryl group, a nitroxyl group, a nitrosyl group, a thiocarbonyl group, an imido group, a thio group.
  • An acyl group such as a carbonyl group, a thiocarbon group, a sulfonyl group or a sulfinyl group is preferred.
  • the LG 4 acyl group is more preferably a carbonyl group, a thiocarbonyl group or a sulfonyl group.
  • LG 4 is C 1-20 alkyl, C 3-20 alkene, aryl, aralkyl, C 1-20 heteroalkyl, heteroaryl, heteroarylalkyl, C 1-20 alkylcarbonyl , arylcarbonyl, aralkylcarbonyl, C 1-20 heteroalkylcarbonyl, heteroarylcarbonyl, heteroarylalkylcarbonyl, C 1-20 alkoxycarbonyl, aryloxycarbonyl, aralkyloxy Carbonyl, C 1-20 alkylthiocarbonyl, arylthiocarbonyl, aralkylthiocarbonyl, C 1-20 alkylaminocarbonyl, arylaminocarbonyl, aralkylaminocarbonyl, C 1-20 heterocycloalkyl Alkoxycarbonyl, heteroaryloxycarbonyl, heteroaralkyloxycarbonyl, C 1-20 heteroalkylthiocarbonyl, heteroarylthiocarbonyl, heteroa
  • LG 4 is a C 1-20 alkyl group, a C 3-20 alkene group, an aryl group, an aralkyl group, a C 1-20 heteroalkyl group, a heteroaryl group, a heteroarylalkyl group or any A substituted form of a group.
  • LG 4 is selected from, but not limited to, methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, undecyl, Dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, allyl, benzyl , trityl, benzyl, methylbenzyl, 1-ethoxyethyl, methoxyethoxymethyl, benzyloxymethyl, methylthiomethyl, tetrahydropyranyl, Acetyl, benzoyl, methoxyacyl, ethoxylated, t-butyloxy, phenoxy, benzyloxy,
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the substituted atom or substituent is selected from a halogen atom, a hydrocarbyl substituent, and a hetero atom-containing substituent, preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, an alkoxy group, an alkenyl group or a nitro group.
  • LG 4 is further preferably methyl, ethyl, n-propyl, isopropyl, tert-butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, undecyl, dodecyl, Tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, allyl, benzyl, triphenyl Base, phenyl, benzyl, methylbenzyl, 1-ethoxyethyl, methoxyethoxymethyl, benzyloxymethyl, methylthiomethyl, tetrahydropyranyl, acetyl , benzoyl, methoxycarbonyl, ethoxycarbonyl, tert-butyloxycarbonyl,
  • LG 4 is methyl, ethyl, n-propyl, isopropyl, tert-butyl, pentyl, hexyl, allyl, benzyl, trityl, phenyl, benzyl, 1-ethoxy Ethyl ethyl, 2-ethoxyethyl, methoxyethoxymethyl, benzyloxymethyl, methylthiomethyl, tetrahydropyranyl, nitrobenzyl, p-methoxybenzyl Any one of a trifluoromethylbenzyl group, a tert-butyloxycarbonyl group, a phenoxycarbonyl group, a benzyloxycarbonyl group, an acetyl group, a trifluoroacetyl group, and the like.
  • LG 4 is methyl, ethyl, n-propyl, isopropyl, tert-butyl, pentyl, hexyl, allyl, benzyl, trityl, phenyl, benzyl, nitrobenzyl Any one of p-methoxybenzyl, trifluoromethylbenzyl and the like.
  • LG 4 is a methyl group, an ethyl group, an allyl group or a benzyl group.
  • X 2 is an atom or a group to which a carbon atom is bonded, and may be selected from any one of a hydrogen atom, a hydroxyl group, a protected hydroxyl group OPG 4 , R 1 or -CH 2 -OX 1 .
  • R 1 and X 1 are consistent with the above, and are not described herein again.
  • Q is not particularly limited as long as it contributes to the induction and conjugation effects of unsaturated bond electrons.
  • Q When Q is on the ring, it can be one or more. When there are a plurality of, the same structure may be used, or a combination of two or more different structures may be used.
  • Q can be an atom or a substituent.
  • Q is selected from a hydrogen atom or a halogen atom, preferably a hydrogen atom or a fluorine atom.
  • Q is selected from the group consisting of, but not limited to, all of the substituents recited in the terminology. It may or may not contain carbon atoms. When a carbon atom is not contained, it may be, for example, a nitro group. When the carbon atom is contained, the number of carbon atoms is not particularly limited, but is preferably 1 to 20 carbon atoms, and more preferably 1 to 10 carbon atoms.
  • the structure of Q is not particularly limited, and includes, but is not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • Q may be selected from a hydrogen atom, a halogen atom, a carbon-free substituent, a hydrocarbon group, a heterohydrocarbyl group, a substituted hydrocarbyl group or a substituted heterohydrocarbyl group.
  • Q is preferably a hydrogen atom, a halogen atom, a nitro group, a nitro group-containing substituent, an acyl group-containing substituent, a C 1-20 haloalkyl group, a C 1-20 alkyl group, a C 2-20 alkenyl group, a C 3-20 opening.
  • substituted hetero atom or substituent in Q is not particularly limited, and includes, but is not limited to, any substituted hetero atom or any substituent listed in the term portion, selected from a halogen atom, a hydrocarbyl substituent, and a hetero atom-containing substituent. Any one.
  • Q is a hydrogen atom, a halogen atom, a nitro group, a nitro group-containing substituent, an acyl group, a terminal group ester group-containing substituent, a terminal group thioester group-containing substituent, a terminal group amide bond-containing substituent, C 1-20 haloalkyl, C 2-20 alkenyl, C 3-20 open chain olefin group, C 3-20 cycloalkenyl group, aryl group, aromatic hydrocarbon group, C 1-20 heteroalkyl group, heteroaryl group, hetero Aralkyl, C 1-20 alkoxy, aryloxy, arylalkyloxy, C 1-20 heteroalkyloxy, heteroaryloxy, heteroaryloxy, C 1-20 alkane Any one or a group of a group, an arylthio group, an aromatic alkylthio group, a C 1-20 heteroalkylthio group, a heteroarylthio group, a heteroarylalky
  • the acyl group is not particularly limited and includes, but is not limited to, any of the acyl groups listed in the terminology.
  • the acyl group in Q may be selected from the group consisting of a carbonyl group, a sulfonyl group, a sulfinyl group, a phosphoryl group, a phosphorous group, a hypophosphoryl group, a nitroxyl group, a nitrosyl group, a thiocarbonyl group, an imido group, a thiophosphorus.
  • An acyl group such as a carbonyl group, a thiocarbon group, a sulfonyl group or a sulfinyl group is preferred.
  • the acyl group is more preferably a carbonyl group, a thiocarbonyl group, a sulfonyl group or a sulfinyl group.
  • Q is a hydrogen atom, a halogen atom, a nitro group, a nitro group-containing substituent, a C 1-20 carbonyl group, a C 1-20 alkylthiocarbonyl group, a C 1-20 sulfonyl group, a C 1-20 alkyl group.
  • Q is a hydrogen atom, a halogen atom, a nitro group, a nitro group-containing substituent, a C 1-10 carbonyl group, a C 1-10 alkylthiocarbonyl group, a C 1-10 sulfonyl group, a C 1-10 alkyl group.
  • Q may be selected from a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a nitro group, a nitrophenyl group, an acetyl group, a benzoyl group, a p-toluenesulfonic acid group, a methanesulfonic acid group, and a methoxy group.
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a halogen atom, an alkoxy group, an alkenyl group, an aryl group or a nitro group.
  • Q is preferably a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a nitro group, a nitrophenyl group, an acetyl group or a benzoyl group.
  • Base p-toluenesulfonic acid group, methanesulfonic acid group, methoxy acid group, ethoxy group, tert-butyloxycarbonyl group, phenoxycarbonyl group, benzyloxycarbonyl group, methylthio group, ethylthio group, Tert-Butylthiocarbonyl, phenylthiocarbonyl, benzylthiocarbonyl, ethylaminoacyl, tert-butylaminocarbonyl, phenylaminocarbonyl, benzylaminocarbonyl, methyl, ethyl, n-propyl, isopropyl Base, butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, vinyl, propenyl, allyl, propynyl, propargyl, cyclopropyl, cyclopropen
  • Q is a hydrogen atom, a fluorine atom, a methyl group, a trifluoromethyl group, a methoxy group, a methyloxycarbonyl group, a p-toluenesulfonyl group, a methylsulfonyl group or the like.
  • Q is any atom or group of a hydrogen atom, a fluorine atom, a methyl group, a trifluoromethyl group, a methoxy group, a methyloxycarbonyl group or the like.
  • M 10 , M 11 , M 12 , M 13 and M 14 are each independently a nitrogen atom or a carbon atom.
  • the adjacent ring-forming atoms are carbon atoms.
  • the substituted hetero atom or substituent is not particularly limited and includes, but is not limited to, any of the substituted hetero atoms or any of the substituents recited in the terminology, and any one selected from the group consisting of a halogen atom, a hydrocarbyl substituent, and a hetero atom-containing substituent.
  • the substituted atom is preferably a halogen atom.
  • the substituent is preferably a group which contributes to the induction and conjugation effect of an unsaturated bond electron.
  • R 7 is a hydrogen atom to which an amino group is bonded, an amino protecting group or a group LG 5 .
  • the number of carbon atoms of LG 5 is not particularly limited.
  • the number of carbon atoms of LG 5 is preferably from 1 to 20, and more preferably from 1 to 10.
  • the structure of LG 5 is not particularly limited and includes, but is not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • LG 5 may or may not contain heteroatoms.
  • LG 5 is selected from any one of a C 1-20 hydrocarbyl group, a C 1-20 heterohydrocarbyl group, a substituted C 1-20 hydrocarbyl group, and a substituted heterohydrocarbyl group.
  • the substituted hetero atom or substituent in LG 5 is not particularly limited, and includes, but is not limited to, any substituted hetero atom or any substituent listed in the terminus, selected from a halogen atom, a hydrocarbyl substituent, a hetero atom-containing substituent. Any of them.
  • LG 5 is a C 1-20 alkyl group, a C 1-20 unsaturated aliphatic hydrocarbon group, an aryl group, an aromatic hydrocarbon group, a C 1-20 heteroalkyl group, a C 1-20 aliphatic arene group, a C 1-20 aliphatic hydrocarbon group.
  • Acyl, aryl acyl, heteroaryl acyl, C 1-20 hydrocarbyloxyacyl, C 1-20 hydrocarbylthioacyl, C 1-20 hydrocarbylaminoacyl, C 1-20 heteroalkyloxyacyl, C 1- 20 heterohydrocarbyl thio group, C 1-20 aminoacyl heterohydrocarbyl any one group or any one group are substituted form.
  • the acyl group in LG 5 is not particularly limited and includes, but is not limited to, any of the acyl groups listed in the terminology.
  • the acyl group in LG 5 may be selected from the group consisting of a carbonyl group, a sulfonyl group, a sulfinyl group, a phosphoryl group, a phosphorous group, a hypophosphoryl group, a nitroxyl group, a nitrosyl group, a thiocarbonyl group, an imido group, a thio group.
  • An acyl group such as a carbonyl group, a thiocarbon group, a sulfonyl group or a sulfinyl group is preferred.
  • the LG 5 acyl group is more preferably a carbonyl group, a thiocarbonyl group or a sulfonyl group.
  • LG 5 is C 1-20 alkyl, C 1-20 alkenyl, C 1-20 alkene, aryl, aralkyl, C 1-20 heteroalkyl, heteroaryl, heteroarylalkyl, C 1-20 alkylcarbonyl, arylcarbonyl, aralkylcarbonyl, C 1-20 heteroalkylcarbonyl, heteroarylcarbonyl, heteroarylalkylcarbonyl, C 1-20 alkoxycarbonyl, aryloxy Carbonyl, aralkyloxycarbonyl, C 1-20 alkylthiocarbonyl, arylthiocarbonyl, aralkylthiocarbonyl, C 1-20 alkylaminocarbonyl, arylaminocarbonyl, aralkylaminocarbonyl , C 1-20 heteroalkyloxycarbonyl, heteroaryloxycarbonyl, C 1-20 heteroalkylthiocarbonyl, heteroarylthiocarbonyl, heteroarylthiocarbonyl, heteroary
  • LG 5 is a C 1-20 alkyl group, a C 1-20 alkenyl group, a C 1-20 alkene group, an aryl group, an aralkyl group, a C 1-20 heteroalkyl group, a heteroaryl group or a heteroarylalkyl group.
  • LG 5 is selected from, but not limited to, methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, undecyl, Dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, allyl, benzyl , trityl, benzyl, methylbenzyl, 1,3,5-dioxane, formyl, acetyl, benzoyl, methoxy acyl, ethoxy acyl, tertiary Butyloxyacyl, phenoxyacyl, benzyloxyacyl, 9-fluorenylmethyloxycarbonyl,
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the substituted atom or substituent is selected from a halogen atom, a hydrocarbyl substituent, and a hetero atom-containing substituent, preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, an alkoxy group, an alkenyl group or a nitro group.
  • LG 5 is further preferably methyl, ethyl, n-propyl, isopropyl, tert-butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, undecyl, dodecyl, Tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, allyl, benzyl, triphenyl Base, phenyl, benzyl, methylbenzyl, 1,3,5-dioxane, formyl, acetyl, benzoyl, methoxycarbonyl, ethoxycarbonyl, tert-butyl Oxycarbonyl, phenoxycarbonyl, benzyloxycarbonyl, 9-fluorenylmethyloxy
  • LG 5 is methyl, ethyl, n-propyl, isopropyl, tert-butyl, pentyl, hexyl, allyl, benzyl, trityl, phenyl, benzyl, nitrobenzyl , p-methoxybenzyl, trifluoromethylbenzyl, 1,3,5-dioxane, 9-fluorenylmethyloxycarbonyl, 2-methylsulfonylethylcarbonyl, 2- Any one of p-toluenesulfonylethyloxycarbonyl, tert-butyloxycarbonyl, benzyloxycarbonyl, formyl, acetyl, trifluoroacetyl, and the like.
  • LG 5 is methyl, ethyl, n-propyl, isopropyl, tert-butyl, pentyl, hexyl, allyl, benzyl, trityl, phenyl, benzyl, nitrobenzyl Any one of p-methoxybenzyl, trifluoromethylbenzyl and the like.
  • LG 5 is a methyl group, an ethyl group, an allyl group or a benzyl group.
  • R 7 is most preferably a hydrogen atom, a methyl group, an ethyl group or a benzyl group.
  • the trivalent ring structure of CC 3 is preferably selected from cyclohexane, furanose ring, pyranose ring, benzene, tetrahydrofuran, pyrrolidine, thiazolidine, cyclohexane, cyclohexene, tetrahydropyran, piperidine, 1, 4-dioxane, pyridine, pyridazine, pyrimidine, pyrazine, 1,3,5-triazine, 1,4,7-triazacyclononane, cyclic tripeptide, hydrazine, indane, hydrazine Bismuth, isoindole, anthracene, naphthalene, dihydroanthracene, xanthene (xanthene), thioxanthene, dihydrophenanthrene, 10,11-dihydro-5H-dibenzo[a,d]cycloheptane Alkane,
  • the tetravalent group in the set G 4 contains two trivalent core structures or one tetravalent core structure.
  • the trivalent core structure is as defined in the above G 3 and will not be described herein.
  • the tetravalent core structure may be one atom CM 4 , one unsaturated bond CB 4 or one cyclic structure CC 4 .
  • the tetravalent nuclear atom CM 4 is not particularly limited as long as four covalent single bonds can be simultaneously formed.
  • a tetravalent carbon atom nucleus a tetravalent silicon nucleus, a tetravalent phosphorus nucleus, or the like can be mentioned.
  • a tetravalent nuclear atom may not be attached to any atom or group, such as a tetravalent nucleus. Other atoms or groups may also be attached.
  • the tetravalent unsaturated bond core structure CB 4 is not particularly limited as long as four covalent single bonds can be simultaneously formed.
  • the unsaturated bond may have two or more bonding atoms. Preferably 2 or 3 are used. More preferably, two. As an example, such as Wait.
  • the tetravalent cyclic core structure CC 4 is not particularly limited as long as four covalent bonds can be simultaneously extracted.
  • the ring-forming atoms which lead to the covalent bond are not particularly limited, and include, but are not limited to, N, C, Si, P, and the like.
  • the cyclic structure may be an aliphatic ring or an aromatic ring, for example Etc.; it can also be a sugar ring, for example Etc.; can also be a condensed ring, for example Wait. It may be a naturally occurring cyclic structure, such as a sugar ring; it may also be a ring formed by a chemical reaction, such as Wait.
  • the ejected covalent single bond can be taken directly from the ring-forming atom or from the unsaturated bond. Either one of the introduced covalent single bonds is taken from a ring-forming atom alone, or two covalent single bonds can be simultaneously taken from the same ring-forming atom. A more typical CC 4 structure is the simultaneous extraction of four covalent single bonds from four ring-forming atoms.
  • CC 4 is selected from, but not limited to, A tetravalent cyclic core structure of any one of them.
  • the tetravalent nuclear structure also includes but is not limited to Wait.
  • the tetravalent ring structure of CC 4 preferably includes, but is not limited to, a furanose ring, a pyranose ring, a cyclamate, a cyclotetrapeptide, tetrahydrofuran, pyrrolidine, a thiazolidine, cyclohexane, benzene, cyclohexene, tetrahydrogen.
  • the k+1 valence group in any set G k+1 ( k ⁇ 4) may contain a k+1 valence ring core structure CC k+1 or 2 or more 3 to k A low-cost ring-shaped nuclear structure.
  • a k+1 valence ring core structure CC k+1 or 2 or more 3 to k A low-cost ring-shaped nuclear structure.
  • the cyclic core structure CC 5 is a cyclic core structure which leads to five covalent single bonds from five ring-forming atoms, including but not limited to a cyclic monosaccharide core structure and a ring. Peptides, azacycloalkanes, and the like. By way of example, such as from a cyclic monosaccharide Also derived from cyclic peptides Wait.
  • the cyclic core structure CC k+1 includes, but is not limited to, a cyclic peptide, an azacycloalkane, a polymer ring or the like.
  • G 6 as an example, as an example, such as:
  • the k+1 valent group in any of the sets G k+1 (k ⁇ 2) may contain a portion other than the 3 to k +1 nucleus structure when it contains a 3 to k +1 nucleus structure.
  • U 01 and U 02 each independently contain any of the above trivalent core structures, preferably containing Any of the trivalent core structures.
  • a moiety other than the k+1 valence core structure When a moiety other than the k+1 valence core structure is contained, it may or may not contain a carbon atom and may or may not contain a hetero atom.
  • the moiety other than the k+1 valence core structure may be a group containing a hetero atom or an alkylene group not containing a hetero atom.
  • the heteroatoms include, but are not limited to, O, S, N, P, Si, F, Cl, Br, I, B, and the like.
  • the number of hetero atoms may be one or two or more.
  • a moiety other than the core structure preferably a C 1-6 alkylene group, an ether bond, a thioether bond, a secondary amino group, a divalent tertiary amino group, an amide bond, a urethane bond, a thiourethane bond or a C 1 a divalent linking group of -6 alkylene groups in combination with any of the others.
  • R 7 , R 18 , R 19 and R 23 are the same as defined in the above R 7 , and are not described herein again. And in the same molecule, R 7 , R 18 , R 19 , R 23 may be the same or different from each other.
  • R 15 is selected from any of halogen atoms.
  • a fluorine atom is preferred.
  • the number of carbon atoms of R 15 is not particularly limited, but the number of carbon atoms is preferably from 1 to 20, and more preferably from 1 to 10.
  • the structure of R 15 is not particularly limited and includes, but is not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • R 15 may contain a hetero atom, may contain hetero atoms.
  • R 15 is selected from a hydrogen atom, a halogen atom, a C 1-20 hydrocarbon group, a C 1-20 heteroalkyl group, a substituted C 1-20 hydrocarbon group or a substituted heterohydrocarbyl group.
  • the substituted atom or substituent in R 15 is not particularly limited, and includes, but is not limited to, any one of the substituted atoms or any of the substituents listed in the term, and is selected from a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent.
  • R 15 is preferably a hydrogen atom, a halogen atom, a C 1-20 hydrocarbon group, a C 1-20 heteroalkyl group, a substituted C 1-20 hydrocarbon group or a substituted heterohydrocarbyl group.
  • R 15 is more preferably a hydrogen atom, a halogen atom, a C 1-20 alkyl group, a C 1-20 unsaturated aliphatic hydrocarbon group, an aryl group, an aromatic hydrocarbon group, a C 1-20 heteroalkyl group, a C 1-20 hydrocarbyloxyacyl group, C Any one or a group of a 1-20 hydrocarbylthioacyl group, a C 1-20 hydrocarbylaminoacyl group, or a substituted form of any one of the groups.
  • the acyl group in R 15 is not particularly limited and includes, but is not limited to, any of the acyl groups listed in the terminology.
  • the acyl group in R 15 may be selected from the group consisting of a carbonyl group, a sulfonyl group, a sulfinyl group, a phosphoryl group, a phosphorous group, a hypophosphoryl group, a nitroxyl group, a nitrosyl group, a thiocarbonyl group, an imido group, a thio group.
  • acyl group such as a carbonyl group, a thiocarbon group, a sulfonyl group or a sulfinyl group is preferred.
  • the acyl group in R 15 is more preferably a carbonyl group or a thiocarbonyl group.
  • R 15 is a hydrogen atom, a halogen atom, a C 1-20 alkyl group, a C 1-20 alkenyl group, an aryl group, an aromatic hydrocarbon group, a C 1-20 aliphatic hydrocarbon group, a heteroaryl group, a heteroaryl hydrocarbon group, C 1- Any atom or group of 20 alkoxyacyl, aryloxyacyl, C 1-20 alkylthioacyl, arylthioacyl, C 1-20 alkylaminoacyl, arylaminoacyl, Or a substituted form of any of the groups.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a halogen atom, an alkenyl group or a nitro group.
  • R 15 is a hydrogen atom, a halogen atom, a C 1-20 alkyl group, a C 1-20 alkenyl group, an aryl group, an aromatic hydrocarbon group, a C 1-20 aliphatic hydrocarbon group, a heteroaryl group, a heteroaryl hydrocarbon group, C 1- 20 alkoxycarbonyl, aryloxycarbonyl, C 1-20 alkylthiocarbonyl, arylthiocarbonyl, C 1-20 alkylaminocarbonyl, arylaminocarbonyl, C 1-20 alkoxy sulfide Carbonyl, aryloxythiocarbonyl, C 1-20 alkylthiothiocarbonyl, arylthiothiocarbonyl, C 1-20 alkylaminothiocarbonyl, arylaminothiocarbonyl An atom or group, or a substituted form of any of the groups.
  • the substituted atom or the substituent is any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, an alkenyl group or a nitro group.
  • R 15 is selected from, but not limited to, a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group.
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom or a nitro group.
  • R 15 is further preferably a hydrogen atom, a fluorine atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a decyl group, a decyl group, an allyl group, or a propylene group.
  • Base vinyl, phenyl, methylphenyl, butylphenyl, benzyl, C 1-10 halohydrocarbyl, halophenyl, halobenzyl, nitrophenyl, methoxycarbonyl, B Oxycarbonyl, phenoxycarbonyl, benzyloxycarbonyl, methylthiocarbonyl, ethylthiocarbonyl, phenylthiocarbonyl, benzylthiocarbonyl, ethylaminocarbonyl, benzylaminocarbonyl, methoxythiocarbonyl, B Oxythiocarbonyl, phenoxythiocarbonyl, benzyloxythiocarbonyl, methylthiocarbonylcarbonyl, ethylthiothiocarbonyl, phenylthiothiocarbonyl, benzylthiothiocarbonyl, ethylamino Any one or a group of a thiocarbon
  • R 15 is most preferably a hydrogen atom, a fluorine atom or a methyl group.
  • a moiety other than the trivalent core structure does not include a trivalent group of a hetero atom, for example, Wait. Also included, but not limited to, the following structure disclosed in paragraph [0199] of the patent document CN104877127A:
  • the moiety other than the trivalent core structure includes a trivalent group of a hetero atom, for example:
  • R 1 , X 1 , X 2 , X 4 , and Q are as described above, and are not described herein again.
  • the set of features in a trivalent group G 3, and G 3 is not set to the range defined.
  • the moiety other than the tetravalent core structure does not include a tetravalent group of a hetero atom, for example:
  • the moiety other than the tetravalent core structure includes a tetravalent group of a hetero atom, for example,
  • the k+1 valence group in the set G k+1 contains the corresponding k+1 valence ring core structure CC k+1 , or from 2 to k-
  • One low-valent group having a 3 to k-valent group is directly linked or combined or indirectly combined with one or more divalent spacers L 10 .
  • L 10 When two or more L 10 are contained, they may be the same or different from each other.
  • L 10 is not particularly limited. L 10 may contain a carbon atom or may not contain a carbon atom; L 10 may contain a hetero atom or may not contain a hetero atom; L 10 may be a subunit formed by a single atom, or may be a subunit composed of two or more atoms. base.
  • L 10 may be a monoatomic subunit, such as -O- or -S-;
  • L 10 may also be a hetero atom-free hydrocarbylene group, preferably a C 1-20 alkylene group, a C 1-20 divalent alkenyl group, a C 1-20 divalent alkene group, a C 1-20 divalent alkynyl group, C a 1-20 divalent alkyne group, a C 1-20 divalent cycloalkyl group, a C 1-20 divalent cycloalkane group, a phenylene group, a divalent condensed aryl group, or a divalent aromatic hydrocarbon group;
  • R 29 is selected from a C 3-20 alkylene group, and its structure is not particularly limited, and may be a linear, branched or cyclic structure; the number of carbon atoms of R 29 is preferably a C 3-12 hydrocarbon group; and the structure of R 29 A linear structure is preferred.
  • the L 10 is more preferably an oxy group, a thio group, a secondary amino group or a divalent tertiary amino group, at which time a stable linkage is formed.
  • the L 10 is most preferably an oxy group, such as an alcoholic hydroxyl group condensed with an alcoholic hydroxyl group to form an ether linkage.
  • L 10 may also be a monodisperse multimeric form of any of -CH 2 CH 2 -O-, -O-CH 2 CH 2 -, -OR 29 -, -R 29 -O-, repeating unit number selection From 2 to 20, preferably from 2 to 10. However, such structures do not appear in the branch centers U 01 and U 02 .
  • the tetravalent group in the aggregate G 4 may be composed of any two trivalent groups in the aggregate G 3 in addition to the tetravalent core structure.
  • the combination may be a direct linkage, such as a tetravalent group derived from erythritol. It can be seen as a connection of two trivalent groups separated by a broken line.
  • Another example is a tetravalent group formed by directly linking two molecular amino acid skeletons. Wait.
  • the combination may be indirectly connected by one or more divalent spacers L 10 .
  • the tetravalent group in the aggregate G 4 contains two or more L 10 groups, they may be the same or different from each other.
  • Some common tetrahydric alcohols are condensed by a tetrahydric alcohol.
  • the corresponding tetravalent group after deamination of a hydroxyl group or a hydroxyl hydrogen atom belongs to this type. As an example, for example, Wait.
  • the tetravalent G may be selected from any of the above-mentioned aggregates G 4 and a tetravalent group.
  • the tetravalent G also includes, but is not limited to, the following structure disclosed in paragraph [0231] of the patent document CN104877127A:
  • the isomeric structure includes, but is not limited to, a pentavalent carbon skeleton of D-ribose, D-arabinose, D-xylose, D-lyxose.
  • Pentavalent groups also include, but are not limited to, six-membered cyclic monosaccharides such as glucose, allose, altrose, mannose, gulose, idose, galactose, talose, psicose, fructose
  • a combination of 3 to k-1 low-valent groups having a 3 to k valence group or one or more divalent spacers L 10 Indirect combination of k+1 groups of G k+1 .
  • the combination between 3 and k-1 low-cost groups is not particularly limited. By way of example, it may include, but is not limited to, a comb combination method, a tree combination method, a branch combination method, a hyperbranched combination, a ring combination method, and the like.
  • the plurality of lower-valent groups may be the same or different from each other, preferably from the same low-valent group.
  • the number of medium and low-priced groups is from 3 to 150; preferably from 3 to 100.
  • the dendritic combination is 2 to 6 generations; preferably 2 to 5 generations, more preferably 2, 3 or 4 generations.
  • a comb-like combination method is exemplified by hexaglycerin, trimeric pentaerythritol, and the like.
  • the algebra of the dendritic combination is not particularly limited, and is preferably 1 to 6 generations, more preferably 1 to 5 generations, and most preferably 2, 3 or 4 generations.
  • the dendritic combination formed by the dendritic combination can be represented by DENR (U denr , NONE, d) or DENR (U denr , L 10 , d), and can also be expressed as [U denr ,] d .
  • U denr represents a polyvalent group repeating unit, NONE, indicating that the multivalent repeating unit is directly connected
  • L 10 represents that the multivalent repeating unit is indirectly connected by the divalent linking group L 10
  • d represents an algebra of the dendritic combination manner. For example:
  • ng 1, 2, 3, 4, 5 or 6.
  • Hyperbranched combination method for example, has the following repeating unit structure Hyperbranched structure:
  • n 5 is an integer of from 3 to 250; preferably an integer of from 3 to 150; more preferably an integer of from 3 to 100.
  • n 6 is an integer of from 2 to 250; preferably an integer of from 2 to 150; more preferably an integer of from 5 to 100.
  • M 9 is O, S or NX 10 .
  • X 10 is a hydrogen atom or a hydrocarbon group having 1 to 20 carbon atoms.
  • the structure of X 10 is not particularly limited and includes, but is not limited to, a linear structure, a branched structure, or a cyclic structure.
  • the type of X 10 is not particularly limited and includes, but not limited to, a linear alkyl group, a branched alkyl group, a cycloalkyl group, an aryl group, an arylalkyl group, a substituted cycloalkyl group, a substituted aryl group, a substituted aralkyl group, etc. .
  • X 10 is preferably hydrogen atom, methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, pentyl, hexyl, heptyl, 2-ethylhexyl, octyl, decyl, decyl, ten Monoalkyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, C 3-20 cycloalkyl, aryl, phenyl, arene, aralkyl, benzyl, butylphenyl, C 3-20 substituted cycloalkyl, substituted aryl, C 7-20 substituted aromatic a group, a C 7-20 substituted aralkyl group, and the like.
  • it is methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, pentyl, heptyl, 2-ethylhexyl, octyl, decyl, decyl, undecyl, ten Dialkyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, benzyl or butylbenzene Base.
  • X 10 is a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms, including but not limited to a hydrogen atom, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, a t-butyl group, a pentyl group, a heptyl group. , 2-ethylhexyl, octyl, decyl, decyl, benzyl, butylphenyl, and the like.
  • X 10 is a hydrocarbon group having a hydrogen atom or 1 to 5 carbon atoms, including but not limited to a hydrogen atom, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, a t-butyl group, a pentyl group and the like.
  • X 10 is more preferably a hydrogen atom or a methyl group.
  • R 3 is a terminal group to which an oxy group or a thio group is bonded.
  • the number of carbon atoms of R 3 is not particularly limited, but is preferably from 1 to 20, and more preferably from 1 to 10.
  • the structure of R 3 is not particularly limited and includes, but not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • R 3 may or may not contain a hetero atom.
  • R 3 is selected from any one of a C 1-20 hydrocarbon group, a C 1-20 heteroalkyl group, a C 1-20 substituted hydrocarbon group, and a C 1-20 substituted heteroalkyl group.
  • the hetero atom or substituent for substituting R 3 is not particularly limited and includes, but is not limited to, any one of the hetero atoms or any of the substituents listed in the terminology, preferably any one of a halogen atom, a hydrocarbon group, and a hetero atom-containing substituent. .
  • R 3 is preferably C 1-20 alkyl, C 3-20 alkene, aryl, arene, C 1-20 aliphatic, heteroaryl, heteroaryl, substituted C 1-20 alkyl, substituted Any one of a C 3-20 alkene group, a substituted aryl group, a substituted aromatic hydrocarbon group, a substituted C 1-20 aliphatic hydrocarbon group, a substituted heteroaryl group, or a substituted heteroaryl hydrocarbon group.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent.
  • R 3 is preferably a C 1-20 linear alkyl group, a C 1-20 branched alkyl group, a C 3-20 cycloalkyl group, an aryl group, an aromatic hydrocarbon group, a C 1-20 aliphatic hydrocarbon group, a heteroaryl group or a heteroaromatic hydrocarbon. , substituted C 1-20 linear alkyl, substituted C 1-20 branched alkyl, substituted C 3-20 cycloalkyl, substituted aryl, substituted arene, substituted C 1-20 Any one of a fatty hydrocarbon group, a substituted heteroaryl group, or a substituted heteroaryl hydrocarbon group.
  • the substituted atom or the substituent is any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and a halogen atom, an alkoxy group, a hydrocarbon group, an aryl group or a nitro group is preferred.
  • R 3 is a C 1-10 linear alkyl group, a C 1-10 branched alkyl group, a C 3-10 cycloalkyl group, an aryl group, an aromatic hydrocarbon group, a C 1-20 aliphatic hydrocarbon group, a heteroaryl group, or a heterocyclic group.
  • the substituted atom or substituent is selected from the group consisting of a halogen atom, a hydrocarbyl substituent, and a hetero atom-containing substituent, preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a hydrocarbon group, an aryl group or a nitro group; A halogen atom, an alkoxy group or a nitro group is preferred.
  • R 3 is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, benzyl, allyl, and the like. A substituted form of one or any of them.
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the substituted atom or substituent is selected from the group consisting of a halogen atom, a hydrocarbyl substituent, and a hetero atom-containing substituent, preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a hydrocarbon group, an aryl group or a nitro group; A halogen atom, an alkoxy group or a nitro group is preferred.
  • R 3 is a methyl group, an ethyl group or a benzyl group.
  • R 8 is selected from any of halogen atoms of F, Cl, Br, and I. Each is preferably independently a fluorine atom.
  • the number of carbon atoms of R 8 is not particularly limited.
  • the number of carbon atoms of R 8 is each independently preferably from 1 to 20, and more preferably from 1 to 10.
  • the structure of R 8 is not particularly limited, and each independently includes, but is not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • R 8 may or may not contain a hetero atom.
  • R 8 is selected from a hydrogen atom, a halogen atom, a C 1-20 hydrocarbon group, a C 1-20 heteroalkyl group, a substituted C 1-20 hydrocarbon group or a substituted heterohydrocarbyl group.
  • the substituted atom or substituent in R 8 is not particularly limited, and includes, but is not limited to, any one of the substituted atoms or any of the substituents listed in the term, and is selected from a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent.
  • R 8 is a hydrogen atom, a halogen atom, a C 1-20 alkyl group, a C 1-20 unsaturated aliphatic hydrocarbon group, an aryl group, an aromatic hydrocarbon group, a C 1-20 heteroalkyl group, a C 1-20 hydrocarbyloxy group, C Any one or a group of a 1-20 hydrocarbylthioacyl group, a C 1-20 hydrocarbylaminoacyl group, or a substituted form of any one of the groups.
  • the acyl group in R 8 is not particularly limited and includes, but is not limited to, any of the acyl groups listed in the terminology.
  • R 8 is more preferably a hydrogen atom, a halogen atom, a C 1-20 alkyl group, a C 1-20 alkenyl group, an aryl group, an aromatic hydrocarbon group, a C 1-20 aliphatic hydrocarbon group, a heteroaryl group, a heteroaryl hydrocarbon group, C 1- Any atom or group of 20 alkoxyacyl, aryloxyacyl, C 1-20 alkylthioacyl, arylthioacyl, C 1-20 alkylaminoacyl, arylaminoacyl, Or a substituted form of any of the groups.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a halogen atom, an alkenyl group or a nitro group.
  • R 8 is more preferably a hydrogen atom, a halogen atom, a C 1-20 alkyl group, a C 1-20 alkenyl group, an aryl group, an aromatic hydrocarbon group, a C 1-20 aliphatic hydrocarbon group, a heteroaryl group, a heteroaryl hydrocarbon group, C 1- 20 alkoxycarbonyl, aryloxycarbonyl, C 1-20 alkylthiocarbonyl, arylthiocarbonyl, C 1-20 alkylaminocarbonyl, arylaminocarbonyl, C 1-20 alkoxy sulfide Carbonyl, aryloxythiocarbonyl, C 1-20 alkylthiothiocarbonyl, arylthiothiocarbonyl, C 1-20 alkylaminothiocarbonyl, arylaminothiocarbonyl An atom or group, or a substituted form of any of the groups.
  • the acyl group in R 8 is more preferably a carbonyl group or a thiocarbonyl group.
  • the substituted atom or the substituent is any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, an alkenyl group or a nitro group.
  • R 8 is selected from, but not limited to, a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group.
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a halogen atom, an alkenyl group or a nitro group.
  • R 8 is further preferably a hydrogen atom, methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, allyl, propenyl, ethylene Base, phenyl, methylphenyl, butylphenyl, benzyl, methoxycarbonyl, ethoxycarbonyl, phenoxycarbonyl, benzyloxycarbonyl, methylthiocarbonyl, ethylthiocarbonyl, phenylsulfonate Carbocarbonyl, benzylthiocarbonyl, ethylaminocarbonyl, benzylaminocarbonyl, methoxythiocarbonyl, ethoxythiocarbonyl, phenoxythiocarbonyl, benzyloxythiocarbonyl, methylthiocarbonylcarbonyl
  • the substituted atom or the substituent is any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, an alkenyl group or a nitro group.
  • R 8 is more preferably a hydrogen atom, a fluorine atom or a methyl group.
  • It is a ring structure containing a water-soluble block in the ring skeleton, and the valence state is n 5 +1, and all the branching points are derived from ring-forming atoms.
  • the structure of the water-soluble block is not particularly limited, and a linear structure is preferred.
  • the stability of the water-soluble block is not particularly limited and may be stably present or degradable.
  • the ring backbone contains at least one water soluble block.
  • the kinds of the water-soluble blocks may be the same or different from each other.
  • the connection mode between the adjacent water-soluble blocks is not particularly limited, and may be directly connected or may be connected by any divalent linking group.
  • the stability of the divalent linking group is not particularly limited and may be stably present or degradable.
  • the water soluble block may be a water soluble oligomer or a water soluble polymer.
  • the source of the water-soluble block is not particularly limited and may be a natural, modified or synthetic water-soluble oligomer or a water-soluble polymer.
  • the kind of the water-soluble polymer block is not particularly limited, and includes, but not limited to, polyalkylene oxides and derivatives (preferably polyethylene glycol and derivatives thereof), polyvinyl alcohol, polyacrylic acid, and derivatives thereof. , polymethyl methacrylate and its derivatives, polyethyl methacrylate and its derivatives, polyacrylamide, poly N-isopropyl acrylamide, polyhydroxyethyl methacrylate, polyglycolic acid, polyhydroxyl Butyrate, propylene glycol fumarate, polyvinylpyrrolidone, water-soluble polysaccharide, chitosan, dextran, polyamino acid, polypeptide, carboxymethyl starch, starch acetate, hydroxymethyl cellulose, carboxymethyl Cellulose, polyhydroxyalkylmethacrylamide, polyhydroxyalkyl methacrylate, poly- ⁇ -hydroxy acid, polyphosphazene, polyoxazoline, poly N-acryloylmorpholine, and the like
  • the monomer units or "monomer unit pairs" constituting the water-soluble oligomer and the water-soluble polymer block include, but are not limited to, ethylene oxide, substituted ethylene oxide, ethylene glycol, vinyl alcohol, Acrylic acid and its derivatives, methyl methacrylate and its derivatives, ethyl methacrylate and its derivatives, acrylamide, N-isopropyl acrylamide, hydroxyethyl methacrylate, glycolic acid, hydroxybutyric acid , fumaric acid and propylene glycol, vinyl pyrrolidone, chain glucose unit, cyclic glucose unit water-soluble polysaccharide, natural amino acid and its derivatives, polypeptide, hydroxyalkyl methacrylamide, hydroxyalkyl methacrylate, ⁇ - Any one or a combination of two or more of a hydroxy acid, a phosphazene, an oxazoline, and an N-acryloylmorpholine.
  • the structural formula of the substituted ethylene oxide is X 9 is not particularly limited as long as it can be stably present under anionic polymerization conditions.
  • the water-soluble oligomer block includes, but is not limited to, a cyclic oligomer composed of the above monomer units (e.g., cyclodextrin).
  • a water-soluble cyclic peptide or the like can also be included.
  • Water soluble blocks include, but are not limited to, cyclic structures derived from oligomers or polymers: polyethylene glycol, polyvinyl alcohol, polyacrylic acid, polymethyl methacrylate, polyethyl methacrylate, poly Acrylamide, poly N-isopropylacrylamide, polyhydroxyethyl methacrylate, polyglycolic acid, polyhydroxybutyrate, propylene glycol fumarate, polyvinylpyrrolidone, water-soluble polysaccharide, chitosan, Portuguese Glycans, polyamino acids, polypeptides, carboxymethyl starch, starch acetate, hydroxymethylcellulose, carboxymethylcellulose, cyclodextrin, cyclic peptides, and the like.
  • R 01 is a functional group or a protected form thereof.
  • R 01 may be a functional group capable of interacting with a biologically relevant substance or a protected form thereof, or may be a functional group or a derivative thereof which does not react with a biologically relevant substance.
  • the functional group disclosed in paragraphs [0280] to [0506] of the patent document CN104877127A a variant of a reactive group, a functional group having a therapeutic targeting property, a functional group such as a fluorescent functional group, and the like (including the corresponding protected form) and corresponding examples and preferred structures are included in the R 01 range of the present invention.
  • the reactive group is active, can form a linkage with a bio-related substance to form a linkage, and mainly refers to a reaction that forms a covalent bond, and forms a non-covalent bond through a dihydrogen bond or multiple hydrogen.
  • the key is complexed.
  • the covalent bond includes, but is not limited to, a covalent bond that can be stably present, a degradable covalent bond, and a dynamic covalent bond.
  • Such variations include, but are not limited to, precursors of reactive groups, active forms thereof as precursors, substituted active forms, protected forms, deprotected forms, and the like.
  • the precursor of the reactive group refers to at least one process of oxidation, reduction, hydration, dehydration, electron rearrangement, structural rearrangement, salt complexation and decomplexation, ionization, protonation, deprotonation, and the like. Converted to the structure of the reactive group.
  • the precursor can be active or inactive.
  • the variant of the reactive group refers to a reactive group undergoing oxidation, reduction, hydration, dehydration, electron rearrangement, structural rearrangement, salt complexation and decomplexation, ionization, protonation, deprotonation.
  • An inactive form (still a reactive group) after at least one process, such as substitution, deprotection, or the like, or a protected inactive form.
  • Fluorescent functional groups are classified as long as they fluoresce, or emit fluorescence (such as fluorescein diacetate) through the action of the microenvironment in the body, or can fluoresce (such as light stimulation, thermal stimulation, etc.) through clinical stimulation.
  • R 01 includes, but is not limited to, any of the functional groups of the class A to the class H, or a variation thereof, and R 01 of these classes is a reactive group or a variant thereof is a reaction. Sex group.
  • Class A Active esters (including but not limited to succinimide active ester, p-nitrophenyl active ester, o-nitrophenyl active ester, benzotriazole active ester, 1,3,5-trichlorobenzene active ester , 1,3,5-trifluorobenzene active ester, pentafluorobenzene active ester, imidazole active ester, etc., and similar structures of active ester groups (such as 2-thione-3-thiazolidinecarboxylate (tetrahydrothiazole) -2-thione-N-formate), 2-thioxothiazolidine-3-carboxylate, 2-thioketopyrrolidine-N-carboxylate, 2-thioketopyrrolidine-N-A An acid ester, 2-thione benzothiazole-N-formate, 1-oxo-3-thioxoisoindoline-N-formate, etc.);
  • Class B sulfonate, sulfinate, sulfone, sulfoxide, 1,3-disulfonyl-2-propylcarbonylphenyl, sulfone methacryloyl, etc.;
  • Class C hydroxylamine, mercapto, amino (primary or secondary), azide, halogenated hydrocarbon, haloacetamide (such as iodoacetamide), tetramethylpiperidinyloxy, dioxapiperidinyloxy (3,5-dioxo-1-cyclohexylamine-N-oxyl), ammonium salt (amine salt), hydrazine, disulfide compound (such as lipoic acid, etc.)
  • Class D amide, hydrazide, carboxamide, carboxyl, aldehyde, glyoxal, acid halide, acetal, hemiacetal, hydrated aldehyde, ketal, hemi-ketal, hemi-ketal, ketal, hydration Ketones, orthoesters, cyanates, isocyanates, esters, siloxanes, silicates, silyls, thioesters, thioesters, dithioesters (dithioesters), trithioesters (three Thiocarbonate), thiohemiacetal, monothiohydrate, dithiohydrate, disulfide (such as dithiopyridine, etc.), thiol hydrate, thioketone, thioacetal, thioketone Hydrate, keto mercaptan, hemi-ketal, dihydrooxazole, isothiocyanate, sulfhydryl, ureido
  • Class E maleimide, N-acrylamide, acrylate, N-methyl acrylamide, methacrylate, norbornene-2-3-dicarboxyimino, maleamic acid, protected Maleimide, 1,2,4-triazoline-3,5-dione, etc.;
  • Class F cyano, alkenyl (including vinyl, propenyl, etc.), olefinic (such as allyl, etc.), cycloalkenyl (such as cyclooctene, norbornene, etc.), alkynyl, alkyne (such as Propargyl), epoxy (glycidyl ether), azo (such as linear azo compound, cyclic F10, etc.), diazo, dienyl, diolefin, tetrazolium, linear a conjugated diene (such as a linear butadienyl group), a nitrile oxide/cyanide oxide, or the like;
  • Class G cycloalkynyl or cycloalkynyl, cyclodiene (eg conjugated cyclopentadiene, 2,5-norbornadiene, bicycloheptadiene/2,5-norbornadiene, 7 -oxabicycloheptadiene, 7-oxa-bicyclo[2.2.1]hept-5-en-2-yl, etc.), hybrid conjugated diene (such as furan), 1,2,4, 5-tetrazinyl group;
  • cyclodiene eg conjugated cyclopentadiene, 2,5-norbornadiene, bicycloheptadiene/2,5-norbornadiene, 7 -oxabicycloheptadiene, 7-oxa-bicyclo[2.2.1]hept-5-en-2-yl, etc.
  • hybrid conjugated diene such as furan
  • 1,2,4, 5-tetrazinyl group 1,2,4, 5-tetrazinyl
  • Class H hydroxyl (including but not limited to alcoholic hydroxyl, phenolic hydroxyl, enoloxy, hemiacetal, etc.), protected hydroxyl, siloxy, protected bis, trihydroxysilyl, protected Trishydroxysilane and the like.
  • class A to class H also includes a precursor of any reactive group, a substituted form, and a protected form such as a protected hydroxyl group, a protected thiol group, a protected alkynyl group, and a protected form.
  • a protected form such as a protected hydroxyl group, a protected thiol group, a protected alkynyl group, and a protected form.
  • Functional groups related to the click reaction and their referenced click reactions reported in the literature Adv. Funct. Mater., 2014, 24, 2572 are incorporated herein by reference.
  • -NH 2 is a precursor of ammonium ion -NH 3 +
  • -COOH is its sodium salt -COONa, negative ion -COO - Precursor, etc.
  • Protected forms include, but are not limited to, protected hydroxyl groups, protected dihydroxy groups, protected trihydroxy groups, protected orthocarbonic acids, protected sulfhydryl groups, protected amino groups, protected carboxyl groups, protected aldehyde groups.
  • Protected maleimide group such as E4
  • protected alkynyl group such as F4
  • a functional group can belong to two subcategories at the same time.
  • the ortho-pyridine disulfide in C13 is also a protected form of a thiol group.
  • C9 is both a protected amino group and a protected dihydroxy group.
  • Esters, thioesters, thioesters, carbonates, thiocarbonates may also belong to a protected hydroxy or thiol group.
  • the group of class A can be amino modified to form an amide bond or a urethane bond
  • the sulfonate or sulfinate in the group of the class B can be used for the alkylation modification, and the sulfone group or sulfoxide group can be used for the modification of the thiol or disulfide bond.
  • Some groups are also frequently found in modified sites of biologically relevant substances, such as sulfhydryl groups, amino groups, disulfide bonds, and the like.
  • groups having similar reactivity such as hydroxylamine, hydrazine
  • protected forms, salt forms and the like in addition to halogens which are easily removed, and the like.
  • iodoacetamide can also be modified with a thiol group.
  • Some groups or their deprotected forms may interact with a hydroxyl group or a group such as CD, such as a carboxyl group, a sulfonic acid group, a hydroxamic acid, an acid halide, an aldehyde group, an isocyanate group, an isothiocyanate group, Oxycarbonylcarbonyl halide, dihydrooxazole, thiocarboxylic acid, ureido, thioureido, thiol and its protonated form, N-carbamoyl-3-imidazole or N-carbamoyl-3-methyl Imidazolium iodide, or a deprotected form of an acetal, a trihydroxy protecting group, a carboxylate (D11), a thiohemiacetal, a squaric acid ester, a hemi- succinate, a thioester, and an amino group, a thiol group,
  • N-carbamoyl-3-imidazole can be reacted with a carboxyl group, and dihydrooxazole can react with a carboxyl group or an acid halide.
  • a mercapto group can form a dihydrogen bond with two carbonyl groups of tanshinone IIa.
  • the group of the group E contains an ⁇ , ⁇ -unsaturated bond, and a 1,2-addition reaction can occur, for example, it can react with an amino group, a mercapto group or a hydroxyl group.
  • the dihalo-substituted maleimide can also undergo a substitution reaction with a bis-indenyl group.
  • Groups of class F can be obtained by substitution reactions of the corresponding halides.
  • the epoxy group includes, but is not limited to, a naked bishydroxy group obtained by ring opening, a ring-opening addition reaction with an amino group, and the like.
  • An alkenyl group of F2 may undergo an addition reaction.
  • Alkynyl and deprotected alkynyl groups are common groups for the click reaction.
  • Functional groups of the invention also include reactive groups that can undergo a click reaction.
  • Cycloalkyne and its precursors, conjugated dienes, 1,2,4,5-tetrazinyl group can undergo cycloaddition or Diels-Alder addition reaction, allyl, propargyl, propadiene and the like
  • the group can undergo a 1,3-dipolar cycloaddition reaction.
  • G10 can be converted into a reactive group in a diazo form by treatment with a hydrazine or the like, and further reacts with a carboxyl group to form an ester bond.
  • the group of the group H is a protected form of a hydroxyl group, a bishydroxy group, a trihydroxy group, or any of them, and is an important functional group starting group (such as from a PEG terminal), a hydroxyl group or a deproton thereof.
  • the group of the chemical form is also an essential component of the initiator center for initiating the polymerization of ethylene oxide in the present invention. Hydroxyl groups in the class H may also be present at the modified site of the biologically relevant substance. Further, H6 and H7 can be converted into an enol-type hydroxyl group under light conditions, and further subjected to an addition reaction with an ⁇ , ⁇ -unsaturated bond such as E.
  • R 01 When not reacting with a biologically relevant substance, it means a non-bonding reaction, which has a special function at this time, and R 01 includes, but is not limited to, a targeting molecule (for example, folic acid, etc.), and a photosensitive group (such as a fluorescent group). And other special functional molecules and their derivatives. The substituted form still needs to have corresponding specific functions and can be classified into corresponding targeting groups and photo-sensitive groups.
  • R 01 includes, but is not limited to, class I to class J:
  • Class I Targeting groups and pharmaceutically acceptable salts thereof, such as folic acid and its derivatives, cholesterol and its derivatives, biotin and its derivatives, and the like.
  • biotin such as D-desulfurized biotin, 2-iminobiotin, and the like.
  • Class J Fluorescent groups, such as fluorescein, rhodamine, guanidine, guanidine, coumarin, fluorescein 3G, carbazole, imidazole, guanidine, anthraquinone, etc., and the functionality of any of the above Derivatives.
  • derivatives of rhodamine include, but are not limited to, tetramethylrhodamine, tetraethylrhodamine (rhodamine B, RB200), rhodamine 3G, rhodamine 6G (rhodamine 590), 5-carboxy-X-rhodan Ming, 6-carboxy-X-rhodamine, sulforhodamine B, sulforhodamine G, sulforhodamine 101, rhodamine X (R101), rhodamine 101, rhodamine 110, rhodamine 123, rhodamine 700, Rhodamine 800, etc., but also include, but are not limited to, the rhodamine derivatives described in the literature "Progress in Chemistry, 2010, 22 (10): 1929-1939" and references cited therein.
  • R 01 is an active ester, Including, but not limited to, carbonates, acetates, propionates, butyrates, valerates, hexanoates, heptanoates, caprylates, phthalates, phthalates, of any of the active esters, Oxalate, malonate, methylmalonate, ethylmalonate, butylmalonate, succinate, 2-methylsuccinate, 2,2-di Methyl succinate, 2-ethyl-2-methyl-succinate, 2,3-dimethylsuccinate, glutarate, 2-methylglutarate, 3- Methyl glutarate, 2,2-dimethylglutarate, 2,3-dimethylglutarate, 3,3-dimethylglutarate, adipate, Gem Any one of an acid ester, a suberate, a sebacate, a sebacate, a maleate, a fumarate, an amino acid ester, a polypeptide acid ester, or a
  • R 01 is an amino group
  • the primary amine including but not limited to methylamine, ethylamine, propylamine, butylamine, pentylamine, hexylamine, heptylamine, octylamine, cyclohexylamine, aniline, etc., loses the primary amino group obtained by the non-amino hydrogen atom or loses the amino hydrogen atom.
  • Secondary amino group obtained, and dimethylamine, diethylamine, dipropylamine, dibutylamine, diamylamine, dihexylamine, diheptylamine, dioctylamine, dicyclohexylamine, N-methylaniline, N- Secondary amines such as ethylaniline, N-propylaniline, N-isopropylaniline, N-butylaniline, N-cyclohexylaniline, azetidine, pyrrolidine, piperidine, etc., lose non-amino hydrogen atoms Secondary amino group.
  • R 01 is an aldehyde group, Including but not limited to formaldehyde, acetaldehyde, propionaldehyde, butyraldehyde, valeraldehyde, hexanal, heptaldehyde, octanal, furfural, furfural, crotonaldehyde, acrolein, methacrolein, 2-ethyl acrolein, Chloroacetaldehyde, iodoacetaldehyde, dichloroacetaldehyde, benzaldehyde, phenylacetaldehyde, methyl benzaldehyde, cinnamaldehyde, nitrocinnamaldehyde, bromobenzaldehyde, chlorobenzaldehyde, etc.
  • formaldehyde acetaldehyde, propionaldehyde, butyraldehyde, valeraldeh
  • butyraldehyde includes, but is not limited to, n-butyraldehyde, isobutyraldehyde, 2-methylpropanal, 2,2-dimethylacetaldehyde.
  • the valeraldehyde includes, but is not limited to, n-pentanal, 2-methylbutanal, isovaleraldehyde.
  • the octanal as described includes, but is not limited to, n-octanal, 2-ethylhexanal.
  • the methyl benzaldehyde includes o-methylbenzaldehyde, m-methylbenzaldehyde, and p-methylbenzaldehyde.
  • cinnamaldehyde includes, but is not limited to, anti-cinnamaldehyde.
  • the nitrocinnamaldehyde includes, but is not limited to, trans-2-nitrocinnamaldehyde.
  • the bromobenzaldehyde includes 2-bromobenzaldehyde, 3-bromobenzaldehyde, 4-bromobenzaldehyde.
  • chlorobenzaldehyde includes 2-chlorobenzaldehyde, 3-chlorobenzaldehyde, 4-chlorobenzaldehyde.
  • Acrolein as described Benzaldehyde is Such as m-methylbenzaldehyde Such as the anti-cinnamaldehyde, including but not limited to
  • R 01 is a carboxyl group, Including but not limited to formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, heptanoic acid, caprylic acid, capric acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, arachidic acid , behenic acid, behenic acid, isobutyric acid, 3-methylbutyric acid, acrylic acid, methacrylic acid, citric acid, vinyl acetic acid, cis citric acid, 6-heptenoic acid, itaconic acid, fragrant Monoacid, monochloroacetic acid, dichloroacetic acid, monofluoroacetic acid, difluoroacetic acid, benzoic acid, methylbenzoic acid, monofluorobenzoic acid, ethoxybenzoic acid, methoxybenzoic acid, ethylbenzoic acid, Vinyl benzoic acid, propy
  • the above structures include various isomeric forms such as cis, trans, D, and L.
  • malic acid includes D and L types.
  • Methylbenzoic acid includes o-methylbenzoic acid, m-methylbenzoic acid, p-methylbenzoic acid; monofluorobenzoic acid includes 2-fluorobenzoic acid, 3-fluorobenzoic acid, 4-fluorobenzoic acid; ethoxylate Benzoic acid includes o-ethoxybenzoic acid, m-ethoxybenzoic acid, p-ethoxybenzoic acid; methoxybenzoic acid includes o-methoxybenzoic acid, m-methoxybenzoic acid, p-methoxybenzoic acid Ethyl benzoic acid includes o-ethyl benzoic acid, m-ethyl benzoic acid, and p-ethyl benzoic acid.
  • the halogen atom may be a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, preferably a chlorine atom and a bromine atom.
  • the halogen atom may be a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, preferably a chlorine atom and a bromine atom.
  • R 01 When R 01 is an acid anhydride, it may be an open chain or an intramolecular acid anhydride, for example, Including but not limited to acetic anhydride, propionic anhydride, butyric anhydride, valeric anhydride, hexanoic anhydride, heptanoic anhydride, caprylic anhydride, phthalic anhydride, phthalic anhydride, lauric anhydride, myristic acid anhydride, palmitic anhydride, stearic anhydride, behenic anhydride, croton Anhydride, methacrylic anhydride, oleic anhydride, linoleic anhydride, linoleic anhydride, chloroacetic anhydride, iodoacetic anhydride, dichloroacetic anhydride, succinic anhydride, methyl succinic anhydride, 2,2-dimethylsuccinic anhydride, Anhydrides such as itaconic
  • the intramolecular acid anhydride also includes, but is not limited to, derived from succinic anhydride, 2,2-dimethyl succinic anhydride, cyclopentane-1,1-diacetic anhydride, 1,1-cyclohexyl diacetic anhydride, 2- Methylene succinic anhydride, glutaric anhydride, karonic anhydride, cyclobutane-1,2-dicarboxylic anhydride, hexahydrophthalic anhydride, methylhexahydrophthalic anhydride, 1,2,3 ,6-tetrahydrophthalic anhydride, 1,2,5,6-tetrahydrophthalic anhydride, 3-methyltetrahydrophthalic anhydride, methyltetrahydrophthalic anhydride, citraconic anhydride, 2,3-dimethyl Kamaine anhydride, 2,3-dichloromaleic anhydride, 3,4,5,6-tetrahydr
  • R 01 is an intramolecular carbon imide, Including but not limited to the imide form corresponding to any of the above-mentioned intramolecular acid anhydrides, such as succinimide corresponding succinimide, maleic anhydride corresponding maleimide, phthalic anhydride corresponding to phthalic acid Imide, etc., will not be repeated one by one. Also included, but not limited to, sulfonylbenzimide.
  • R 01 is a maleimide group, Including but not limited to from 3,4,5,6-tetrahydrophthalimide, maleimidoacetyl, 3-maleimidopropionyl, 4-maleimide Butyryl, 5-maleimidopentanoyl, 6-(maleimido)hexanoyl, 3-maleimidobenzoyl, 4-maleimidobenzoyl, 4-(N-maleimidomethyl)cyclohexane-1-formyl, 4-(4-maleimidophenyl)butanoyl, 11-(maleimido) Undecanoic acid acyl, 4-(4-maleimidophenyl)butanoyl, 11-(maleimido)undecanoyl acyl, N-(2-aminoethyl)male A maleimide group such as an imide, N-(4-aminophenyl)maleimide or 2-maleimidoethyl.
  • maleimide group such
  • R 01 is a cyano group, Including but not limited to carbonitrile, acetonitrile, butyronitrile, valeronitrile, hexanenitrile, heptonitrile, octonitrile, phthalonitrile, phthalonitrile, undecylnitrile, allyl, acrylonitrile, crotononitrile, methacrylonitrile
  • a monovalent functional group corresponding to a cyano compound such as dichloroacetonitrile, fluoroacetonitrile, benzonitrile, benzyl nitrile, methylbenzyl nitrile, chlorobenzonitrile or methyl benzonitrile loses a hydrogen atom.
  • R 01 is an alkynyl group
  • alkynyl group include, but are not limited to, ethynyl, propynyl, propargyl, cycloalkynyl, and the like.
  • R 01 is a hydroxyl group, Including but not limited to methanol, ethanol, propanol, butanol, pentanol, hexanol, heptanol, octanol, decyl alcohol, decyl alcohol, undecyl alcohol, dodecanol, tridecyl alcohol, tetradecanol, fifteen Alcohol, cetyl alcohol, heptadecyl alcohol, stearyl alcohol, stearyl alcohol, oleyl alcohol, benzyl alcohol, cumene alcohol, phenol, cresol, phenol, propanol, cinnamyl phenol, naphthol, cyclopentanol, A monohydric alcohol such as cyclohexanol loses a corresponding monovalent functional group after a non-hydroxyl hydrogen atom.
  • R 01 is cholesterol or a derivative thereof
  • a molecule such as, but not limited to, a derivative of cholesterol, a cholesteryl hydrosuccinate, or the like, is modified at the end of the PEG.
  • R 01 is biotin or a derivative thereof, Including but not limited to biotin-N-succinimidyl ester, 3-[3-[2-(biotinamide)ethyl]amino-3-oxopropyl]dithio]propionic acid succinyl Amine, 3-[[2-(biotinamide)ethyl]dithio]propionic acid sulfosuccinimide, N-(3-azidopropyl) biotinamine, N-biotin -3,6-dioxooctane-1,8-diamine, N-biotin-3,6,9-trioxadecane-1,11-diamine, biotinyl-6-aminoquin Porphyrin, N-(6-[biotinamine]hexyl)-3'-(2'-pyridinedithio)propanamide, 15-[D-(+)-biotinamino]-4,
  • R 01 is fluorescein or a derivative thereof, Including but not limited to 5-carboxyfluorescein succinimide ester, 6-carboxyfluorescein succinimide ester, 5-aminofluorescein, 6-aminofluorescein, 5(6)-aminofluorescein, 5-( Aminomethyl)fluorescein hydrochloride, 6-([4,6-dichlorotriazin-2-yl]amino)fluorescein hydrochloride, 5'-fluorescein phosphoramidate, fluorescein 5-maleamide Amine, fluorescein 6-maleimide, 5-carboxyfluorescein, 6-carboxyfluorescein, 2,7-bis(2-carboxyethyl)-5(6)-carboxyfluorescein, 5-(4 , 6-dichlorotriazine) aminofluorescein, CI 45350 and other molecules modified at the end of the PEG formed residues.
  • R 01 is rhodamine or a derivative thereof, Including but not limited to tetramethylrhodamine, tetraethylrhodamine (rhodamine B, RB200), rhodamine 3G, rhodamine 6G (rhodamine 590), 5-carboxy-X-rhodamine, 6-carboxy-X - rhodamine, sulforhodamine B, sulforhodamine G, sulforhodamine 101, rhodamine X (R101), rhodamine 101, rhodamine 110, rhodamine 123, rhodamine 700, rhodamine 800, 5 -carboxytetramethylrhodamine, 6-carboxytetramethylrhodamine, 5-carboxytetramethylrhodamine succinimide ester, 6-carboxytetramethylrh
  • R 01 is hydrazine or a derivative thereof, Including but not limited to 9-oxime methanol, 1-aminoindole, 2-aminoindole, 9-nonanoxine, 10-methylindole-9-formaldehyde, 9-anthracenecarboxylic acid, 9-fluorene methyl acrylate, methacrylic acid A residue formed by modifying a molecule such as methyl-9-methyl ester, 9-valeraldoxime or 9-fluorenyl acrolein at the end of the PEG.
  • R 01 is hydrazine or a derivative thereof, Including but not limited to 1-indole methanol, 7,8,9,10-tetrahydrobenzo[a]indol-7-ol, N-hydroxysuccinimide ester 1-indolyl butyric acid, 1-indolyl formaldehyde, 1 - indolebutyric acid, 1-indolecarboxylic acid (1-indolecarboxylic acid), 1-indole acetic acid, 10-(1-indolyl) decanoic acid, 1-decanoic acid, Fmoc-3-(1-indenyl)- L-alanine, tert-butyloxycarbonyl-3-(1-indolyl)-D-alanine, tert-butyloxycarbonyl-3-(1-indolyl)-L-alanine, 1- Molecular modification of aminoguanidine, 1,3-diaminopurine,
  • R 01 is oxazolium or a derivative thereof, Including but not limited to carbazole, 9-oxazole ethanol, 2-hydroxycarbazole, 2-(9H-carbazolyl)ethylboronic acid pinacol ester, 2-(9H-carbazolyl)ethylboronic acid diethanolamine
  • R 01 is imidazole or a derivative thereof, Including but not limited to 4-(hydroxymethyl)imidazole, 4-hydroxyethylimidazole, 1-(2-hydroxyethyl)imidazole, 1-methyl-2-hydroxymethyl-1H-imidazole, 1-(2 -Hydroxypropyl ester)imidazole, 1-( ⁇ -hydroxyethyl)-2-methylimidazole, 4-hydroxymethyl-5-methyl-2-phenylimidazole, 1-hydroxyethyl-3-methyl Imidazole, 1-hydroxyethyl-3-methylimidazolium chloride, 4-hydroxymethyl-5-methylimidazole, 4-bromo-1H-imidazole, 2-bromo-1H-imidazole, 1-methyl-2 -bromo-1H-imidazole, 5-chloro-1-methylimidazole, 2-aminoimidazole, 4-aminoimidazole, 1-(3-aminopropyl)imidazole, 1-methyl-4-imida
  • R 01 is hydrazine or a derivative thereof, Including but not limited to 4-hydroxyindole, 5-hydroxyindole, 6-hydroxyindole, 7-hydroxyindole, 5-hydroxy-2-methylindole, 4-hydroxy-2-methylindole, 3-(2-methylaminoethyl)anthracene, 2-(2-aminoethyl)anthracene, 3-(2-aminoethyl)-6-methoxyindole, 4-aminoindole, 5-aminoindole, 6-aminopurine, 7-aminopurine, 4-methyl-5-aminopurine, 3-bromoindole, 4-bromoindole, 5-bromoindole, 6-bromo ⁇ , 7-bromoindole, 5-bromo-1-methyl-1H-indole, 3-(2-aminoethyl)indol-5-ol, 5-hydroxyindole-2-carboxylic acid, 6 -hydroxy-2-
  • R 01 includes, but is not limited to, any one of the following categories A to J:
  • E 02 and E 03 correspond to a carbonyl group and the other is bonded to OH.
  • X 6 is a terminal group attached to an ester group or an oxygen atom in a thioester group, and is selected from a hydroxy protecting group or a group LG 4 .
  • Y 1 is a leaving group to which a sulfonyl group, a sulfinyl group, an oxysulfonyl group or an oxysulfinyl group is bonded.
  • Y 1 is not particularly limited.
  • Y 1 preferably has a C 1-10 hydrocarbyl group or a fluoro C 1-10 hydrocarbyl group.
  • Y 1 has any one of a C 1-10 alkyl group, a C 1-10 alkenyl group, a phenyl group, and the like, or a substituted form thereof.
  • the substituted atom or the substituent group is a halogen atom, an alkenyl group, an alkoxy group or a nitro group.
  • Y 1 may be selected from, but not limited to, methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, vinyl Any one of phenyl, benzyl, p-methylphenyl, 4-(trifluoromethoxy)phenyl, trifluoromethyl, 2,2,2-trifluoroethyl, and the like.
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl includes, but is not limited to, n-octyl, 2-ethylhexyl.
  • Y 1 is preferably any of a methyl group, a p-methylphenyl group, a 2,2,2-trifluoroethyl group, a trifluoromethyl group, and a vinyl group.
  • W is F, Cl, Br or I, preferably Br or Cl.
  • W 2 is F, Cl, Br or I, preferably I.
  • Ring structures containing a nitrogen atom, a double bond, an azo, a triple bond, a disulfide bond, an acid anhydride, and a diene including but not limited to a carbocyclic ring, a heterocyclic ring, a benzoheterocyclic ring, a substituted carbocyclic ring. a substituted heterocyclic ring or a substituted benzoheterocyclic ring or the like.
  • M is a carbon atom or a hetero atom on the ring, including but not limited to a carbon atom, a nitrogen atom, a phosphorus atom, or a silicon atom.
  • M 8 is a carbon atom or a hetero atom located on the ring.
  • M 8 is preferably a carbon atom, a nitrogen atom, a phosphorus atom or a silicon atom.
  • the number of ring atoms of the ring in which M 8 is present is not particularly limited, but is preferably 4 to 50, more preferably 4 to 32, still more preferably 5 to 32, and still more preferably 5 to 18.
  • M 8 may be a carbon atom or a hetero atom on a ring of 4 to 50 members, preferably a carbon atom, a nitrogen atom, a phosphorus atom or a silicon atom on a ring of 4 to 32 members, more preferably a carbon atom or a nitrogen atom on a ring of 5 to 32 members.
  • the atom, the phosphorus atom or the silicon atom is more preferably a carbon atom, a nitrogen atom, a phosphorus atom or a silicon atom on a ring of 5 to 18 members.
  • R 8 , R 9 , R 10 , R 11 and R 12 are the same as defined in the above R 8 , and are not described herein again. Further, in the same molecule, R 8 , R 9 , R 10 , R 11 and R 12 may be the same as or different from each other.
  • R 8 is most preferably a methyl group.
  • R 2 is an acetal, a ketal, a hemiacetal, a hemi-ketal, an orthoester, a thioacetal, a thioketal, a thio hemiacetal, a thiosemi-ketal, a thioorthoester
  • An end group or a divalent linking group to which an oxygen or sulfur atom is attached such as D7, D8, D12, D18.
  • R 2 is selected from a hydrogen atom, any one of R 21 or R 3 or a group.
  • R 21 is a divalent linking group and participates in ring formation.
  • the number of carbon atoms of R 21 is not particularly limited, and is preferably from 1 to 20, and more preferably from 1 to 10.
  • the structure of R 21 is not particularly limited and includes, but not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • the above aliphatic ring, aromatic ring, sugar ring, and condensed ring are preferred.
  • R 21 may or may not contain a hetero atom.
  • R 21 is selected from a C 1-20 alkylene group, a divalent C 1-20 heteroalkyl group, a substituted C 1-20 alkylene group, a substituted divalent C 1-20 heteroalkyl group, or a divalent linking group.
  • the substituent atom or the substituent is not particularly limited and includes, but is not limited to, any of the substituted atoms or any substituents recited in the terminology, and any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent.
  • R 21 is preferably a C 1-20 open chain alkylene group, a C 1-20 open chain alkenylene group, a C 1-20 cycloalkylene group, a C 1-20 cycloalkylene group, an arylene group, an arylene group, Divalent C 1-20 fattyalkyl, divalent C 1-20 aliphatic heteroalkenyl, divalent heteroaryl, divalent heteroaryl, substituted alkylene, substituted C 1-20 open chain alkylene , substituted C 1-20 cycloalkylene, substituted C 1-20 cycloalkylene, substituted arylene, substituted arylene, substituted divalent C 1-20 heteroalkyl, substituted a divalent C 1-20 oligoalkenyl group, a substituted divalent heteroaryl group, a substituted divalent heteroaryl group, a divalent linking group, a combination of any two, or a combination of any three A divalent linking group.
  • a substituted atom or a substituent is
  • R 21 is a C 1-10 open chain alkylene group, a C 1-10 open chain alkenylene group, a C 3-10 cycloalkylene group, a C 1-10 cycloalkylene group, an arylene group, or an arylene group.
  • divalent C 1-10 oxaalkyl divalent C 1-10 alialkenyl, divalent heteroaryl, divalent heteroaryl, substituted alkylene, substituted C 1-10 open chain Alkenyl, substituted C 1-10 cycloalkylene, substituted C 1-10 cycloalkylene, substituted arylene, substituted aralkyl, substituted divalent C 1-10 oxaalkyl a divalent linking group of a substituted divalent C 1-10 alicyclic alkenyl group, a substituted divalent heteroaryl group, a substituted divalent heteroaryl group, or a combination of any two or any three Valence link.
  • R 21 is selected from the group consisting of methylene, ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, fluorenylene, fluorenylene, 1,2- Any one of a phenyl group, a benzylidene group, a C 1-20 oxaalkylene group, a C 1-20 thiaalkylene group, a C 1-20 azaalkylene group, an azaheteroaryl group, or any of A substituted form of a group or a combination of any two or more of the same or different groups or groups substituted forms.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and a halogen atom, an alkoxy group or a nitro group is preferable.
  • R 21 is preferably selected from the group consisting of methylene, ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, fluorenylene, fluorenylene, 1,2-phenylene, Any one of a benzylidene group, a C 1-20 oxaalkylene group, a C 1-20 thiaalkylene group, a C 1-20 azaalkylene group, an azaheteroaryl group, or a group thereof A substituted form or a combination of any two or more than two identical or different groups or groups substituted forms.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and a halogen atom, an alkoxy group or a nitro group is preferable.
  • R 21 is more preferably 1,2-ethylene, 1,3-propylene.
  • R 4 is selected from any of halogen atoms.
  • a fluorine atom is preferred.
  • the number of carbon atoms of R 4 is not particularly limited, but the number of carbon atoms is preferably from 1 to 20, and more preferably from 1 to 10.
  • the structure of R 4 is not particularly limited and includes, but is not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • R 4 may contain a hetero atom, may contain hetero atoms.
  • R 4 is selected from a hydrogen atom, a halogen atom, a C 1-20 hydrocarbon group, a C 1-20 heteroalkyl group, a substituted C 1-20 hydrocarbon group or a substituted heterohydrocarbyl group.
  • the substituted atom or substituent in R 4 is not particularly limited, and includes, but is not limited to, any one of the substituted atoms or any of the substituents listed in the term, and is selected from a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent.
  • R 4 is a hydrogen atom, a halogen atom, a C 1-20 alkyl group, a C 1-20 unsaturated aliphatic hydrocarbon group, an aryl group, an aromatic hydrocarbon group, a C 1-20 heteroalkyl group, a C 1-20 hydrocarbyloxy group, C Any one or a group of a 1-20 hydrocarbylthioacyl group, a C 1-20 hydrocarbylaminoacyl group, or a substituted form of any one of the groups.
  • the acyl group in R 4 is not particularly limited and includes, but is not limited to, any of the acyl groups listed in the terminology.
  • the acyl group in R 4 is more preferably a carbonyl group or a thiocarbonyl group.
  • R 4 is more preferably a hydrogen atom, a halogen atom, a C 1-20 alkyl group, a C 1-20 alkenyl group, an aryl group, an aromatic hydrocarbon group, a C 1-20 aliphatic hydrocarbon group, a heteroaryl group, a heteroaryl hydrocarbon group, C 1- Any atom or group of 20 alkoxyacyl, aryloxyacyl, C 1-20 alkylthioacyl, arylthioacyl, C 1-20 alkylaminoacyl, arylaminoacyl, Or a substituted form of any of the groups.
  • R 4 is more preferably a hydrogen atom, a halogen atom, a C 1-20 alkyl group, a C 1-20 alkenyl group, an aryl group, an aromatic hydrocarbon group, a C 1-20 aliphatic hydrocarbon group, a heteroaryl group, a heteroaryl hydrocarbon group, C 1- 20 alkoxycarbonyl, aryloxycarbonyl, C 1-20 alkylthiocarbonyl, arylthiocarbonyl, C 1-20 alkylaminocarbonyl, arylaminocarbonyl, C 1-20 alkoxy sulfide Carbonyl, aryloxythiocarbonyl, C 1-20 alkylthiothiocarbonyl, arylthiothiocarbonyl, C 1-20 alkylaminothiocarbonyl, arylaminothiocarbonyl An atom or group, or a substituted form of any of the groups.
  • R 4 is selected from, but not limited to, a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group.
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the substituted atom or the substituent is any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, an alkenyl group or a nitro group.
  • R 4 is further preferably a hydrogen atom, methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, allyl, propenyl, ethylene Base, phenyl, methylphenyl, butylphenyl, benzyl, methoxycarbonyl, ethoxycarbonyl, phenoxycarbonyl, benzyloxycarbonyl, methylthiocarbonyl, ethylthiocarbonyl, phenylsulfonate Carbocarbonyl, benzylthiocarbonyl, ethylaminocarbonyl, benzylaminocarbonyl, methoxythiocarbonyl, ethoxythiocarbonyl, phenoxythiocarbonyl, benzyloxythiocarbonyl, methylthiocarbonylcarbonyl
  • R 4 is preferably hydrogen atom, methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, allyl, propenyl, vinyl Any one or a group of a phenyl group, a methylphenyl group, a butylphenyl group or a benzyl group.
  • R 4 is most preferably a hydrogen atom, a methyl group or a benzyl group.
  • R 24 is a terminal group attached to a disulfide bond, preferably a C 1-20 alkyl group, an aryl group, an aromatic hydrocarbon group, a hybrid phenyl group or the like, such as an ortho-pyridyl group.
  • R 27 is a substituent attached to azo, preferably a phenyl group, a substituted phenyl group or a hybrid phenyl group.
  • R 30 is a hydrocarbon group, preferably a benzyl group in which a C 1-20 alkyl group, a benzyl group, or a benzene ring hydrogen atom is substituted with a C 1-20 hydrocarbon group.
  • M 19 , M 20 and M 21 are each independently an oxygen atom or a sulfur atom, and may be the same or different from each other in the same molecule.
  • X 11 is a terminal group to which a carbonyl group or a thiocarbonyl group is bonded, preferably a C 1-20 alkyl group, more preferably a methyl group, an ethyl group, an isopropyl group or a t-butyl group.
  • X 12 is a terminal group to which a carbonate group or a thiocarbonate group is bonded, and is selected from a hydrocarbon group (which may or may not include a benzene ring), preferably a C 1-20 hydrocarbon group, more preferably a C 1-20 alkyl group, a phenyl group.
  • a hydrocarbyl or hydrocarbyl substituted phenyl group is selected from a hydrocarbon group (which may or may not include a benzene ring), preferably a C 1-20 hydrocarbon group, more preferably a C 1-20 alkyl group, a phenyl group.
  • X 5 is a terminal group attached to a thio group, and is selected from a thiol protecting group or a group LG 2 .
  • X 5 is selected from the group consisting of fluorenyl protecting groups in the combinations exemplified for PG 2 .
  • the number of carbon atoms of LG 2 is not particularly limited.
  • the number of carbon atoms of LG 2 is preferably from 1 to 20, and more preferably from 1 to 10.
  • the structure of LG 2 is not particularly limited and includes, but is not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • LG 2 may or may not contain a hetero atom.
  • LG 2 is selected from any one of a C 1-20 hydrocarbyl group, a C 1-20 heterohydrocarbyl group, a substituted C 1-20 hydrocarbyl group, and a substituted heterohydrocarbyl group.
  • the substituted hetero atom or substituent in LG 2 is not particularly limited, and includes, but is not limited to, any substituted hetero atom or any substituent listed in the terminology, and is selected from a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent. Any of them.
  • LG 2 is more preferably C 1-20 alkyl, C 1-20 unsaturated aliphatic hydrocarbon, aryl, aromatic hydrocarbon, C 1-20 heteroalkyl, C 1-20 alkylthio, C 1-20 aliphatic hydrocarbon sulfur , arylthio, arenethio, C 1-20 aliphatic arehenyl, C 1-20 aliphatic acyl, aryl acyl, heteroaryl acyl, C 1-20 hydrocarbyl acyl, C 1 Any one of a -20 hydrocarbylthioacyl group, a C 1-20 hydrocarbylaminoacyl group, a C 1-20 heteroalkyloxyacyl group, a C 1-20 heteroalkylthioacyl group, a C 1-20 heteroalkylaminoacyl group or A substituted form of any of the groups.
  • the acyl group in LG 2 is not particularly limited and includes, but is not limited to, any of the acyl groups listed in the terminology.
  • the acyl group in LG 2 may be selected from the group consisting of a carbonyl group, a sulfonyl group, a sulfinyl group, a phosphoryl group, a phosphorous group, a hypophosphoryl group, a nitroxyl group, a nitrosyl group, a thiocarbonyl group, an imido group, a thio group.
  • An acyl group such as a carbonyl group, a thiocarbon group, a sulfonyl group or a sulfinyl group is preferred.
  • the acyl group in LG 2 is more preferably a carbonyl group, a thiocarbonyl group or a sulfonyl group.
  • LG 2 is C 1-20 alkyl, aryl, aralkyl, C 1-20 heteroalkyl, heteroaryl, heteroarylalkyl, C 1-20 alkylthio, arylthio, aromatic Alkylthio, C 1-20 heteroalkylthio, heteroarylthio, heteroaralkylthio, C 1-20 alkylcarbonyl, arylcarbonyl, aralkylcarbonyl, C 1-20 Alkylcarbonyl, heteroarylcarbonyl, heteroarylalkylcarbonyl, C 1-20 alkoxycarbonyl, aryloxycarbonyl, aralkyloxycarbonyl, C 1-20 alkylthiocarbonyl, arylthio Carbonyl, aralkylthiocarbonyl, C 1-20 alkylaminocarbonyl, arylaminocarbonyl, aralkylaminocarbonyl, C 1-20 heteroalkyloxycarbonyl, heteroaryloxycarbonyl, heteroaryloxy
  • LG 2 is C 1-20 alkyl, aryl, aralkyl, C 1-20 heteroalkyl, heteroaryl, heteroarylalkyl, C 1-20 alkylthio, arylthio, aromatic A substituted form of any one of alkylthio, C 1-20 heteroalkylthio, heteroarylthio, heteroarylalkylthio or any of the groups.
  • LG 2 is selected from, but not limited to, methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, undecyl, Dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, allyl, benzyl , trityl, phenyl, benzyl, methylbenzyl, nitrobenzyl, tert-butylthio, benzylthio, 2-pyridylthio, ethylacyl, phenylyl, Methoxy, ethoxy, t-butyloxy, phenoxy, benzyloxy, methyl-prop
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom or a nitro group.
  • LG 2 is further preferably methyl, ethyl, n-propyl, isopropyl, tert-butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, undecyl, dodecyl, Tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, allyl, benzyl, triphenyl Base, phenyl, benzyl, methylbenzyl, nitrobenzyl, tert-butylthio, benzylthio, 2-pyridylthio, acetyl, benzoyl, methoxycarbonyl, ethoxy Carbocarbonyl, tert-butyloxycarbonyl, phenoxycarbonyl
  • LG 2 is tert-butyl, benzyl, trityl, phenyl, benzyl, methylbenzyl, tert-butylthio, benzylthio, 2-pyridylthio, 2-pyridyl Carbonyl, tert-butyloxycarbonyl, phenoxycarbonyl, benzyloxycarbonyl, tert-butyloxythiocarbonyl, phenoxythiocarbonyl, benzyloxythiocarbonyl, tert-butylthiothiocarbonyl Any one of a phenylthiothiocarbonyl group, a benzylthiothiocarbonyl group, a trifluoroacetyl group, and the like.
  • LG 2 is a t-butyl group, a benzyl group, a trityl group, a phenyl group, a benzyl group, a methylbenzyl group, a t-butylthio group, a benzylthio group or a 2-pyridylthio group.
  • LG 2 is a methyl group, an ethyl group, an allyl group or a benzyl group.
  • Q 3 is a H atom or a group which contributes to the induction and conjugation effect of an unsaturated bond electron
  • Q 3 is selected from all but substituted atoms and combinations of substituents including, but not limited to, the terminology, as long as it contributes to the induction and conjugation effects of the unsaturated bond electrons.
  • Q 3 may contain carbon atoms or no atoms. When a carbon atom is not contained, it may be, for example, a nitro group. When the carbon atom is contained, the number of carbon atoms is not particularly limited, but is preferably 1 to 20 carbon atoms, and more preferably 1 to 10 carbon atoms.
  • the structure of Q 3 is not particularly limited and includes, but is not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • Q 3 may be selected from any one of a hydrogen atom, a halogen atom, a carbon-free substituent, a hydrocarbon group, a heteroalkyl group, a substituted hydrocarbon group or a substituted heteroalkyl group.
  • the substituted hetero atom or substituent in Q 3 is not particularly limited, and includes but is not limited to any substituted hetero atom or any substituent listed in the terminology, and is selected from a halogen atom, a hydrocarbyl substituent, and a hetero atom-containing substituent. Any of them.
  • Q 3 is a hydrogen atom, a halogen atom, a C 1-20 alkyl group, a C 2-20 alkenyl group, a C 3-20 open chain olefin group, a C 3-20 cycloalkene group, an aryl group, an aromatic hydrocarbon group, C 1 .
  • heteroalkyl heteroaryl, heteroarylalkyl, C 1-20 alkoxy, aryloxy, arylalkyloxy, C 1-20 heteroalkyloxy, heteroaryloxy, hetero Any one or a group of an aromatic hydrocarbonoxy group, a C 1-20 heteroalkylthio group, a heteroarylthio group, a heteroarylalkylthio group, a C 1-20 haloalkyl group, or the like, or a group of any one of Replaced form.
  • Q 3 is a hydrogen atom, a halogen atom, a C 1-10 haloalkyl group, a C 1-10 alkyl group, a C 2-10 alkenyl group, a C 3-10 open chain olefin group, a C 3-10 cycloalkene group, and an aromatic group.
  • a base an aromatic hydrocarbon group, a C 1-10 heteroalkyl group, a heteroaryl group, a heteroarylalkyl group, a C 1-10 alkoxy group, an aryloxy group, an aromatic hydrocarbonoxy group, a C 1-10 heteroalkyloxy group, Any one or a group of a heteroaryloxy group, a heteroarylalkyloxy group, or the like, or a substituted form of any one of the groups.
  • Q 3 may be selected from a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group, and a 2- Ethylhexyl, decyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, N-nonyl, eicosyl, vinyl, propenyl, allyl, propynyl, propargyl, cyclopropyl, cyclopropenyl, phenyl, benzyl, but
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a halogen atom, an alkoxy group, an alkenyl group or a nitro group.
  • Q 3 is preferably a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a decyl group or a fluorenyl group.
  • Base vinyl, propenyl, allyl, propynyl, propargyl, cyclopropyl, cyclopropenyl, phenyl, benzyl, butylphenyl, p-methylphenyl, p-nitrophenyl , o-nitrophenyl, p-methoxyphenyl, pyridyl, methoxy, ethoxy, phenoxy, benzyloxy, methylthio, ethylthio, phenylthio, benzylthio, tri Any atom or group of fluoromethyl, 2,2,2-trifluoroethyl, or the like, or a substituted form of any of the groups.
  • the substituted atom or the substituent is preferably a fluorine atom, an alkoxy group, an alkenyl group or a nitro group.
  • Q 3 is any atom or group of a hydrogen atom, a methyl group, a trifluoromethyl group, a phenyl group, a p-nitrophenyl group, an o-nitrophenyl group, a pyridyl group or the like.
  • Q 3 is a hydrogen atom, a methyl group, a phenyl group, a pyridyl group, a diazaphenyl group or a triazaphenyl group.
  • Q 3 is a hydrogen atom, a methyl group, a phenyl group or a pyridyl group.
  • Q 3 is most preferably a hydrogen atom, a phenyl group or a pyridyl group.
  • Q 5 is selected from a hydrogen atom, a substituted atom or a substituent, and is not particularly limited, and is preferably selected from a H atom, a methyl group, an ethyl group or a propyl group.
  • Q 5 When Q 5 is on the ring, it may be one or more. When it is more than one, it may be the same structure, or a combination of two or more different structures.
  • the ring in which Q 5 is present includes but is limited to hydrazine, carbazole, norbornene, 7-oxa-bicyclo[2.2.1]hept-5-en-2-yl.
  • Q 6 is a hydrogen atom or a methyl group.
  • Q 7 is a hydrogen atom, a methyl group, a phenyl group or a substituted phenyl group.
  • the substituted phenyl group such as p-methoxyphenyl.
  • Q 6 and Q 7 may be the same or different.
  • Q 8 is a substituted atom or a substituent on the imidazole group, and is not particularly limited, and is preferably a hydrogen atom, a methyl group, a methyl group, a propyl group, a butyl group or a phenyl group.
  • Q 8 can be one or more. When it is more than one, it may be the same structure, or a combination of two or more different structures.
  • Q 11 is a substituent on the nitrogen atom of the tetrazole, preferably a phenyl group, a substituted phenyl group or an azaphenyl group.
  • PG 2 is a thiol protecting group, and the structure after sulfhydryl protection is represented by SPG 2 .
  • PG 3 is an alkynyl protecting group.
  • PG 4 is a hydroxy protecting group, and the structure in which the hydroxy group is protected is represented by OPG 4 .
  • PG 5 is an amino-protecting group, and the structure in which the amino group is protected is represented by NPG 5 .
  • PG 6 is a bishydroxy protecting group, and PG 6 and two oxygen atoms constitute a five-membered or six-membered ring acetal structure.
  • PG 6 is selected from a methylene group or a substituted methylene group.
  • the substituent of PG 6 is a hydrocarbyl substituent or a hetero atom-containing substituent including, but not limited to, the following groups: methylene, 1-methylmethylene, 1,1-dimethylmethylene, 1,1-cyclopentylene group, 1,1-cyclohexylene group, 1-phenylmethylene group, 3,4-dimethylphenylmethylene group and the like.
  • PG 8 is a protected group of orthocarbonic acid or orthosilicate
  • D8 is a protected form of ortho acid
  • H5 is a protected form of ortho silicic acid.
  • PG 8 can be a single trivalent end group such as Take D8 as an example, corresponding to PG 8 can also be two or three independent end groups, and correspondingly, D8 corresponds to H5 corresponds to
  • the PG 2 is a thiol protecting group, and is not particularly limited.
  • SPG 2 is a structure in which a mercapto group is protected, and is not limited to a specific structure, and is preferably a structure such as a sulfide, a disulfide, a silyl sulfide, or a thioester, including but not limited to the following structures: methyl sulfide, ethyl sulfur Ether, propyl sulfide, tert-butyl sulfide, butyl sulfide, isobutyl sulfide, benzyl sulfide, p-methoxybenzyl sulfide, o-hydroxybenzyl sulfide, p-hydroxybenzyl sulfide Ether, o-acetoxybenzyl sulfide, p-acetoxybenzyl sulfide, p-nitrobenzyl
  • the SPG 2 is preferably tert-butyl sulfide, trityl sulfide, substituted trityl sulfide, tert-butyldimethylsilyl sulfide, triisopropylsilyl sulfide, benzyl sulfide Ether, substituted benzyl sulfide, p-nitrobenzyl sulfide, o-nitrobenzyl sulfide, acetyl thioester, benzoyl thioester, trifluoroacetyl thioester, tert-butyl Any of thioether, substituted phenyl disulfide, 2-pyridine disulfide, and the like.
  • the PG 3 is an alkynyl protecting group, and is not particularly limited.
  • PG 3 is not limited to a specific structure, and is preferably a silicon group including, but not limited to, the following structures: trimethylsilyl, triethylsilyl, tert-butyldimethylsilyl, dimethyl (1,1,2- Trimethylpropyl)silyl, dimethyl[1,1-dimethyl-3-(tetrahydrofuran-2H-2-oxy)propyl]silyl, biphenyldimethylsilyl, triisopropyl A silyl group, a biphenyldiisopropylsilyl group, a tert-butyldiphenylsilyl group, a 2-(2-hydroxy)propyl group or the like.
  • the PG 4 is a hydroxy protecting group, and is not particularly limited. Among them, PG 4 may be a protective group of an alcoholic hydroxyl group or a phenolic hydroxyl group.
  • OPG 4 is a structure in which a hydroxyl group is protected, and is not limited to a specific structure, and is preferably an ether, a silyl ether, an ester, a carbonate, a sulfonate or the like, including but not limited to the following structures: methyl ether, methoxymethyl ether , methylthiomethyl ether, (phenyldimethylsilyl)methoxymethyl ether, benzyloxymethyl ether, p-methoxybenzyloxymethyl ether, p-nitrobenzyloxy Methyl ether, o-nitrobenzyloxymethyl ether, (4-methoxybenzyloxy) methyl ether, o-methoxyphenol methyl ether, tert-butoxymethyl ether, 4-p
  • the OPG 4 is preferably methyl ether, 1-ethoxyethyl ether, tert-butyl ether, allyl ether, benzyl ether, p-methoxybenzyl ether, o-nitrobenzyl ether, p-nitro Benzyl ether, 2-trifluoromethylbenzyl ether, methoxymethyl ether, 2-methoxyethoxymethyl ether, benzyloxymethyl ether, p-methoxybenzyloxymethyl ether, Methylthiomethyl ether, tetrahydropyranyl ether, trimethylsilyl ether, triethylsilyl ether, triisopropylsilyl ether, tert-butyldimethylsilyl ether, acetate, chlorine Any of acetate, trifluoroacetate, carbonate, and the like.
  • the PG 5 is an amino-protecting group, and is not particularly limited. PG 5 may be a protecting group such as a primary amine, a secondary amine, or a hydrazine.
  • NPG 5 is a structure in which an amino group is protected, and is not limited to a specific structure, and is preferably a carbamate, an amide, an imide, an N-alkylamine, an N-arylamine, an imine, an enamine, an imidazole, a pyrrole, or an anthracene. ⁇ and other structures, including but not limited to the following structures: methyl carbamate, urethane, 9-methyl carbamic acid methyl ester, 9-(2-thio) fluorene carbamate, 9-(2) carbamic acid ,7-dibromo)methyl ester, 17-tetrabenzo[a,c,g,i]methyl carbamate, 2-chloro-3-indolyl carbamate, 1,1-dicarba
  • NPG 5 is preferably formamide, acetamide, trifluoroacetamide, carbamate, carbamic acid 2-iodo-ethyl carbamate, benzyl carbamate, 9-fluorenylmethyl ester, 2-trimethylsilylcarbamate, 2-methylsulfonylcarbamate, 2-(p-toluenesulfonyl)carbamate, phthalimide, diphenylmethyleneamine, 1 , 3,5-dioxane, methylamino, triphenylmethylamino, tert-butylamino, allylamino, benzylamino, 4-methoxybenzylamino, benzylimine Any of them.
  • Z 1 is a divalent linking group, which is defined in detail later, and is not disclosed in detail here. As an example, Including but not limited to any of the following categories A to J:
  • Z 2 is a divalent linking group which can be stably present or degradable, and is hereinafter defined in detail, and is not disclosed in detail herein.
  • M 9 is O, S or NX 10 .
  • M 16 is C, N, P or Si.
  • Q 9 and Q 10 are each independently selected from the group consisting of hydrogen, C 1-20 alkyl, C 6-20 aryl, C 6-20 aromatic hydrocarbon, hybrid C 6-20 aryl, hybrid C 6 -20 aromatic hydrocarbon group. In the same molecule, Q 9 and Q 10 may be the same or different from each other. Each of Q 9 and Q 10 is independently preferably a hydrogen atom, a C 1-6 alkyl group, a phenyl group, a hybrid phenyl group or a substituted phenyl group.
  • X 3 is a hydrocarbon group, a heteroalkyl group, a substituted hydrocarbon group or a substituted heteroalkyl group in the acyl group.
  • the number of carbon atoms of X 3 is not particularly limited.
  • the number of carbon atoms of X 3 is preferably from 1 to 20, and more preferably from 1 to 10.
  • the structure of X 3 is not particularly limited, and each independently includes, but is not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • X 3 is selected from a C 1-20 hydrocarbyl group, a C 1-20 heterohydrocarbyl group, a substituted C 1-20 hydrocarbyl group or a substituted heterohydrocarbyl group.
  • the substituted hetero atom or substituent in X 3 is not particularly limited, and includes, but is not limited to, any substituted hetero atom or any substituent listed in the terminus, selected from a halogen atom, a hydrocarbyl substituent, a hetero atom-containing substituent. Any of them.
  • X 3 is a C 1-20 alkyl group, a C 1-20 unsaturated aliphatic hydrocarbon group, an aryl group, an aromatic hydrocarbon group, a C 1-20 heteroalkyl group, a C 1-20 hydrocarbyloxy group, an aryloxy group, an aromatic hydrocarbon group.
  • X 3 is C 1-20 alkyl, C 3-20 alkenyl, C 3-20 alkynyl, C 5-20 dienyl, C 3-20 alkene, C 3-20 alkyne, C 5- 20 diolefin, aryl, aromatic hydrocarbon, C 3-20 aliphatic hydrocarbon, heteroaryl, heteroaryl, C 1-20 alkoxy, C 2-20 alkenyloxy, C 2-20 alkynyloxy , C 2-20 alkoxy, C 2-20 alkoxy, aryloxy, areneoxy, C 1-20 alkylthio, C 2-20 alkenethio, C 2-20 alkyne Any one of a thio group, an arylthio group, an aromatic thio group, a C 1-20 alkylamino group, a C 2-20 alkenylamino group, a C 2-20 alkylamino group, an arylamino group, an aromatic alkyl group or the like.
  • X 3 is C 1-20 alkyl, C 3-20 alkenyl, C 3-20 alkynyl, C 5-20 dienyl, C 3-20 alkene, C 3-20 alkyne, C 5- A substituted form of any one or any of the groups of 20 diolefin, aryl, arene, C 3-20 aliphatic, heteroaryl, heteroaryl, and the like.
  • X 3 may be selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, decyl, decyl, undecyl, and ten.
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a fluorine atom, an alkoxy group, an alkenyl group or a nitro group.
  • X 3 is methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, vinyl, allyl, phenyl, benzyl, butylphenyl, p-methylphenyl Any one of C 1-10 fluoroalkyl, nitrophenyl, vinylphenyl, methoxyphenyl, fluorophenyl, and the like.
  • X 3 is most preferably methyl, trifluoromethyl, 2,2,2-trifluoroethyl, p-methylphenyl or vinyl.
  • R 20 is a pendant group of an amino acid and a derivative thereof, a protected form of a pendant group or a substituted form of a pendant group.
  • the amino acid derived from R 20 is a derivative of an amino acid or an amino acid, and the amino acid is an L-form or a D-form.
  • R 20 is selected from any of the following including but not limited to any category of an amino acid side groups and derivatives thereof, the side groups are in protected form or in the form of side groups is substituted with:
  • Neutral amino acids and derivatives thereof glycine, alanine, valine, leucine, isoleucine, phenylalanine, proline, sarcosine;
  • Acidic amino acids and derivatives thereof aspartic acid, glutamic acid, asparagine, glutamine;
  • Basic amino acids and derivatives thereof lysine, arginine, histidine, tryptophan.
  • R 25 and R 26 are each independently a hydrogen atom or a methyl group.
  • R 31 , R 32 , R 33 and R 34 are each independently a hydrogen atom or a C 1-6 hydrocarbon group, and may be the same or different from each other in the same part.
  • R 31 , R 32 , R 33 and R 34 are each independently preferably a hydrogen atom or a methyl group.
  • the portion in which Z 2 is bonded to Z 1 in the present invention is not particularly limited.
  • the definition of LG 5 is consistent with the above, and will not be described here.
  • R 22 is a divalent linking group and forms a cyclic substituent, preferably a ring atom of from 3 to 8, more preferably a C 3-8 ring, more preferably a C 3-8 saturated ring.
  • F 1 and F 2 are respectively succinimide propionate and succinimide acetate (corresponding to the class A1
  • R 01 is a succinimide group, -(Z 2 ) q -(Z 1 ) q1 - 1,2-ethylene, methylene), propionaldehyde and butyraldehyde (corresponding to D5)
  • R 01 are both CHO, -(Z 2 ) q - (Z 1 ) q1 - 1,2-ethylene, 1,3-propylene), acetic acid and propionic acid (corresponding to D4,
  • R 01 is COOH, -(Z 2 ) q -(Z 1 ) When q1 - methylene and 1,2-ethylene, respectively
  • L 0 , L 1 , L 2 , L 3 , L 4 , L 5 , L 6 in D 1 , D 2 , D 3 , D 4 , EF 1 or EF 2 , W 0 , W 01 , W 02 , Z 1 , and Z 2 are all divalent linking groups, and are independent of each other, and may be the same or different in the same molecule.
  • L 0 , Z 1 , and Z 2 are groups in D 1 , D 2 , D 3 , D 4 , EF 1 or EF 2
  • L 0 is taken as an example, and may be represented as L 0 (D 1 ), L 0 (D 2 ), L 0 (D 3 ), L 0 (D 4 ), L 0 (EF 1 ), L 0 (EF 2 ), and the like.
  • L 0 , L 1 , L 2 , L 3 , L 4 , L 5 , L 6 , W 0 , W 01 , W 02 , Z 1 , Z 2 are not particularly limited, and each independently includes, but is not limited to, a linear chain. Structure, branched structure or ring-containing structure.
  • the number of non-hydrogen atoms of L 0 , L 1 , L 2 , L 3 , L 4 , L 5 , L 6 , W 0 , W 01 , W 02 , Z 1 , and Z 2 is not particularly limited, and each is preferably 1 to 1 independently.
  • the non-hydrogen atom is a carbon atom or a hetero atom.
  • the heteroatoms include, but are not limited to, O, S, N, P, Si, B, and the like.
  • the non-hydrogen atom may be a carbon atom or a hetero atom.
  • the type of the non-hydrogen atom is not particularly limited, and may be one type or two or more types.
  • carbon atoms and carbon may be used. An atom, a carbon atom and a hetero atom, a hetero atom and a hetero atom are combined.
  • L 0 , L 1 , L 2 , L 3 , L 4 , L 5 , L 6 , W 0 , W 01 , W 02 , Z 1 , Z 2 each independently preferably have 1 to 50 non-hydrogen atoms;
  • the non-hydrogen atom is C, O, S, N, P, Si or B; when the number of non-hydrogen atoms is more than 1, the type of the non-hydrogen atom is one type, or two types, or two or more types, and the non-hydrogen atom is A carbon atom is combined with a carbon atom, a carbon atom and a hetero atom, and a hetero atom or a hetero atom.
  • the divalent linking group is a linker STAG or a degradable linker DEGG which is stable in existence.
  • the conditions for the stable presence are not particularly limited, and include, but are not limited to, stable in light, heat, enzyme, redox, acid, alkaline, physiological conditions, in vitro simulated environment, etc., preferably in light, heat, enzyme It can be stably present under conditions such as redox, acidity and alkalinity.
  • the conditions for the degradation are not particularly limited, and include, but are not limited to, degradation under conditions of light, heat, enzyme, redox, acid, alkaline, physiological conditions, in vitro simulated environment, etc., preferably in light, heat, enzyme, oxidation. It can be degraded under conditions of reduction, acidity and alkalinity.
  • a valency linker or a divalent linker of the divalent linker to an adjacent heteroatom group is a stable linker STAG, and the remaining divalent linker or the divalent linker and an adjacent heteroatom group
  • the divalent linking group is a linking group DEGG which is a degradable linker.
  • the definitions of M 9 , X 10 , and R 37 are the same as those described above, and are not
  • the U 1 (O-) 3 and U 2 (O-) 3 of the present invention preferably do not contain a -OCH 2 CH 2 O- unit.
  • the -O(L 0 ) g0 --, -O(Z 2 ) q -(Z 1 ) q1 -- of the present invention preferably does not contain an -OCH 2 CH 2 O- unit.
  • the polyfunctionalized H-type polyethylene glycol derivative can be stably present or degradable.
  • the number of degradable sites in the same molecule may be one or more. According to the difference between the number of degradable sites and the position of degradable sites, including but not limited to the following situations:
  • Degradation may occur at any of Z 1 (F 1 ) and Z 2 (F 1 ), and the remaining divalent link positions may be independently present or degradable independently; or Z 1 (F 2 ), Z Degradation may occur at any of 2 (F 2 ), and the remaining divalent link positions may be independently present or degradable independently;
  • any one of Z 1 (F 1 ), Z 2 (F 1 ), and any one of Z 1 (F 2 ) and Z 2 (F 2 ), degradation may occur, and the remaining divalent linking groups may be
  • the positions are each independently stable or degradable;
  • Degradation may occur at any one of L 0 (F 1 ) and L 0 (F 2 ), and the remaining positions of the above-mentioned divalent linking groups may be stably present or degradable independently;
  • Degradation may occur at any of L 5 and L 6 , and the remaining positions of the above divalent linking groups may be stably present or degradable independently;
  • Both L 5 and L 6 can be degraded, and the remaining divalent linking sites are independently stable or degradable;
  • Degradation may occur at any of W 0 , W 01 , and W 02 , and the remaining positions of the above-mentioned divalent linking groups may be independently present or degradable independently.
  • (1) may be located at U 01 , U 02 , L 1 , L 2 , L 3 , L 4 , L 5 , L 6 , W 0 , W 01 , W 02 , (L 0 ) g0 ,
  • any of the degradable groups of G, (Z 2 ) q -L (2) may also occur at the junction of any of the above groups with an adjacent group, but not for Z 1 -R 01
  • the degradability of the connection position is limited.
  • the degradable group contains a degradable divalent linking group such as an ester group or a carbonate group.
  • the stability of the polymer and the releasability of the modified drug are important.
  • (1) When degradation occurs between a functional group at the end of a polyethylene glycol chain and a polyethylene glycol chain, that is, the position of -(Z 2 ) q -L-, a drug molecule and a polyethylene glycol structure The detachment exposes the active site of the drug molecule to the maximum extent, and the drug molecule can be maximally close to the state before unmodification.
  • (a) g 0 or 1, and degrading at the divalent junction between the trivalent core structure of the trivalent branched structure and the PEG branching chain, wherein U 1 (O-) 3 is in U 01 -L 1 At least one of -O, U 01 -L 2 -O is degradable, and U 2 (O-) 3 is degradable at least one position of U 02 -L 3 -O in U 02 -L 4 -O;
  • (b) g 0 or 1, and degradation occurs at the divalent junction between the trivalent core structure of the trivalent branched structure and the PEG backbone, wherein U 1 (O-) 3 is in U 01 -L 5 The -O position is degradable and U 2 (O-) 3 is degradable at the U 02 -L 6 -O position;
  • (f) g 1, only the position (L0) G0 of degradation, comprising (L0) within g0, O- (L0) g0 connection, (L0) g0 -G connection;
  • the degradability of the two sides is independent, that is, the trivalent nuclear structure of the two branched central structures, the divalent connection between the trivalent nuclear structure and the PEG branching chain, and the third
  • the divalent linkage between the valency core structure and the PEG backbone, and the degradability of (L 0 ) g0 -G-((Z 2 ) q -L) k0 at the end of the PEG branch chain are independent and may be the same or different.
  • One or more types of degradation modes are allowed in the polyfunctional polyethylene glycol derivative.
  • gradient degradation can occur, and the degradation kinetics of the modified product can be more flexibly controlled; for PEG-modified drugs, the pharmacokinetic control in the body is more flexible and fine. More able to meet the needs of complex therapeutic effects.
  • the stable linker STAG or the degradable linker DEGG in the present invention may be present in the above L 0 , L 1 , L 2 , L 3 , L 4 , L 5 , L 6 , W 0 , W 01 , Any of divalent linking groups of W 02 , Z 1 , and Z 2 , or a divalent linking group present in any of the divalent linking groups and adjacent hetero atomic groups, may also be present in any of the branching centers
  • the conditions in which the STAG can be stably existed are not particularly limited, and can be stably present under any conditions including, but not limited to, light, heat, enzyme, redox, acidity, alkaline conditions, physiological conditions, in vitro simulated environment, and the like, preferably in light or heat. It can be stably present under any conditions such as enzyme, redox, acidity and alkalinity.
  • the type of STAG is not particularly limited, and includes but is not limited to an alkylene group, a divalent heteroalkyl group, a double bond, a triple bond, and a divalent two.
  • the STAG includes, but is not limited to, any one of the following structures or a combination of two or more of the following:
  • ⁇ -aminocarboxylic acid is preferably H 2 N(CH 2 ) j1 COOH, wherein the integer j 1 is selected from 2 to 20, preferably 2 to 12, more preferably 2 to 6, most preferably 2.
  • R 7 , R 18 , R 19 , R 8 , R 9 , R 10 , R 11 , M 5 , M 6 and M 5 and M 6 are located are as described above, and are not described herein again.
  • typical STAG examples include, but are not limited to, R 1 is a hydrogen atom, a methyl group or an ethyl group; R 3 is a methyl group, an ethyl group or a benzyl group; and R 7 , R 18 and R 19 are each independently a methyl group.
  • R 8 , R 9 , R 10 and R 11 are a hydrogen atom or a methyl group.
  • L 11 is an alkylene group or a substituted alkylene group which is stable in existence.
  • the substituted hetero atom or the substituent is not particularly limited, and includes, but is not limited to, any one of the substituted hetero atoms or any of the substituents listed in the term, and any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent. .
  • L 11 is not particularly limited and includes, but not limited to, a linear structure, a branched structure, or a cyclic structure.
  • the number of carbon atoms of L 11 is not particularly limited, and is preferably 1 to 20 carbon atoms, more preferably 1 to 10 carbon atoms.
  • L 11 is preferably a C 1-20 alkylene group or a substituted C 1-20 alkylene group which is stable in existence.
  • the steadily present condition is not particularly limited, and is preferably stable under conditions of light, heat, enzyme, redox, acid, basic, physiological conditions, in vitro simulated environment, and the like.
  • L 11 is a C 1-20 alkylene group or a substituted C 1-20 alkylene group which is stably present under conditions of light, heat, enzyme, redox, acid, basic, physiological conditions, in vitro simulated environment and the like.
  • L 11 includes but is not limited to:
  • L 11 Taking methylene or substituted methylene as an example, the structure of L 11 includes but is not limited to:
  • R 3 , R 7 , R 18 , R 19 , R 19 , R 23 , R 21 , PG 2 , and PG 4 are the same as those described above, and are not described herein again.
  • the structure includes but is not limited to: methylene,
  • L 11 is methylene, 1,1-ethylene, 1,2-ethylene, 1,3-propylene, 1,2-propylene, isopropylidene, butylene, or Pentyl, hexylene, heptylene, octylene, fluorenylene, fluorenylene, undecylene, dodecylene, tridecylene, tetradecyl, heptadecane , hexadecyl, heptadecyl, octadecyl, undecylene, decylene, cyclopropylene, cyclopentylene, cyclohexylene, cyclohexene a substituted alkylene group, a cyclooctylene group, a cyclopentylene group, a p-phenylene group, an phenylene group, an isophenylene group, a benzylidene group, or a substituted form
  • X 7 and X 8 are present in the same molecule, each independently linking an oxy or a thio group, any of which is R 3 and the other is X 4 when attached to the oxy group, and when attached to the thio group X 5 .
  • R 3 , X 4 , and X 5 are consistent with the above, and are not described herein again.
  • R 13 and R 14 are each independently a hydrogen atom, a hetero atom or a substituent on a secondary or tertiary carbon.
  • the hetero atom and the substituent in R 13 and R 14 are not particularly limited.
  • the number of carbon atoms of R 13 and R 14 is not particularly limited.
  • the aliphatic hydrocarbon group or the aliphatic hydrocarbon group is preferably independently independently a carbon number of from 1 to 20, more preferably from 1 to 10.
  • the number of carbon atoms of the aryl group, the aromatic hydrocarbon group, the heteroaryl group, the heteroaryl hydrocarbon group and the fused heterocyclic hydrocarbon group is not particularly limited.
  • R 13 and R 14 are each independently selected from, but not limited to, a hydrogen atom, a halogen atom, a C 1-20 hydrocarbon group, a C 1-20 heteroalkyl group, a substituted C 1-20 hydrocarbon group, a substituted C 1-20 heteroalkyl group, and the like. An atom or group of any of them.
  • the substituent atom or the substituent is not particularly limited and includes, but is not limited to, all of the substituent atoms and substituents recited in the terminology, and any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent.
  • R 13 and R 14 are each independently preferably a hydrogen atom, a halogen atom, a C 1120 alkyl group, a C 3-20 unsaturated hydrocarbon group, a C 1-20 linear aliphatic hydrocarbon group, a C 3-20 branched aliphatic hydrocarbon group, or a C 3-20 group.
  • the substituted atom and the substituent are preferably a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a C 1-6 alkyl group, a C 1-6 alkenyl group, an aryl group, an alkoxy group or a nitro group.
  • acyl group is not particularly limited and includes, but is not limited to, any of the acyl groups listed in the terminology.
  • Preferred are carbonyl, sulfonyl, sulfinyl, phosphoryl, phosphoryl, hypophosphoryl, nitroxyl, nitrosyl, thiocarbonyl, imidoyl, thiophosphoryl, dithiophosphoryl, tri A thiophosphoryl group, a thiophosphoryl group, a dithiophosphoryl group, a thiophosphoryl group, a thiophosphonyl group, a dithiophosphonyl group, a thiophosphinyl group, and the like. More preferably, any one of a carbonyl group, a thiocarbonoyl group, a sulfonyl group, and a sulfinyl group is used.
  • R 13 and R 14 are each independently more preferably a hydrogen atom, a halogen atom, a C 1-20 alkyl group, a C 220 alkenyl group, a C 2-20 alkynyl group, a C 4-20 dienyl group, a C 3-20 alkene group, C 3-20 alkyne group, C 5-20 diolefin group, C 1-20 linear aliphatic hydrocarbon group, C 3-20 branched aliphatic hydrocarbon group, C 3-20 cycloalkyl group, C 3-20 cycloalkenyl group, C 3-20 cycloalkyne, C 5-20 cyclodienyl , phenyl, fused ring hydrocarbon, aromatic hydrocarbon, C 1-20 open chain heteroalkyl, C 3-10 aliphatic heterocycloalkyl, heteroaryl, heteroaromatic Base, aryl fused heterocycloalkyl, hetero fused heterocyclic hydrocarbon, C 1-20 alkoxy, C 2-20 alkeny
  • R 13 and R 14 each independently may be selected from a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a butyl group, a pentyl group, and a hexyl group.
  • butyl includes, but not limited to, n-butyl group and tert-butyl group.
  • Octyl groups include, but are not limited to, n-octyl, 2-ethylhexyl.
  • the acyl group is any of the above acyl groups.
  • the substituted atom or the substituent is selected from a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and is preferably a halogen atom, a C 1-6 alkyl group, an alkoxy group, a C 1-6 alkenyl group, Any of the nitro groups.
  • R 13 and R 14 are each independently more preferably a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a butyl group, a pentyl group, a hexyl group or a heptyl group.
  • R 13 and R 14 are each independently more preferably a hydrogen atom, a fluorine atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a decyl group or a fluorenyl group.
  • R 13 and R 14 are each independently more preferably a hydrogen atom, a fluorine atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a butyl group, a phenyl group, a benzyl group, a butylphenyl group or a p-methylphenyl group. Any one or a group of a trifluoromethyl group, a 2,2,2-trifluoroethyl group, or a substituted form of any one of them.
  • R 13 and R 14 are each independently most preferably a hydrogen atom or a methyl group.
  • the structure of -NR 7 - includes, but is not limited to, -NH-,
  • R 5 and R 6 are each independently a hydrocarbylene group or a substituted alkylene group which may be stably present; and in the same molecule, R 5 and R 6 may be the same as or different from each other.
  • the conditions in which the stability can be present are not particularly limited.
  • R 5 and R 6 are not particularly limited, and each independently includes, but is not limited to, a linear structure, a branched structure, or a cyclic structure.
  • the number of carbon atoms of R 5 and R 6 is not particularly limited, and each independently is preferably 1 to 20 carbon atoms, more preferably 1 to 10 carbon atoms.
  • R 5 and R 6 may each independently be selected from any one of a C 1-20 alkylene group or a substituted C 1-20 alkylene group which may be stably present.
  • the steadily present condition is not particularly limited, and is preferably stable under conditions of light, heat, enzyme, redox, acid, basic, physiological conditions, in vitro simulated environment, and the like.
  • R 5 and R 6 are each independently more preferably any one of a linear alkylene group, a branched alkylene group, a cycloalkyl group, a phenyl group, a fused aryl group, and an aralkyl group, or any one of them is C.
  • R 5 and R 6 each independently preferably have 1 to 10 carbon atoms.
  • R 5 and R 6 may each independently be selected from the group consisting of, but not limited to, methylene, 1,1-ethylene, 1,2-ethylene, 1,3-propylene, 1,2-propylene, isopropylidene, butylene, pentylene, hexylene, heptylene, octylene, fluorenylene, fluorenylene, undecylene, dodecylene , tridecylene, tetradecylene, pentadecyl, hexadecyl, heptadecyl, octadecyl, undecylene, decylene, sub a substituted alkyl, a cyclohexylene group, a cyclohexylene group, a cyclopentylene group, a p-phenylene group, an o-phenylene group, an isophenylene group, a benzylidene group, or
  • the substituent is selected from any one of a C 1-6 alkyl group, a phenyl group, a benzyl group, a methylphenyl group, and a butylphenyl group.
  • the pentylene group includes, but is not limited to, 1,5-pentylene, 3,3-pentylene. among them.
  • the heptylene group includes, but is not limited to, 1,7-heptylene, 1,1-diisopropylmethylene.
  • R 5 and R 6 are each independently more preferably methylene, 1,2-ethylene, 1,3-propylene, 1,2-propylene, isopropylidene, butylene, pentylene. , hexylene, 1,7-heptylene, 1,1-diisopropylmethylene, octylene, cyclopropylene, p-phenylene, o-phenylene, m-phenylene, benzylidene, 1 -benzylmethylene, 1-phenylmethylene and the like.
  • R 5 and R 6 are each independently most preferably methylene, 1,2-ethylene, 1,3-propylene, 1,4-butylene, 1,5-pentylene, 1,6- Any of the sub-hexyl groups.
  • -M 17 (R 22 )- is a 1,1-cyclic divalent linking group, and the number of ring atoms is preferably from 3 to 8 (3, 4, 5, 6, 7, or 8).
  • M 17 is a carbon atom or a hetero atom located on the ring.
  • a carbon atom, a phosphorus atom or a silicon atom located on the ring is preferred.
  • the substituted hetero atom or the substituent is not particularly limited, and includes, but is not limited to, any one of the substituted hetero atoms or any of the substituents listed in the term, and any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent.
  • R 22 is a divalent linking group and participates in ring formation.
  • the number of carbon atoms of R 22 is not particularly limited, and is preferably from 1 to 20, and more preferably from 1 to 10.
  • the structure of R 22 is not particularly limited and includes, but not limited to, a linear structure, a branched structure containing a side group, or a cyclic structure.
  • the cyclic structure is not particularly limited and includes, but is not limited to, any of the cyclic structures recited in the terminology.
  • R 22 may or may not contain a hetero atom.
  • R 22 is selected from the group consisting of a C 1-20 alkylene group, a C 1-20 divalent heteroalkyl group, a substituted C 1-20 alkylene group, a substituted C 1-20 divalent heteroalkyl group, or any two of the divalent linking groups.
  • the substituent atom or the substituent is not particularly limited and includes, but is not limited to, any of the substituted atoms or any substituents recited in the terminology, and any one selected from the group consisting of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent.
  • R 22 is a C 1-20 open chain alkylene group, a C 1-20 open chain alkenylene group, a C 3-20 cycloalkylene group, a C 1-20 cycloalkylene group, an arylene group, C 1- 20 divalent fatty alkyl, C 1-20 divalent heteroalkenyl, divalent heteroaryl, substituted alkylene, substituted C 1-20 open alkenylene, substituted C 1-20 Cycloalkyl, substituted C 1-20 cycloalkylene, substituted aralkyl, substituted C 1-20 divalent heteroalkyl, substituted C 1-20 divalent heteroalkenyl, substituted A divalent linking group formed by any one of divalent linking groups or a combination of two or any three of the divalent heteroaromatic hydrocarbon groups.
  • the hetero atom is not particularly limited, and any of O, S, N, P, and Si is preferable.
  • R 22 is more preferably C 1-10 open chain alkylene, C 1-10 open alkenylene, C 3-10 cycloalkylene, C 1-10 cycloalkylene, arylene, C 1- 10 divalent fatty alkyl, C 1-10 divalent heteroalkenyl, divalent heteroaryl, substituted alkylene, substituted C 1-10 open alkenylene, substituted C 1-10 Cycloalkyl, substituted C 1-10 cycloalkylene, substituted aralkyl, substituted C 1-10 divalent heteroalkyl, substituted C 1-10 divalent heteroalkenyl, substituted A divalent linking group formed by any one of divalent linking groups or a combination of two or any three of the divalent heteroaromatic hydrocarbon groups.
  • R 22 is selected from the group consisting of methylene, ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, fluorenylene, fluorenylene, C 1-20 a substituted form of a valent oxaalkyl group, a C 1-20 divalent thiaalkyl group, a C 1-20 divalent azaalkyl group, a divalent aza heteroaryl group, or a group of any one Or a combination of any two or more than two identical or different groups or groups substituted forms.
  • the substituted atom or the substituent is selected from any one of a halogen atom, a hydrocarbon group substituent, and a hetero atom-containing substituent, and a halogen atom, an alkoxy group or a nitro group is preferable.
  • R 22 is preferably 1,2-ethylene, 1,2-vinylidene or 1,3-propylene.
  • R 22 is 1,2-ethylene, corresponding Corresponding when R 22 is 1,2-vinylidene
  • R 38 is a hydrocarbon group, preferably a C 1-20 hydrocarbon group, more preferably a C 1-20 alkyl group, more preferably a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group or a hexyl group.
  • R 39 is a hydrogen atom or a substituent to which a nitrogen atom is bonded, preferably a hydrogen atom or a C 1-20 hydrocarbon group, further preferably a hydrogen atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, an n-butyl group or a benzyl group. base.
  • R 39 is preferably NH 2 , NHR 39 or N(R 39 ) 2 .
  • SG is a collection of amino acid skeletons; any one of amino acid skeletons in SG is derived from derivatives of amino acids or amino acids; and the amino acids are L -form or D -form.
  • SG is a collection of amino acid skeletons; any one of amino acid skeletons in SG is derived from derivatives of amino acids or amino acids; and the amino acids are L -form or D -form.
  • any of the amino acid backbones in SG are derived from derivatives including, but not limited to, any one of the following classes of amino acids or any of the amino acids:
  • Neutral amino acids glycine, alanine, valine, leucine, isoleucine, phenylalanine, proline, sarcosine;
  • Amino acid having a hydroxyl group or sulfur serine, threonine, cysteine, methionine, tyrosine, hydroxyproline;
  • Acidic amino acids aspartic acid, glutamic acid, asparagine, glutamine;
  • Basic amino acids lysine, arginine, histidine, tryptophan.
  • SG includes, but is not limited to, a collection of the following amino acid backbones:
  • R 20 is -H, -CH 3 , -CH(CH 3 ) 2 , -CH 2 -CH(CH 3 ) 2 or -CH(CH 3 )-CH 2 CH 3 ;
  • R 20 is -CH 2 -OH, -CH 2 -OPG 4 , -CH 2 -OR 3 , -CH(CH 3 )-OH, -CH(CH 3 )-OPG 4 , -CH(CH 3 )-OR 3 , -CH 2 -SH, -CH 2 -SPG 2 ,- CH 2 -SR 3 or -CH 2 CH 2 -S-CH 3 ;
  • R 3 , R 7 , R 18 , PG 4 , and PG 5 are as defined above, and will not be described herein.
  • cyclic linkers include, but are not limited to, the following cyclic linkers:
  • R 7 is a hydrogen atom, PG 5 or LG 5 .
  • the definitions of PG 5 and LG 5 are consistent with the above.
  • Q 2 is consistent with the above definition of O, and details are not described herein again.
  • M 4 is a carbon atom or a hetero atom located on the ring, including but not limited to a carbon atom, a nitrogen atom, a phosphorus atom, a silicon atom or the like. among them, Represents a heteroaromatic ring containing a triazole structure, a fused heterocyclic ring, a substituted heteroaryl ring or a substituted fused heterocyclic ring.
  • L 0 may comprise an oligopeptide or a polypeptide formed by N- and C-terminal ends of a plurality of amino acids, which may be the same or different, but does not include a polypeptide fragment which is degradable by an in vivo biological enzyme.
  • L 0 may also contain -(L 11 O) nj -, -(OL 11 ) nj -, -(R 29 O) nj -, -(OR 29 ) nj -, -(CH 2 CH 2 O) Any of nj -, -(OCH 2 CH 2 ) nj - and the like.
  • the definitions of L 11 and R 29 are consistent with the above.
  • the integer nj is the number of repeating units of the monodisperse structure, and is selected from 2 to 20, preferably 2 to 10.
  • the DEGG degradable condition is not particularly limited, and may be degraded under any conditions including, but not limited to, light, heat, enzyme, redox, acid, alkaline, physiological conditions, in vitro simulated environment, etc., preferably in light, heat, enzyme, It can be degraded under any conditions such as redox, acidity and alkalinity.
  • the divalent linking group formed by combining any of DEGG with any of the STAGs is a degradable linking group.
  • DEGG is not particularly limited and includes, but is not limited to, containing a disulfide bond, a vinyl ether bond, an ester group, a thioester group, sulfur Ester group, dithioester group, carbonate group, thiocarbonate group, dithiocarbonate group, trithiocarbonate group, urethane group, thiocarbamate group, disulfide A carbamate group, an acetal, a cyclic acetal, a thioacetal, an azaacetal, a nitrogen heterocyclic acetal, a nitrogen thioacetal, a dithioacetal, a hemiacetal, a thio hemiacetal Aza-hemiacetal, ketal, sulfur-thione, aza- ketal, azacyclohexanone, azathioketal, imine bond, hydrazone bond, hydrazide bond, hydrazone bond, thiol ether group, Semi
  • the carbamate group, the thiourethane group, the carboxamide, the phosphoramide or the like can be used as a linker which can be stably present or as a degradable linker.
  • the optional structure of DEGG includes, but is not limited to, a structure containing any one of the following structures, or a combination of any two or more of the structures, or any one or more structures and a divalent linking group L which can be stably present 9 formed combination:
  • ester bonds are degradable except under acid and alkali conditions. And such as benzyloxycarbonyl, The ester group in the case can also be degraded under special light conditions (Journal of Polymer Science: Part A: Polymer Chemistry, 2008, 46, 6896-6906).
  • L 9 is any divalent linking group which can be stably present, and may be any of the above STAGs.
  • r1 and r2 are each independently 0 or 1.
  • r3 is 2, 3, 4, 5 or 6;
  • R 3 , R 5 , R 6 , R 7 , R 18 , R 19 , R 23 , R 8 , R 9 , R 13 , R 14 , R 15 , M 5 , M 6 have the same meanings as defined above, here No longer.
  • R 41 and R 42 are each independently selected from C 1-20 alkyl, phenyl, benzyl, C 1-20 alkyl substituted phenyl, C 1-20 alkyl substituted benzyl, C 1 Any one of -20 alkoxy groups, preferably C 1-6 alkyl, phenyl, benzyl, C 1-6 alkyl substituted phenyl, C 1-6 alkyl substituted benzyl, C 1-6 Any one of alkoxy groups, more preferably any one of a C 1-6 alkyl group, a phenyl group, and a benzyl group.
  • M 19 and M 20 are each independently an oxygen atom or a sulfur atom, and in the same molecule, the two may be the same or different from each other.
  • M 15 is a hetero atom selected from an oxygen atom, a sulfur atom, and a nitrogen atom; PG 9 is a protecting group corresponding to M 15 , and deprotection occurs under the action of acid basicity, enzyme, redox, light, temperature; When M 15 is O, PG 9 corresponds to the hydroxy protecting group PG 4 , when M 15 is S, PG 9 corresponds to the thiol protecting group PG 2 , and when M 15 is N, PG 9 corresponds to the amino protecting group PG 5 .
  • n 7 is the number of double bonds selected from a natural number of 0 or 1-10. among them, It is a cyclic structure that can be degraded into at least two separate fragments. As an example, for example, a lactide ring.
  • R 3 is selected from methyl, ethyl or benzyl.
  • the definitions of M 15 , PG 9 , M 19 , M 20 , and n 7 are the same as those described above, and are not described herein again.
  • DEGG also includes combinations of any of the above-described degradable divalent linking groups with any suitable stable divalent linking group.
  • r1 and r2 are each independently 0 or 1.
  • R 5 , R 6 , R 7 , and Q are consistent with the above, and are not described herein again.
  • degradable divalent linking group containing an aromatic ring it can also be derived from an aromatic ring (such as ) combined with a degradable divalent linking group, for example:
  • the degradable trivalent or tetravalent or higher valent group needs to contain at least one degradable divalent linking group DEGG.
  • degradable trivalent groups including but not limited to a stable trivalent group containing a trivalent nuclear structure and a degradable divalent linking group, a trivalent aromatic ring and a degradable divalent linking group a group, a combination of a degradable trivalent ring structure and a stable divalent linking group, a combination of a degradable trivalent ring structure and a degradable divalent linking group, and any of the above degradable divalent groups
  • the trivalent form of the linker refers to a trivalent cyclic structure which is degradable into at least two independent fragments. It may be a trivalent closed ring structure in which two or more degradable groups are connected in series.
  • a cyclic peptide such as a cyclic structure in which two or more ester bonds are connected in series.
  • the degradable trivalent group U may be composed of a trivalent aromatic ring and a degradable divalent linking group, or a combination of a degradable trivalent ring structure and a divalent linking group which may be stably present or degradable. It may also be a trivalent form of any of the above-described degradable divalent linking groups.
  • the degradable U composed of a degradable divalent linking group can be exemplified as follows:
  • the degradable trivalent ring structure refers to a trivalent cyclic structure which is degradable into at least two independent fragments. It may be a trivalent closed ring structure in which two or more degradable groups are connected in series.
  • a cyclic peptide such as a cyclic structure in which two or more ester bonds are connected in series.
  • the trivalent form of the above degradable divalent linking group can be exemplified as follows:
  • the definitions of M 19 , M 20 , M 15 , PG 9 , and n 7 are the same as those described above, and are not described herein again.
  • U 01 and U 02 each independently preferably contain any of the following structures:
  • U 01 and U 02 are further independently independently contained in the above structure, and are selected from one, two or three identical or different divalent linking groups selected from the group consisting of an oxy group, a thio group, a secondary amino group, a divalent tertiary amino group and a carbonyl group. Structure; when participating in an initiator molecule constituting living anionic polymerization, a structure containing no carbonyl group or secondary amino group is further preferred.
  • U 01 , U 02 may be selected from any of the following structures: Wait. When the initiator molecule constituting the living anionic polymerization is used, a structure containing no carbonyl group or secondary amino group is further preferred.
  • the definition of Q 5 is consistent with the above.
  • the branching groups U 01 and U 02 are each independently optimized
  • U 01 and U 02 may each independently be selected from a trivalent skeleton structure of an amino acid or a derivative thereof, but are not involved in an initiator molecule constituting living anionic polymerization; wherein the amino acid is an L -form or a D -form.
  • the amino acid may be derived from, but not limited to, the following amino acids or derivatives thereof: hydroxyl or sulfur containing amino acids and derivatives thereof: serine, threonine, cysteine, tyrosine, hydroxyproline; Amino acids and their derivatives: aspartic acid, glutamic acid, asparagine, glutamine; basic amino acids and their derivatives: lysine, arginine, citrulline, histidine, tryptophan .
  • the branching groups U 1 and U 2 are each independently include, but are not limited to:
  • Q 5 is a H atom, a methyl group, an ethyl group or a propyl group; and R 28 is a methyl group, an isopropyl group or an isobutyl group.
  • the branching groups U 1 and U 2 are each independently preferably
  • G is not particularly limited, and each independently includes, but is not limited to, a branched, a ring-containing structure, a comb, a tree, a hyperbranched, and the like. G is degradable or stable.
  • L 0 is a divalent linking group linking the PEG segment to the terminal branching structure G, which may or may not be present. L 0 can be stably present or degradable. L 0 may be selected from any of the above STAG or DEGG.
  • the structural types of the terminal branching groups G may be the same or different. When they have the same structure type, for example, they are three-branched structures, or the same four-branched structure, or the same comb-like structure, or the same tree-like structure, or the same hyperbranched structure, or the same ring structure. In the case of the same type of structure, the structure of the end of the PEG chain is not completely consistent, and is mainly directed to a special structure such as a comb, a tree, a hyperbranched, or a ring.
  • the difference in valence state due to the inconsistent number of repeating units is allowed; for the hyperbranched structure, the number of branching units is not required to be strictly uniform, and each branching unit is allowed to be randomly connected. Therefore, in the same molecule, when the end of the PEG chain is a comb or hyperbranched structure, the terminal k may be unequal. For tree and ring structures, the structure is required to be completely consistent, and the corresponding k is also completely equal.
  • G is a trivalent group, including but not limited to the trivalent group in the above set G 3 , U 01 , U 02 , U 1 , U 2 .
  • (L 0 ) g0 -G preferably contains a structure selected from the group consisting of any of the above U 01 , U 02 , U 1 , U 2 , Any of the structures.
  • G is a tetravalent group, including but not limited to the tetravalent group in the above set G 4 ;
  • the tetravalent G preferably contains an atom CM 4 , an unsaturated bond CB 4 , a cyclic structure Any of the four-valent nuclear structures in CC 4 , or contain two trivalent nuclear structures.
  • (L 0 ) g0 -G further preferably contains any of the following structures:
  • the G of the k+1 valence includes, but is not limited to, the k+1 valent group in the above set G k+1 .
  • the G+1 valence G may contain one k+1 valence core structure, or may be directly linked or combined by 2 to k-1 3 to k valence low valence groups or one or more of two
  • the valence spacer L 10 is indirectly combined.
  • the low-valent groups of 3 to k valence may be the same or different, and their valence states may be the same or different.
  • the k+1 valence core structure when k ⁇ 4, when the k+1 valence core structure is contained, the k+1 valence core structure is preferably a ring structure.
  • L 10 may be the same or different from each other. The definition of L 10 is consistent with the above.
  • the G+1 (k ⁇ 4) valence G which is directly or indirectly combined, includes but is not limited to a comb combination mode, a tree combination mode, a branch combination mode, a hyperbranched combination release, and a ring Form combination, etc.
  • the plurality of lower-valent groups may be the same or different from each other, preferably by combining the same low-cost groups.
  • the basic unit of the polyvalent G constituting the dendritic structure is preferably a trivalent G or a tetravalent G.
  • the tree-like combination structure is for example Wait.
  • ng represents the algebra of the tree combination.
  • d represents an algebra of a dendritic combination, and d is preferably 2 to 6 generations, more preferably 2 to 5 generations, and most preferably 2, 3 or 4 generations.
  • M 9 is O, S or NX 10 , wherein the definition of X 10 is consistent with the above.
  • the basic unit of the polyvalent G constituting the branched or hyperbranched combination structure is preferably a trivalent G or a tetravalent G.
  • the preferred basic unit includes, but is not limited to, the above-described tree combination, and includes Wait.
  • the branched or hyperbranched combination structure differs from the above-described tree-like combination structure in that it is a hybrid combination of multivalent G and its low-cost form.
  • the low-cost form of the multivalent G for example Low price form
  • the basic unit of the polyvalent G constituting the comb-shaped combined structure is preferably trivalent G, tetravalent G or pentavalent G.
  • the basic units of the multivalent G of the combined structure include, but are not limited to, glycerin, pentaerythritol, substituted propylene oxide, substituted propylene oxide and carbon dioxide groups, acrylates and derivatives thereof, methacrylates and derivatives thereof,
  • the basic unit of the acetal structure (such as (1 ⁇ 6) ⁇ -D glucopyranoside), amino acid or thio group-containing amino acid and derivatives thereof, acidic amino acid and derivatives thereof, basic amino acid and derivatives thereof, and the like.
  • G may also be a D-glucopyranose unit through a ⁇ -1,6 glycosidic bond, an ⁇ -1,6 glycosidic bond, a ⁇ -1,4 glycosidic bond, an ⁇ -1,4 glycosidic bond, a ⁇ -1,3 glycoside
  • the repeating unit of the comb-like combination structure may also be a suitable trihydric alcohol, a suitable tetrahydric alcohol, an open-chain pentitol, an open-chain hexitol, and the corresponding raw materials are preferably other than the ether bond hydroxyl group.
  • the hydroxy group is in a protected form, such as glycerol, trishydroxyethylethane, trishydroxyethylpropane.
  • glycerol trishydroxyethylethane
  • trishydroxyethylpropane trishydroxyethylpropane.
  • n 5 , X 4 , and R 7 are as defined above, wherein X 4 is a hydrogen atom to which an oxy group is bonded, a hydroxy protecting group or a group LG 4 ; R 7 is a hydrogen atom to which an amino group is bonded, an amino protecting group or Group LG 5 .
  • the multivalent G of the cyclic combination is preferably a residue of a cyclic peptide or a derivative thereof, a residue of a cyclic monosaccharide or a derivative thereof, a cyclic polysaccharide or a derivative thereof (such as a functional derivative of a cyclodextrin) , the residue of 1,4,7-tri-tert-butoxycarbonyl-1,4,7,10-tetraazacyclododecane, 2-hydroxymethylpiperidine-3,4,5-three
  • G is a pentavalent group including, but not limited to, a pentavalent group in the above-described set G5.
  • the pentavalent G may include one pentavalent nuclear structure, one tetravalent nuclear structure and one trivalent nuclear structure, or three trivalent nuclear structures.
  • (L 0 ) g0 -G preferably contains any of the following structures:
  • a dendritic structure in which three trivalent Gs are directly or indirectly combined and a comb structure in which three trivalent Gs are directly or indirectly combined.
  • a comb-like structure in which three trivalent groups are directly combined including but not limited to a trimeric lysine skeleton, a trimeric glutamic acid skeleton, a trimeric aspartic acid skeleton, a trimeric glycerol skeleton, and the like, such as
  • a comb-like structure in which three trivalent groups are indirectly combined such as three lysines in which amino acids such as glycine and alanine are combined as a spacer.
  • G is a hexavalent group including, but not limited to, the hexavalent group in the above set G 6 .
  • Hexavalent G may include a hexavalent nuclear structure, a pentavalent nuclear structure and a trivalent nuclear structure, two tetravalent nuclear structures, one tetravalent nuclear structure and two trivalent nuclear structures, or 4 A trivalent nuclear structure.
  • (L 0 ) g0 -G preferably contains any of the following structures: a comb structure in which four trivalent Gs are directly or indirectly combined (for example, tetrameric glycerol, tetrameric lysine, tetrameric aspartic acid, Tetraglutamic acid, etc.), Wait.
  • the bio-related substance modified by the polyfunctionalized H-type polyethylene glycol derivative disclosed in the present invention may be a biologically related substance or a modified biologically related substance; the biologically related substance may be a naturally occurring organism
  • Related substances can also be synthetic bio-related substances.
  • the manner of obtaining the biologically relevant substance is not particularly limited, and includes, but is not limited to, natural extracts and derivatives thereof, degradation products of natural extracts, genetically recombinant products (molecular cloning products), chemical synthetic substances, and the like.
  • the hydrophilicity of the bio-related substance is not particularly limited, and may be hydrophilic or water-soluble, or may be hydrophobic or fat-soluble.
  • the biologically relevant substance may be a biologically related substance itself, or may be a dimer or a polymer thereof, a partial subunit or a fragment or the like.
  • the biologically relevant substance may be a biologically related substance itself, or a precursor, an activated state, a derivative, an isomer, a mutant, an analog, a mimetic, a polymorph, a pharmaceutically acceptable salt, Fusion proteins, chemically modified substances, genetically recombinant substances, etc., may also be corresponding agonists, activators, activators, inhibitors, antagonists, modulators, receptors, ligands or ligands, antibodies and fragments thereof, Action enzymes (such as kinases, hydrolases, lyases, oxygen reductases, isomerases, transferases, deaminase, deiminase, invertase, synthetase, etc.), enzyme substrates (such as coagulation cascade proteases) Substrate, etc.).
  • enzymes such as kinases, hydrolases, lyases, oxygen reductases, isomerases, transferases, deaminase, dei
  • Such derivatives include, but are not limited to, terpenoids, nucleosides, amino acids, and polypeptide derivatives.
  • the chemically modified product forming a new reactive group, and the modified product formed by additionally introducing a functional group, a reactive group, an amino acid or an amino acid derivative, a polypeptide, etc., are all chemically modified by a biologically relevant substance. substance.
  • the bio-related substance may also allow a target molecule, an appendage or a carrier to be bound thereto to form a modified organism before or after binding to the polyfunctionalized H-type polyethylene glycol.
  • Related substances or complex biologically relevant substances are all chemically modified by a biologically relevant substance.
  • the application fields of the above biological related substances are not particularly limited, including but not limited to medicine, regenerative medicine, tissue engineering, stem cell engineering, bioengineering, genetic engineering, polymer engineering, surface engineering, nano engineering, detection and diagnosis, chemical staining, fluorescence Marking, cosmetics, food, food additives, nutrients and other fields.
  • medical biological related substances including but not limited to drugs, drug carriers, medical devices, can be used for disease treatment and prevention, wound treatment, tissue repair and replacement, imaging diagnosis and the like.
  • related substances may also include: dye molecules for quantitative or semi-quantitative analysis; for example, fluorocarbon molecules that can be used for contrast diagnosis, blood substitutes, and the like; for example, antiparasitic drugs such as primaquine; It is used as a carrier for antidote, such as chelating agent ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA) and the like.
  • dye molecules for quantitative or semi-quantitative analysis for example, fluorocarbon molecules that can be used for contrast diagnosis, blood substitutes, and the like
  • antiparasitic drugs such as primaquine
  • It is used as a carrier for antidote, such as chelating agent ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA) and the like.
  • EDTA ethylenediaminetetraacetic acid
  • DTPA diethylenetriaminepentaacetic acid
  • a biologically relevant substance When a biologically relevant substance is used as a drug, there are no particular restrictions on the therapeutic field, including but not limited to drugs for treating cancer, tumor, liver disease, hepatitis, diabetes, gout, rheumatism, rheumatoid, senile dementia, cardiovascular diseases and the like.
  • anti-allergic drugs anti-infectives, antibiotics, antivirals, antifungals, vaccines, central nervous system inhibitors, central nervous system stimulants, psychotropic drugs, respiratory drugs, peripheral nervous system drugs, at synaptic junctions Drugs, smooth muscle active drugs, histaminative agents, antihistamines, blood and hematopoietic drugs, gastrointestinal drugs, steroids, cytostatics, and intestinal mites that act on point or neuroeffector junction sites
  • Agent antimalarial agent, antiprotozoal agent, antimicrobial agent, anti-inflammatory agent, immunosuppressant, Alzheimer's disease drug or compound, imaging agent, antidote, anticonvulsant, muscle relaxant, anti-inflammatory drug, Appetite suppressant, migraine treatment, muscle contraction, antimalarial, anti-vomiting agent / antiemetic, tracheal dilator, antithrombotic, anti-high Blood pressure drugs, antiarrhythmic drugs, antioxidants, anti-asthma drugs, diuretics, lipid regulator
  • typical anti-cancer or anti-tumor drugs include, but are not limited to, breast cancer, ovarian cancer, cervical cancer, uterine cancer, endometrial cancer, gastrointestinal cancer, intestinal cancer, metastatic colorectal cancer, rectal cancer, colon cancer, colorectal Cancer, gastric cancer, squamous cell carcinoma, laryngeal cancer, esophageal cancer, esophageal cancer, malignant tumor, lung cancer, small unit lung cancer (small cell lung cancer), non-small cell lung cancer, liver cancer, thyroid cancer, kidney cancer, cholangiocarcinoma, brain cancer , skin cancer, pancreatic cancer, prostate cancer, bladder cancer, testicular cancer, nasopharyngeal carcinoma, head and neck cancer, gallbladder and cholangiocarcinoma, retinal cancer, renal cell carcinoma, gallbladder adenocarcinoma, multidrug resistant cancer, melanoma, Lymphoma, non-Hodgkin's lymphoma,
  • “Pharmaceutical” as used in the present invention includes any agent, compound, composition or mixture that provides a physiological or pharmacological effect in vivo or in vitro, and often provides a beneficial effect.
  • the type thereof is not particularly limited and includes, but not limited to, drugs, vaccines, antibodies, vitamins, foods, food additives, nutrients, nutraceuticals, and other agents that provide a beneficial effect.
  • the range in which the "drug” produces a physiological or pharmacological action in the body is not particularly limited, and may be a systemic effect or may be produced only locally.
  • the activity of the "drug” is not particularly limited, and may be an active substance that can interact with other substances, or an inert substance that does not interact; but an inert drug can be converted into an active form by in vivo action or certain stimulation. .
  • the kind of the biologically relevant substance is not particularly limited, and includes but is not limited to the following substances: drugs, proteins, polypeptides, oligopeptides, protein mimetics, fragments and analogs, enzymes, antigens, antibodies and fragments thereof, receptors, small molecules Drugs, nucleosides, nucleotides, oligonucleotides, antisense oligonucleotides, polynucleotides, nucleic acids, aptamers, polysaccharides, proteoglycans, glycoproteins, steroids, terpenoids, lipids, hormones , vitamins, vesicles, liposomes, phospholipids, glycolipids, dyes, fluorescent substances, targeting factors, cytokines, neurotransmitters, extracellular matrix substances, plant or animal extracts, viruses, vaccines, cells, vesicles , micelles, etc.
  • drugs drugs, proteins, polypeptides, oligopeptides, protein mimetics, fragments and analog
  • bio-related substances are classified and enumerated as follows.
  • a biologically relevant substance can occur in one or more of the following categories.
  • Protein is the foundation of life.
  • the proteins and polypeptides which can be modified are not particularly limited, and specific examples are as follows:
  • Hormones such as growth hormone, growth hormone releasing hormone, luteinizing hormone, luteinizing hormone releasing hormone, pituitary hormone, thyroid hormone, androgen, estrogen, adrenaline, amylin, gonadotropin, follicle stimulating hormone, thyroid Gland hormone, thymosin (such as thymosin ⁇ 1, thymosin ⁇ , thymosin ⁇ 4, thymosin ⁇ 9, thymosin ⁇ 10, thymosin ⁇ 1, thymosin iib/iiia, etc.), 1-dihydrotestosterone, glucocorticoid, antibiotic Diuretic hormone, small stimulator, bicalutamide, diethylstilbestrol, etc.;

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une substance d'origine biologique modifiée par un dérivé du polyéthylèneglycol multifonctionnalisé (formule 1). Ladite substance présente une structure en forme de H et comprend une partie centrale LPEG linéaire et quatre chaînes PEG ramifiées, dans laquelle n1, n2, n3 et n4 sont respectivement les degrés de polymérisation des chaînes ramifiées, U1 et U2 sont des groupes de ramification trivalents reliant le LPEG à deux chaînes PEG ramifiée, F1 et F2 contiennent un groupe fonctionnel ou une de ses formes protégées R01, et le nombre de R01 est au moins un. N'importe lequel d'un groupe de liaison dans la molécule ou n'importe quel groupe de liaison formé avec un groupe hétéroatomique adjacent peut soit rester stable, soit être dégradé; n'importe lequel d'un segment PEG dans la molécule possède, de manière distincte, une polydispersité ou une monodispersité. Diverses ou plusieurs substances d'origine biologique peuvent être modifiées par une molécule en forme de H, les produits modifiés sont flexibles dans une structure de ramification, procurent une charge élevée en médicament, une pharmacocinétique et une distribution tissulaire optimisables, et peuvent également porter deux substances d'origine biologique à fonctions différentes, ce qui permet d'obtenir une propriété de fluorescence ou une fonction de ciblage.
PCT/CN2015/091176 2014-10-01 2015-09-30 Substance d'origine biologique modifiée par un dérivé du polyéthylèneglycol multifonctionnalisé WO2016050208A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201410523242.9 2014-10-01
CN201410523242.9A CN104530413B (zh) 2014-10-01 2014-10-01 一种多官能化h型聚乙二醇衍生物修饰的生物相关物质
CN201510349134.9 2015-06-23
CN201510349134.9A CN104877127B (zh) 2015-06-23 2015-06-23 一种八臂聚乙二醇衍生物、制备方法及其修饰的生物相关物质

Publications (1)

Publication Number Publication Date
WO2016050208A1 true WO2016050208A1 (fr) 2016-04-07

Family

ID=55629447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/091176 WO2016050208A1 (fr) 2014-10-01 2015-09-30 Substance d'origine biologique modifiée par un dérivé du polyéthylèneglycol multifonctionnalisé

Country Status (1)

Country Link
WO (1) WO2016050208A1 (fr)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9732080B2 (en) 2006-11-03 2017-08-15 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
US10071979B2 (en) 2010-04-22 2018-09-11 Vertex Pharmaceuticals Incorporated Process of producing cycloalkylcarboxamido-indole compounds
US10081621B2 (en) 2010-03-25 2018-09-25 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
US10206877B2 (en) 2014-04-15 2019-02-19 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
CN111187339A (zh) * 2018-11-15 2020-05-22 江苏豪森药业集团有限公司 一种从发酵液中提取fr901379的方法
CN111471655A (zh) * 2020-03-19 2020-07-31 浙江正熙生物医药有限公司 抗人il12/23稳转细胞株及其构建方法和应用
CN111908626A (zh) * 2020-06-03 2020-11-10 山东省食品发酵工业研究设计院 高适配性绿色阻垢剂生产方法及其复合阻垢剂
CN112903854A (zh) * 2021-01-22 2021-06-04 武汉赛尔夫科技有限公司 利用高效液相色谱仪检测非那雄胺中异构体杂质的方法
CN113899831A (zh) * 2021-10-11 2022-01-07 湖北科益药业股份有限公司 一种枸橼酸托法替布起始物料的液相色谱检测方法
CN114209881A (zh) * 2021-12-15 2022-03-22 江苏独步生物科技有限公司 一种功能生物材料及其制备方法和应用
US11324827B2 (en) 2014-10-01 2022-05-10 Xiamen Sinopeg Biotech Co., Ltd. Multifunctionalized polyethylene glycol derivative and preparation method therefor
CN114524943A (zh) * 2022-04-22 2022-05-24 天津凯莱英制药有限公司 聚乙二醇-甘油衍生物及其中间体各自的制备方法
CN114716662A (zh) * 2021-01-06 2022-07-08 北京键凯科技股份有限公司 一种丙烯酸及其衍生物官能化的水溶性聚合物及其应用
CN114965761A (zh) * 2022-05-17 2022-08-30 深圳赛保尔生物药业有限公司 聚乙二醇化蛋白药物中n-羟基琥珀酰亚胺的检测方法
CN115089590A (zh) * 2022-06-13 2022-09-23 同济大学 环戊基三唑嘧啶类药物作为药物成分在肝炎药物中的应用
CN115245514A (zh) * 2021-04-28 2022-10-28 上海市胸科医院 一种治疗非小细胞肺癌的药物组合物
CN117487813A (zh) * 2023-12-19 2024-02-02 江南大学 特异性识别阿奇霉素的单链dna适配体序列及其应用
CN117589905A (zh) * 2023-11-21 2024-02-23 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种可作为胃癌诊断标志物的脂质代谢物组合及其应用
CN117487813B (zh) * 2023-12-19 2024-06-07 江南大学 特异性识别阿奇霉素的单链dna适配体序列及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011123031A1 (fr) * 2010-03-30 2011-10-06 Spago Imaging Ab Dérivés de polyéthylèneglycol ramifiés compacts
WO2012158622A2 (fr) * 2011-05-13 2012-11-22 The Regents Of The University Of California Systèmes micellaires réticulés de façon réversible
WO2013147015A1 (fr) * 2012-03-30 2013-10-03 日油株式会社 Dérivé de polyéthylène glycol multi-bras, intermédiaire de celui-ci et son procédé de fabrication
CN103881084A (zh) * 2014-03-14 2014-06-25 厦门赛诺邦格生物科技有限公司 一种支化聚乙二醇的磷脂类衍生物及其组成的脂质膜结构体
CN104530417A (zh) * 2014-10-01 2015-04-22 厦门赛诺邦格生物科技有限公司 一种多官能化h型聚乙二醇衍生物及其制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011123031A1 (fr) * 2010-03-30 2011-10-06 Spago Imaging Ab Dérivés de polyéthylèneglycol ramifiés compacts
WO2012158622A2 (fr) * 2011-05-13 2012-11-22 The Regents Of The University Of California Systèmes micellaires réticulés de façon réversible
WO2013147015A1 (fr) * 2012-03-30 2013-10-03 日油株式会社 Dérivé de polyéthylène glycol multi-bras, intermédiaire de celui-ci et son procédé de fabrication
CN103881084A (zh) * 2014-03-14 2014-06-25 厦门赛诺邦格生物科技有限公司 一种支化聚乙二醇的磷脂类衍生物及其组成的脂质膜结构体
CN104530417A (zh) * 2014-10-01 2015-04-22 厦门赛诺邦格生物科技有限公司 一种多官能化h型聚乙二醇衍生物及其制备方法

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9732080B2 (en) 2006-11-03 2017-08-15 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
US10081621B2 (en) 2010-03-25 2018-09-25 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
US10071979B2 (en) 2010-04-22 2018-09-11 Vertex Pharmaceuticals Incorporated Process of producing cycloalkylcarboxamido-indole compounds
US10206877B2 (en) 2014-04-15 2019-02-19 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
US11324827B2 (en) 2014-10-01 2022-05-10 Xiamen Sinopeg Biotech Co., Ltd. Multifunctionalized polyethylene glycol derivative and preparation method therefor
CN111187339A (zh) * 2018-11-15 2020-05-22 江苏豪森药业集团有限公司 一种从发酵液中提取fr901379的方法
CN111187339B (zh) * 2018-11-15 2023-12-01 江苏豪森药业集团有限公司 一种从发酵液中提取fr901379的方法
CN111471655A (zh) * 2020-03-19 2020-07-31 浙江正熙生物医药有限公司 抗人il12/23稳转细胞株及其构建方法和应用
CN111908626A (zh) * 2020-06-03 2020-11-10 山东省食品发酵工业研究设计院 高适配性绿色阻垢剂生产方法及其复合阻垢剂
CN111908626B (zh) * 2020-06-03 2023-05-12 山东省食品发酵工业研究设计院 高适配性绿色阻垢剂生产方法及其复合阻垢剂
CN114716662A (zh) * 2021-01-06 2022-07-08 北京键凯科技股份有限公司 一种丙烯酸及其衍生物官能化的水溶性聚合物及其应用
CN112903854A (zh) * 2021-01-22 2021-06-04 武汉赛尔夫科技有限公司 利用高效液相色谱仪检测非那雄胺中异构体杂质的方法
CN115245514A (zh) * 2021-04-28 2022-10-28 上海市胸科医院 一种治疗非小细胞肺癌的药物组合物
CN113899831B (zh) * 2021-10-11 2023-08-15 湖北科益药业股份有限公司 一种枸橼酸托法替布起始物料的液相色谱检测方法
CN113899831A (zh) * 2021-10-11 2022-01-07 湖北科益药业股份有限公司 一种枸橼酸托法替布起始物料的液相色谱检测方法
CN114209881A (zh) * 2021-12-15 2022-03-22 江苏独步生物科技有限公司 一种功能生物材料及其制备方法和应用
CN114524943A (zh) * 2022-04-22 2022-05-24 天津凯莱英制药有限公司 聚乙二醇-甘油衍生物及其中间体各自的制备方法
CN114965761A (zh) * 2022-05-17 2022-08-30 深圳赛保尔生物药业有限公司 聚乙二醇化蛋白药物中n-羟基琥珀酰亚胺的检测方法
CN115089590A (zh) * 2022-06-13 2022-09-23 同济大学 环戊基三唑嘧啶类药物作为药物成分在肝炎药物中的应用
CN115089590B (zh) * 2022-06-13 2023-05-12 同济大学 环戊基三唑嘧啶类药物作为药物成分在肝炎药物中的应用
CN117589905A (zh) * 2023-11-21 2024-02-23 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种可作为胃癌诊断标志物的脂质代谢物组合及其应用
CN117589905B (zh) * 2023-11-21 2024-04-26 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种可作为胃癌诊断标志物的脂质代谢物组合及其应用
CN117487813A (zh) * 2023-12-19 2024-02-02 江南大学 特异性识别阿奇霉素的单链dna适配体序列及其应用
CN117487813B (zh) * 2023-12-19 2024-06-07 江南大学 特异性识别阿奇霉素的单链dna适配体序列及其应用

Similar Documents

Publication Publication Date Title
WO2016050208A1 (fr) Substance d'origine biologique modifiée par un dérivé du polyéthylèneglycol multifonctionnalisé
CN104530413B (zh) 一种多官能化h型聚乙二醇衍生物修饰的生物相关物质
CN104725628B (zh) 一种含可降解基团的单一官能化支化聚乙二醇、制备方法及其生物相关物质
CN104530415A (zh) 一种异官能化y型聚乙二醇衍生物、制备方法及其生物相关物质
WO2016050209A1 (fr) Dérivé de polyéthylèneglycol hétérofonctionalisé, procédé de préparation et substance d'origine biologique
US20220105191A1 (en) Bioorthogonal compositions
US11433136B2 (en) Polyacetal polymers, conjugates, particles and uses thereof
WO2016050210A1 (fr) Dérivé de polyéthylène glycol multifonctionnalisé et son procédé de préparation
CN104530417B (zh) 一种多官能化h型聚乙二醇衍生物及其制备方法
TWI597065B (zh) 蛋白質－聚合物－藥物共軛體
CA3236754A1 (fr) Conjugaison specifique pour un conjugue anticorps-medicament
JP7174757B2 (ja) 切断可能なリンカーを含む化合物及びその使用
CA3085634C (fr) Conjugue d'un analogue de tubulysine avec des lieurs ramifies
TW202108179A (zh) 細胞毒性劑經由支鏈連接子與細胞結合分子的偶聯物
EP3606559B1 (fr) Compositions bio-orthogonales
NZ752394A (en) Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers
CA3013412A1 (fr) Lieurs de conjugaison specifique, immunoconjugues specifiques de ceux-ci, procedes de fabrication et utilisations desdits conjugues de ceux-ci
CN109803687A (zh) 纳米载体向肿瘤的抗体介导的自催化靶向递送
US20210386864A1 (en) Cytostatic conjugates with integrin ligands
CA3163886A1 (fr) Compositions de dendrimeres et methodes d'administration de medicament
CN112334127A (zh) 生物响应水凝胶基质及使用方法
WO2023122599A1 (fr) Dendrimères glycosylés pour une administration intracellulaire ciblée
BR112021012365A2 (pt) Compostos que compreendem ligante clivável e usos dos mesmos
JPWO2020094471A5 (fr)
KR20240046744A (ko) 면역 불내성의 감소 및 자가면역 장애의 치료를 위한 조성물 및 방법

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15846747

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15846747

Country of ref document: EP

Kind code of ref document: A1